Цимбалюк В.І. Національна академія медичних наук України, Київ, Україна

 https://orcid.org/0000-0001-7544-6603

Вадзюк С.Н. Тернопільський національний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна

 https://orcid.org/0000-0001-9105-8205

Толокова Т.І. Тернопільський національний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-8944-8685

Паньків І.Б. Тернопільський національний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна

 https://orcid.org/0000-0001-8458-7213 

1. Moiseienko RA, Mokretsov SY, Dudina OO, Kryzyna NP. [Reproductive health of the population of Ukraine as the main criterion for the effectiveness of socio-economic policy]. Zdorovia natsii. 2012;2(3):86-91. Ukrainian. Available from: http://nbuv.gov.ua/UJRN/Uzn_2012_2-3_17
2. Joshua P Vogel, Saifon Chawanpaiboon, Ann-Beth Moller, Kanokwaroon Watananirun, Mercedes Bo­net, Pisake Lumbiganon. The global epidemiology of pre­term birth. Best Practice & Research Clinical Obstetrics & Gynaecology. 2018;52:3-12. doi: https://doi.org/10.1016/j.bpobgyn.2018.04.003
3. Sara McElroy, Sindana Ilango, Anna Dimitrova, Alexander Gershunov, Tarik Benmarhnia. Extreme heat, preterm birth, and stillbirth: A global analysis across 14 lower-middle income countries. Environment Interna­tional.2022;158:106902. doi: https://doi.org/10.1016/j.envint.2021.106902
4. Dalugoda Y, Kuppa J, Phung H, Rutherford S, Phung D. Effect of Elevated Ambient Temperature on Maternal, Foetal, and Neonatal Outcomes: A Scoping Review. International Journal of Environmental Research and Public Health. 2022;19(3):1771. doi: https://doi.org/10.3390/ijerph19031771
5. Blencowe H, Cousens S, Oestergaard M, Chou D, Moller AB, Narwal R, et al. National, regional and world­wide estimates of preterm birth. The Lancet. 2012 June 9;379(9832):2162-72. doi: https://doi.org/10.1016/S0140-6736(12)60820-4
6. Radzinskii VE. [Premature birth and prospects for the use of progesterone for their prevention]. Health of woman. 2013;(3):96-98. Available from: http://nbuv.gov.ua/UJRN/Zdzh_2013_3_22
7. Lakatosh VP, Narytnyk TT, Bila VV, Akso­no­va AV, Tkalich VO. [Premature birth: contradictions and modern realities]. Health of woman. 2014;7(93):10-18. Ukrainian. Available from: http://nbuv.gov.ua/UJRN/Zdzh_2014_7_3
8. Young N, Dugas E. Representations of Climate Change in Canadian National Print Media: The Banalization of Global Warming / Canadian Review of   Sociology / Revue canadienne de sociologie. 2011 Feb. 01;48:1-22.
   doi: https://doi.org/10.1111/j.1755-618X.2011.01247.x
9. Masson-Delmotte V, Zhai P, Pörtner H-O, Ro­berts D, Skea J, Shukla PR, et al. An IPCC Special Report on the impacts of global warming of 1.5°C above pre-industrial levels and related global greenhouse gas emission pathways, in the context of strengthening the global response to the threat of climate change, sustainable development, and ef­forts to eradicate poverty. Waterfield T, editor. Intergovern­mental Panel on Climate Change; 2019. Available from:https://report.ipcc.ch/sr15/pdf/sr15_spm_final.pdf
10. Jeremiah Bohr. Reporting on climate change: A computational analysis of U.S. newspapers and sources of bias, 1997-2017. Global Environmental Change. 2020 march;61:102038. doi: https://doi.org/10.1016/j.gloenvcha.2020.102038
11. Potts M, Henderson CE. Global warming and reproductive health. International Journal of Gynecology and Obstetrics. 2012;119:S64-S67. doi: https://doi.org/10.1016/j.ijgo.2012.03.020
12. Masson-Delmotte V, Zhai P, Pörtner HO, Ro­berts D, Skea J, Shukla PR, et al. An IPCC Special Report on the impacts of global warming of 1.5°C above pre-industrial levels and related global greenhouse gas emission pathways, in the context of strengthening the global response to the threat of climate change, sustainable development, and efforts to eradicate poverty. In Press: Intergovernmental Panel on Climate Change [Internet]; 2019 [cited 2022 May 27]. Available from: https://www.ipcc.ch/report/ar6/wg2/
13. Holovatch YV. [The whole is more than the sum of the parts]. Visnyk of the National Academy of Sciences of Ukraine. 2021;12:18-26. doi: https://doi.org/10.15407/visn2021.12.018
14. Masson-Delmotte V, Zhai P, Pirani A, Con­nors SL, Péan C, Berger S, et al, editors. IPCC, 2021: Climate Change 2021: The Physical Science Basis. Contribution of Working Group I to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change [Internet]. In Press: Cambridge University Press.; 2021 [cited 2022 May 27]. Available from: https://www.ipcc.ch/report/ar6/wg1/
15. Szopa S, Naik V, Adhikary B, ArtaxoP, Bernt­sen T, Collins WD, et al. 2021: Short-Lived Climate Forcers. In Climate Change 2021: The Physical Science Basis. Contribution of Working Group I to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change. Masson-Delmotte V, Zhai P, Pirani A, Connors SL, Péan C, Berger S, et al, editors. In Press: Cambridge University Press; Available from: https://www.ipcc.ch/report/ar6/wg1/downloads/report/IPCC_AR6_WGI_Full_Report.pdf
16. gov.ua [Internet]. 2021 [cited 2022 May 27]. Available from: https://meteo.gov.ua/ua/33345/zmi/articles/read/61
17. [On the approval of the Implementation Concept state policy in the field of change climate for the period until 2030]. Order of 2016, Pub. No. 932. (Dec. 7, 2016). Ukrainian. Available from: https://www.kmu.gov.ua/npas/249573705
18. ua [Internet]. [The European Parliament has declared a climate emergency]; 2019 [cited 2022 May 20]. Available from: https://www.rbc.ua/ukr/news/evroparlament-obyavil-klimaticheskoe-chrezvychaynoe-1574945815.html
19. ipcc.ch [Internet]. Geneva: Climate Change 2007: Synthesis Report. World Meteorological Organization; 2007 [cited 2022 May 20]. Available from: http://www.ipcc.ch/pdf/assessment-report/ar4/syr/ar4_syr.pdf
20. Menezo Y, Dale B, Elder K. The negative impact of the environment on methylation/epigenetic marking in gametes and embryos: A plea for action to protect the fertility of future generations. Mol Reprod Dev. 2019;86:1273-82. doi: https://doi.org/10.1002/mrd.23116
21. Taha Z, Hassan Ahmed A, Wikkeling-Scott L, Papandreou D. Factors Associated with preterm birth and Low Birth Weight in Abu Dhabi, the United Arab EmiratesInt. J. Environ. Res. Public Health 2020;17:1382. doi: https://doi.org/10.3390/ijerph17041382
22. Wang Q, Zhang H, Huang C. Chapter 12 - Air pollution, climate change, and reproductive health in China. In: Meng Gao, Zifa Wang, Gregory Carmichael, editors. Air Pollution, Climate, and Health. Elsevier; 2021. p. 249-71. doi: https://doi.org/10.1016/B978-0-12-820123-7.00020-6
23. Barreca A, Schaller J. The impact of high ambient temperatures on delivery timing and gestational lengths. Nat. Chang. 2020;10:77-82. doi: https://doi.org/10.1038/s41558-019-0632-4
24. ua [Internet]. [Climate change negatively affects childbirth – scientists]. 2019 [cited 2022 Jun 20]. Ukrainian.Available from: https://tsn.ua/nauka_it/zmina-klimatu-negativno-vplivaye-na-pologi-vcheni-1453239.html
25. Shanshan Lia, Gongbo Chena, Jouni J K Jaak­kolab, Gail Williamsc, Yuming Guoa. Temporal change in the impacts of ambient temperature on preterm birth and stillbirth: Brisbane, 1994-2013. Science of the Total Environment. 2018;634:579-85 doi: https://doi.org/10.1016/j.scitotenv.2018.03.385
26. Avalos LA, Chen H, Li DK, Basu R. The impact of high apparent temperature on spontaneous preterm delivery: a case-crossover study. Environ Health. 2017;16(5). doi: https://doi.org/10.1186/s12940-017-0209-5
27. Tansey EA, Johnson CD. Recent advances in thermoregulation. Adv Physiol Educ. 2015;39:139-48. doi: https://doi.org/10.1152/advan.00126.2014
28. Eiden LE, Gundlach AL, Grinevich V, Lee MR, Mecawi AS, Chen D, et al. Regulatory peptides and systems biology: A new era of translational and reverse-translational neuroendocrinology. Journal of Neuroen­docrinology. 2020;32(5):e12844. doi: https://doi.org/10.1111/jne.12844
29. Strand LB, Barnett AG, Tong S. Maternal expo­sure to ambient temperature and the risks of preterm birth and stillbirth in Brisbane, Australia. Am. J. Epidemiol. 2012;175:99-107. doi: https://doi.org/10.1093/aje/kwr404
30. Patil AS, Gaikwad NW, Grotegut CA, Dow­den SD, Haas DM. Alterations in endogenous proges­terone meta­bolism associated with spontaneous very preterm delivery. Human Reproduction Open. 2020;2020(2):1-10. doi: https://doi.org/10.1093/hropen/hoaa007
31. Gabbe SG, Niebil JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. Phila­delphia: Churchill Livingstone, Elsevier. 2007. ISBN: 9780443069307, ISBN: 0443069301.
32. Guo T, Wang Y, Zhang H, Zhang Y, ZhaoJ, Wang Y, et al. The association between ambient tempe­rature and the risk of preterm birth in China. Science of the Total Environment. 2018;613-614:439-46. doi: https://doi.org/10.1016/j.scitotenv.2017.09.104
33. ZhangY, Yu C, Wang L. Temperature exposure during pregnancy and birth outcomes: An updated syste­matic review of epidemiological evidence. Environmental Pollution. 2017 June;225:700-12 doi: https://doi.org/10.1016/j.envpol.2017.02.066
34. Tsymbaliuk V, VadziukS, Tolokova T, Tabas  Prevalence of premature birth in conditions of global warming. Medicni perspektivi. 2021 Sep 30;26(3):152-61. doi: https://doi.org/10.26641/2307-0404.2021.3.242167
35. An R, Ji M, Zhang S. Global warming and obe­sity: a systematic review. Obesity Etiology/Public2018 Feb;19(2):150-63. doi: https://doi.org/10.1111/obr.12624
36. Metwally M, Li TC, Ledger WL. The impact of obesity on female reproductive function. Complications of Obesity. 2007 Nov;8(6):515-23. doi: https://doi.org/10.1111/j.1467-789X.2007.00406.x
37. Larsen EC, Christiansen OB, Kolte AM, Mack­lon N. New insights into mechanisms behind miscarriage. BMC Med. 2013;11:154. doi: https://doi.org/10.1186/1741-7015-11-154
38. Frey HA, Klebanoff MA. The epidemiology, etio­logy, and costs of preterm birth.Semin. Fetal Neonatal Med. 2016;21(2):68-73. doi: https://doi.org/10.1016/j.siny.2015.12.011
39. Vogel JP, Chawanpaiboon S, Moller AB, Wata­nanirum K, Bonet M, Lumbiganon P. The global epidemiology of preterm birth. Best Practice & Research Clinical Obstetrics and Gynaecology. 2018 Oct;52:3-12. doi: https://doi.org/10.1016/j.bpobgyn.2018.04.003
40. Barreca A, Schaller J. The impact of high ambient temperatures on delivery timing and gestational lengths. NatureClimate Change, 2020 Jan;10:77-82. doi: https://doi.org/10.1038/s41558-019-0632-4
41. Marushko RV, Dudina ОО. Modern aspects of perinatal mortality in Ukraine. Ukrainian Journal of Perinatology and Pediatrics. 2020;2(82):76-85. doi: https://doi.org/10.15574/PP.2020.82.76
42. Flouris AD, Spiropoulos Y, Sakellariou GJ, Kou­tedakis Y. Effect of seasonal programming on fetal development and longevity: Links with environmental temperature. American Journal of Human Biology. 2009;21(2):214-16. doi: https://doi.org/10.1002/ajhb.20818
43. Weng YH, Yang CY, Chiu YW. Adverse neona­tal outcomes in relation to ambient temperatures at birth: A nationwide survey in Taiwan. Archives of En­vironmental & Occupational Health. 2018;73(1):48-55. doi: https://doi.org/10.1080/19338244.2017.1299084
44. Stepanenko SM, Polovyi AM, Loboda NS. [Cli­mate change and their impact on the economy of Ukraine]. Stepanenko SM, Polovyi AM, editors. Odesa: TES; 2015. Ukrainian. Available from: http://eprints.library.odeku.edu.ua/id/eprint/2269
45. Johanzon M, Odesjo H, Jacobsson B, Sand­berg K, Wennerholm Ulla_Britt. Extreme Preterm Birth: Onset of Delivery and Its Effect on Infant Survival and Morbidity. Obstetrics & Gynecology. 2008;111(1):42-50. doi: https://doi.org/10.1097/01.AOG.0000295866.97499.35
46. Blencowe H, Cousens S, Oestergaard M, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. The Lancet. 2012 June;9;379(9832):2162-72. doi: https://doi.org/10.1016/S0140-6736(12)60820-4
47. Schifano P, Lallo A, Asta F, De Sario M, Davoli M, Michelozzi P. Effect of ambient temperature and air pollutants on the risk of preterm birth, Rome 2001-2010. Environ 2013;61:77-87. doi: https://doi.org/10.1016/j.envint.2013.09.005
48. Kent ST, McClure LA, Zaitchik BF, Smith TT, Gohlke JM. Heat waves and health outcomes in Alabama (USA): the importance of heat wave definition. Environ Health 2014;122(2):151-8. doi: https://doi.org/10.1289/ehp.1307262
49. Wyrobek AJ, Gordon LA, Burkhart JG, Fran­cis MW, Kapp RW, Letz G, et al. An evaluation of human sperm as indicators of chemically induced alterations of spermatogenic function: A report of the U.S. en­vironmental protection agency Gene-Tox program. Mutation Research/Reviews in Genetic Toxicology. 1983;115(1):73-148. ISSN 0165-1110. doi: https://doi.org/10.1016/0165-1110(83)90015-5
50. Niels E. Skakkebaek, Ewa Rajpert-De Meyts, Germaine M Buck Louis, Jorma Toppari, et al. Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility. Physiol Rev. 2016;96(1):55-97. doi: https://doi.org/10.1152/physrev.00017.2015
51. Kyung-Taek Rim. Reproductive Toxic Chemicals at Work and Efforts to Protect Workers' Health: A Literature Review. Safety and Health at Work. 2017 June;8(2):143-50. doi: https://doi.org/10.1016/j.shaw.2017.04.003
52. World Health Organization. Health topics: infer­tility. Geneva: Department of Reproductive Health and Research, WHO [Internet]; 2013. Available from: https://www.who.int/ 
    

Яворовський О.П. Національний медичний університет ім. О.О. Богомольця, Київ, Україна

 https://orcid.org/0000-0002-4573-8039

Зазуляк Т.С. Львівський національний медичний університет ім. Данила Галицького, Львів, Україна

 https://orcid.org/0000-0001-5896-0475

Остапів Д.Д. Інститут біології тварин НААН України, Львів, Україна

 https://orcid.org/0000-0001-8112-5398

Рябовол В.М. Національний медичний університет ім. О.О. Богомольця, Київ, Україна, 
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-1582-7188

Демецька О.В. Інститут медицини праці ім. Ю.І. Кундієва НАМН України, Київ, Україна

 https://orcid.org/0000-0002-8174-7813

1. Waghmode MS, Gunjal AB, Mulla JA, et al. Stu­dies on the titanium dioxide nanoparticles: biosyn­thesis, applications and remediation. SN Appl. Sci. 2019;1:310. doi: https://doi.org/10.1007/s42452-019-0337-3
2. Zahornyi M, Tyschenko N, Shyrokov O, et al. The Effect of Ag Content on the Structural, Optical, and Cytotoxicity Properties of TiO2 Nanopowders Grown from TiO(OH)2 Precursor by the Chemical Deposition Method. Nanosistemi, Nanomateriali, Nanotehnologii. 2021;19(4):923-40. doi: https://doi.org/10.15407/nnn.19.04.923
3. Zahornyi MM, Yavorovsky OP, Riabovol VM, et al. [Morphological, spectral and toxicological features of new composite material of titanium nanodioxide with nanosilver for use in medicine and biology]. Medicni perspektivi. 2022;27(1):152-9. Ukrainian. doi: https://doi.org/10.26641/2307-0404.2022.1.254381
4. Pankivska YuB, Biliavska LO, Povnitsa OYu, et al. [Antiadenoviral activity of titanium dioxide nano­particles]. Mikrobiolohichnyi zhurnal. 2019;81(5):73-84. Ukrainian. doi: https://doi.org/10.15407/microbiolj81.05.073
5. Kermani SA, Salari S, Nejad Almani PG. Com­parison of antifungal and cytotoxicity activities of tita­niumdioxide and zinc oxide nanoparticles with ampho­tericin Bagainst different Candida species: In vitro evaluation. J Clin Lab Anal. 2021;35(1):e23577. doi: https://doi.org/10.1002/jcla.23577
6. de Dicastillo CL, Correa MG, Martínez FB, et al. Antimicrobial Effect of Titanium Dioxide Nanoparticles. In: Mareș M, Lim SHE, Lai K, Cristina R, editors. Anti­microbial Resistance – A One Health Perspective [Inter­net]. London: IntechOpen; 2020 [cited 2022 Jul 12]. doi: https://doi.org/10.5772/intechopen.90891
7. Riabovol VM, Kozar TI. [Investigation of acute toxic effects of nanopowders of titanium dioxide and its composites with nanosilver in laboratory mice. Ecological and hygienic problems of the sphere of human life]. Col­lection of materials of the scientific-practical confe­ren­ce with international participation; Kyiv; 2022. p. 160-2. Ukrainian.
8. Alaee S, Ilani M. Effect of Titanium Dioxide Na­noparticles on Male and Female Reproductive Systems. Journal of Advanced Medical Sciences and Applied Technologies. 2017;3(1):3-8. doi: https://doi.org/18869/nrip.jamsat.3.1.3
9. Guerreiro DD, Mbemya GT, Bruno JB, et al. In­vitro culture systems as an alternative for female repro­ductive toxicology studies. Zygote. 2019;27(2):55-63. doi: https://doi.org/10.1017/S0967199419000042
10. Demetska OV, Didenko MM, Movchan VO, et al. [Screening assessment of the damaging effect of nano­materials using bovine spermatozoa as a test object]. Pivdennoukrainskyi medychnyi naukovyi zhurnal. 2021;29:12-15. Ukrainian.
11. [Express method for determining the toxicity of nanomaterials in in vitro solutions using bovine sperma­tozoa as a test object]: pat. 101308 Ukraine. No. u201412531; appl. 19.12.2014; publ. 10.09.2015, bull. No. 17. 2 p. Ukrainian. Available from: http://www.medfoundation.od.ua/zhurnaly/29_2021.pdf
12. Vlizlo VV, Fedoruk RS, Ratych IB, et al. [Labo­ratory research methods in biology, animal husbandry and veterinary medicine]. Vlizlo VV, edotir. Lviv: Spolom; 2012. Ukrainian. ISBN 976-966-665-677-6.
13. Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. Кyiv: Med­inform. 2018. Russian.

 Фещенко Ю.І. ДУ “Національний інститут фтизіатрії і пульмонології ім. Ф.Г. Яновського НАМН України”, Київ, Україна

 https://orcid.org/0000-0002-8933-8811

Яшина Л.О. ДУ “Національний інститут фтизіатрії і пульмонології ім. Ф.Г. Яновського НАМН України”, Київ, Україна 

 https://orcid.org/0000-0002-4264-1207

Опімах С.Г. ДУ “Національний інститут фтизіатрії і пульмонології ім. Ф.Г. Яновського НАМН України”, Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 http://orcid.org/0000-0002-4631-2048

Гуменюк Г.Л. ДУ “Національний інститут фтизіатрії і пульмонології ім. Ф.Г. Яновського НАМН України”, Київ, Україна

 https://orcid.org/0000-0001-8160-7856

Ігнатьєва В.І. ДУ “Національний інститут фтизіатрії і пульмонології ім. Ф.Г. Яновського НАМН України”, Київ, Україна

 https://orcid.org/0000-0003-0604-4349

Полянська М.О. ДУ “Національний інститут фтизіатрії і пульмонології ім. Ф.Г. Яновського НАМН України”, Київ, Україна

 https://orcid.org/0000-0003-0305-7988

Зволь І.В. ДУ “Національний інститут фтизіатрії і пульмонології ім. Ф.Г. Яновського НАМН України”, Київ, Україна

 http://orcid.org/0000-0001-8533-2618

Москаленко С.М. ДУ “Національний інститут фтизіатрії і пульмонології ім. Ф.Г. Яновського НАМН України”, Київ, Україна

 http://orcid.org/0000-0002-0364-2047

1. Pertseva TA, Konopkina LI, Koval DS, Gu­ba YuV. [The processes of inflammation and fibrosis in patients with chronic obstructive pulmonary disease]. Medicni perspektivi. 2020;25(4):59-65. Ukrainian. doi: https://doi.org/10.26641/2307-0404.2020.4.221229
2. Feshchenko YuI, Golubovska OA, Dziub­lyk AYa, Gavrysyuk VK, Dziublyk YaA, Liskina IV. [Pulmonary disease in COVID-19]. Ukr Pulmonol J. 2021;1:5-14. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2021-29-1-5-14
3. Feshchenko YI, Lynnyk МІ, Gumeniuk МІ, Kala­bukha IA, Іgnatieva VІ, Gumeniuk GL, et al. [Diagnosis of disappearing lung syndrome as a complication of non-hospital pneumonia of viral etiology (COVID-19)]. Infusion & Chemotherapy. 2021;3:5-11. Ukrainian. doi: https://doi.org/10.32902/2663-0338-2021-3-5-11
4. Ambardar SR, Hightower SL, Huprikar NA, Chung KK, Singhal A, Collen JF. Post-COVID-19 Pul­monary Fibrosis: Novel Sequelae of the Current Pan­demic. Journal of Clinical Medicine. 2021;10(11):2452. doi: https://doi.org/10.3390/jcm10112452
5. Bellan M, Soddu D, Balbo PE, et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021;4(1):e2036142. doi: https://doi.org/10.1001/jamanetworkopen.2020.36142
6. Borczuk AC, Salvatore SP, Seshan SV, Patel SS, Bussel JB, et al. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol. 2020;33(11):2156-68. doi: https://doi.org/10.1038/s41379-020-00661-1
7. Chun HJ, Coutavas E, Pine A, et al. Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC). Preprint. medRxiv. 2021;2021.01.31.21250870. doi: https://doi.org/10.1101/2021.01.31.21250870
8. Fahriani M, Ilmawan M, Fajar JK, et al. Per­sistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis – A systematic review and meta-analysis. Narra J. 2021;1(2):e36. doi: http://doi.org/10.52225/narraj.v1i2.36
9. Faverio P, Luppi F, Rebora P, Busnelli S, Stai­ner A, et al. Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study. Respiration. 2021;100:1078-87. doi: https://doi.org/10.1159/000518141
10. Fogarty H, Townsend L, Morrin H, et al; the Irish COVID-19 Vasculopathy Study (iCVS) investigators. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546-3. doi: https://doi.org/10.1111/jth.15490
11. Grosse C, Grosse A, Salzer HJF, Dünser MW, Motz R, Langer R. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc Pathol. 2020;49:107263. doi: https://doi.org/10.1016/j.carpath.2020.107263
12. Jiang DH, Roy DJ, Gu BJ, Hassett LC, McCoy RG. Postacute Sequelae of Severe Acute Respiratory Synd­rome Coronavirus 2 Infection: A State-of-the-Art Review. J Am Coll Cardiol Basic Trans Science. 2021;9-10:796-811. doi: https://doi.org/10.1016/j.jacbts.2021.07.002
13. Konopka KE, Perry W, Huang T, Farver CF, Myers JL. Usual Interstitial Pneumonia is the Most Com­mon Finding in Surgical Lung Biopsies from Patients with Persistent Interstitial Lung Disease Following Infection with SARS-CoV-2. eCli­nicalMedicine; 2021. doi: https://doi.org/10.1016/j.eclinm.2021.101209
14. Lombardi F, Calabrese A, Iovene B. et al. Resi­dual respiratory impairment after COVID-19 pneumonia. BMC Pulm Med. 2021;21:241. doi: https://doi.org/10.1186/s12890-021-01594-4
15. Maltezou HC, Pavli A, Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021;9(5):497. doi: https://doi.org/10.3390/vaccines9050497
16. Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Interna­tional Journal of Immunopathology and Pharmacology. 2021;35:1-16. doi: https://doi.org/10.1177/20587384211048026
17. Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadel­mann ER, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5(5):1164-1177. doi: https://doi.org/10.1182/bloodadvances.2020003568
18. Mittal A, Sabharwal S, Foley R. Bullous lung disease complicating COVID-19 pneumonia. Chest. 2021;160(4):A908. doi: https://doi.org/10.1016/j.chest.2021.07.846
19. Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Ann Am Thorac Soc. 2021;18(5):799-806. doi: https://doi.org/10.1513/AnnalsATS.202008-1002OC
20. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-15. doi: https://doi.org/10.1038/s41591-021-01283-z
21. Pandey P, Agarwal S, Rajkumar. Lung pathology in COVID-19: A systematic review. Int J App Basic Med Res. 2020;10:226-3. doi: https://doi.org/10.4103/ijabmr.IJABMR_381_20
22. Rendeiro AF, Ravichandran H, Bram Y, et al. The spatial landscape of lung pathology during COVID-19 progression. Nature. 2021;593:564-9. doi: https://doi.org/10.1038/s41586-021-03475-6
23. Reno C, Sanmarchi F, Stoto MA, Fantini MP, Lenzi J, Golinelli D. The impact of health policies and vaccine rollout on the COVID-19 pandemic waves in Italy. Health Policy and Technology. 2022;100604. doi: https://doi.org/10.1016/j.hlpt.2022.100604
24. Salem AM, Al Khathlan N, Alharbi AF, Algha­mdi T, AlDuilej S, Alghamdi M, et al. The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors. Int J Gen Med. 2021;14:3271-80. doi: https://doi.org/10.2147/IJGM.S319436
25. Shah W, Hillman T, Playford ED, Hishmeh L. Mana­ging the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: https://doi.org/10.1136/bmj.n136
26. Siddiqui S, Brightling CE. Pathological disease in the lung periphery after acute COVID-19. Lancet Respir Med. 2021;9(10):1089-90. doi: https://doi.org/10.1016/S2213-2600(21)00378-7
27. Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of Post-Acute Lung Complications of COVID-19. Radiology. 2021;301(2):E383-95. doi: https://doi.org/10.1148/radiol.2021211396
28. Stockley JA, Alhuthail EA, Coney AM, et al. Lung function and breathing patterns in hospitalised COVID-19 survivors: a review of post-COVID-19 Clinics. Respir Res. 2021;22:255. doi: https://doi.org/10.1186/s12931-021-01834-5
29. Wild JM, Porter JC, Molyneaux PL, et al. Under­standing the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID). BMJ Open Respir Res. 2021;8(1):e001049. doi: https://doi.org/10.1136/bmjresp-2021-001049
30. Wu Q, Zhong L, Li H, Guo J, Li Y, et al. A Fol­low-Up Study of Lung Function and Chest Computed Tomography at 6 Months after Discharge in Patients with Coronavirus Disease 2019. Canadian Respiratory Journal. 2021;6692409. doi: https://doi.org/10.1155/2021/6692409
31. Zawbaa HM, Osama H, El-Gendy A, et al. Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease. J Med Virol. 2021;94:197-204. doi: https://doi.org/10.1002/jmv.27293
32. Zayet S, Zahra H, Royer P-Y, Tipirdamaz C, Mer­cier J, Gendrin V, et al. Post-COVID-19 Syndrome: Nine Mo­nths after SARS-CoV-2 Infection in a Cohort of 354 Pa­tients: Data from the First Wave of COVID-19 in Nord Fran­che-Comté Hospital, France. Microorganisms. 2021;9(8):1719. doi: https://doi.org/10.3390/microorganisms9081719
33. Zhang S, Bai W, Yue J, et al. Eight months fol­low-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors. Sci Rep. 2021;11:13854. doi: https://doi.org/10.1038/s41598-021-93191-y

Соколова K.В. Дніпровський державний медичний університет, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-5022-3227

Ставицький В.В. Дніпровський національний університет імені Олеся Гончара, Дніпро, Україна

 http://orcid.org/0000-0001-5897-5845

Коновалова С.О. Донбаська державна машинобудівна академія, Краматорськ, Україна

 http://orcid.org/0000-0003-3410-2550

Подплетня O.A. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0003-4113-4665

Коваленко С.І. Запорізький державний медичний університет, Запоріжжя, Україна

https://orcid.org/0000-0001-8017-9108

Aвдєєнкo A.П. Донбаська державна машинобудівна академія, Краматорськ, Україна

 http://orcid.org/0000-0003-0549-2131

1. Ellison DH. Clinical Pharmacology in Diuretic Use. Clinscal Journal of the Americal Society of Nephro­logy (CJASN). 2019;14(8):1248-57. doi: https://doi.org/10.2215/CJN.09630818
2. Supuran CT. How many carbonic anhydrase sin­hibition mechanisms exits? Jornal of Enzyme Inhibitoin and Medical Chemistry. 2016;31(3):345-60. doi: https://doi.org/10.3109/14756366.2015.1122001
3. Alterio V, Di Fiore A, D’Ambrosio K, Supu­ran CT, De Simone G. Multiple Binding Modes of Inhi­bitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms? Chemical Reviews. 2012;112(8):4421-68. doi: https://doi.org/10.1021/cr200176r
4. Mishra CB, Tiwari M, Supuran CT. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Med Res Rev. 2020:1‐81. doi: https://doi.org/10.1002/med.21713
5. Doretta Cuffaro, Elisa Nuti, Armando Rossello. An overview of carbohydrate-based carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2020;35(1):1906-22. doi: https://doi.org/1080/14756366.2020.1825409
6. Kumari D, Bansal H. Benzohydrazides: As poten­tial bio-active agents. The Pharma Innovation Journal. 2018;7(8):543-50. doi: https://doi.org/10.22271/tpi
7. de Oliveira Carneiro Brum Juliana, França Tanos CC, LaPlante Steven R, Villar José Daniel Figueroa. Syn­thesis and Biological Activity of Hydrazones and Deri­vatives: A Review. Mini Reviews in Medicinal Che­mistry. 2020;20(5):342-68. doi: https://doi.org/10.2174/1389557519666191014142448
8. Patil M, Bendre R. Synthesis, Characterization and Antioxidant Potency of Naturally Occurring Phenolic Monoterpenoids Based Hydrazide Motifs. Medicinal Chemistry. 2018;8(7):177-80. doi: https://doi.org/10.4172/2161-0444.1000509
9. Taha M, Shah SAA, Khan A, Arshad F, Is­mail NH, et al. Synthesis of 3,4,5-trihydroxyben­zohyd­razone and evaluation of their urease inhibition potential. Arabian Journal of Chemistry. 2019;12:2973-82. doi: http://doi.org/10.1016/j.arabjc.2015.06.036
10. Alisi IO, Uzairu A, Abechi SE. In silico design of hydrazone antioxidants and analysis of their free radical-scavenging mechanism by thermodynamic studies. Beni-Suef University Journal of Basic and Applied Sciences. 2019;8:11. doi: https://doi.org/10.1186/s43088-019-0011-2
11. Taha M, Sultan S, Herizal M, Fatmi MQ, Sel­varaj M, Ramasamy K, et al. Synthesis, anticancer, mole­cular docking and QSAR studies of benzoylhydrazone. Journal of Saudi Chemical Society. 2019;23:1168-79. doi: https://doi.org/10.1016/j.jscs.2019.07.007
12. Maniak H, Talma M, Matyja K, Trusek A, Giurg M. Synthesis and Structure-Activity Relationship Studies of Hydrazide-Hydrazones as Inhibitors of Laccase from Trametes versicolor. Molecules. 2020;25:1255. doi: https://doi.org/10.3390/molecules25051255
13. Martínez MJA, Benito PB. Biological Activity of Quinones. Studies in Natural Products Chemistry. 2005:303-66. doi: https://doi.org/10.1016/s1572-5995(05)80036-5
14. Madeo J Zubair А, Marianne F. A review on the role of quinones in renal disorders. SpringerPlus. 2013;2:139. Available from: http://www.springerplus.com/content/2/1/139
15. Bolton JL, Dunlap T. Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects. Chemical Research in Toxicology. 2016;30(1):13-37. doi: https://doi.org/10.1021/acs.chemrestox.6b00256
16. El-Najjar N, Gali-Muhtasib H, Ketola RA, Vuo­rela P, Urtti A, Vuorela H. The chemical and biological activities of quinones: overview and implications in analy­tical detection. Phytochemistry Reviews. 2011;10(3):353-70. doi: https://doi.org/10.1007/s11101-011-9209-1
17. org [Internet]. USA: Protein Data Bank; 2022 [cited 2022 Nov 6].Available from: http://www.rcsb.org/pdb/home/home
18. MarvinSketch version 20.20.0. ChemAxon. [In­ternet]. [cited 2022 Nov 6]. 
    Available from: http://www.chemaxon.com
19. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-61.
20. Discovery Studio Visualizer v19.1.018287. [Inter­net]. Accelrys Software Inc. 2022 [cited 2022 Nov 6]. Available from: https://www.3dsbiovia.com
21. ProTox-II – Prediction of Toxicity of Chemicals. [Internet]. 2021 [cited 2022 Nov 6]. Available from: https://tox-new.charite.de/protox_II/index.php?site=home
22. European convention for the protection of verte­brate animal used for experimental and other scientific purposes. Council of Europe, Strasbourg; 1986.
23. Bryukhanov VM, Zverev YuF, Lampatov VV, Zharikov AYu. [Methodological approaches to the study of kidney function in animal experiments]. Nefrologiia. 2009;13(3):52-62. Russian.
24. Stefanov OV. [Preclinical studies of drugs]. Kyiv: Avitsena; 2001. Ukrainian. Available from: https://cryo.net.ua/xmlui/bitstream/handle/123456789/77/Руководство%20Стефанов%2C%202001.pdf?sequence=1&isAllowed=y
25. Lapach SN, Chubenko AV, Babich PN. [Statis­tical methods in biomedical research using EXCEL]. Kyiv: Morion; 2000. Russian.
26. Breitmaier E. Structure Elucidation by NMR in Organic Chemistry: A Practical Guide’, Eberhard Breit­maier, 3rd Revised Edition, Wiley; 2002.

Іванов В.С. ДУ «Інститут стоматології та щелепно-лицевої хірургії Національної академії медичних наук України», Одеса, Україна

 https://orcid.org/0000-0002-0480-7368

Макаренко О.А. ДУ «Інститут стоматології та щелепно-лицевої хірургії Національної академії медичних наук України», Одеса, Україна

 https://orcid.org/0000-0001-8029-4392

Дєньга О.В. ДУ «Інститут стоматології та щелепно-лицевої хірургії Національної академії медичних наук України», Одеса, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-8630-9943

1. Zarubina IV [Modern ideas about the patho­genesis of hypoxia and its pharmacological correction]. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii. 2011;9(3):31-48. Russian.
2. Maksimov AL, Averjanova IV. [Informative value of the test with respiration to assess the resistance of the body of young men to the combined effects of hypoxia and hypercapnia]. Fiziologicheskii zhurnal im. IM Sechenova. 2017;103(9):1057-68. Russian.
3. Gridin LA. [Modern ideas about the physiological and therapeutic and prophylactic effects of hypoxia and hypercapnia]. Medicina. 2016;4(3):45-68. Russian. Available from: https://www.fsmj.ru/download/15/06.pdf
4. European convention for the protection of ver­tebrale animals used for experimental and other scientific purposes. [Internet]. Strasburg: Council of Europe; 1986 [cited 2022 Oct 20]. Available from: http://www.worldlii.org/int/other/treaties/COETSER/1986/1.html
5. [Order of the Ministry of Education and Science of Ukraine dated March 16, 2012, No. 249 "On the approval of the Procedure for carrying out experiments and experiments on animals by scientific institutions"]. (2012). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z0416-12#Text
6. Shnaider SA, Levitsky AP. [Experimental Den­tistry. Pt.1. Experimental models of dental diseases]. Odesa: KP «Odeska miska drukarnia»; 2017. Russian.
7. Tkachenko YeK, Nikolaeva AV, Novosels­kaya NG. [The effect of preparations of plant polyphenols and vitamin-mineral complex on the state of the intercellular matrix of the periodontium and the oral mucosa of rats with hypoestrogenism]. Visnyk stoma­tolohii. 2014;1(86):16-20. Russian. Available from: http://www.visnyk.od.ua/index.php/mainjournal/issue/view/13
8. Tsviakh OO. [The influence of stress on the state of the pro-oxidant-antioxidant system of the stomach of rats with a lack and excess of melatonin]. Visnyk problem biolohii i medytsyny. 2013;1(102):254-258. Ukrainian. Available from: http://www.irbis-nbuv.gov.ua/cgi-bin/irbis_nbuv/cgiirbis_64.exe?C21COM=2&I21DBN=UJRN&P21DBN=UJRN&IMAGE_FILE_DOWNLOAD=1&Image_file_name=PDF/Vpbm_2013_3(1)__57.pdf
9. Yelins’ka AM, Kostenko VO. [Mechanisms of diso­rganization of rat periodontal connective tissue under condi­tions of systemic inflammation]. Aktualni problemy suchas­noi medytsyny: Visnyk ukrainskoi medychnoi stomatolo­hichnoi akademii. 2018;1(61):175-7. Ukrainian. Available from: http://repository.pdmu.edu.ua/bitstream/123456789/11328/1/Mechanisms_of_connective_tissue_disruption.pdf
10. Granchuk A, Granchuk G, Gudumak VS. [Acti­vity of metabolic processes in the mandibular bone tissues of albino rats using zinc coordination compounds (experi­mental study, stage 1)]. Mezhdunarodnyi nauchno-issle­dovatelskii zhurnal. 2019;12-2(90):196-200. doi: https://doi.org/10.23670/IRJ.2019.90.12.041

Коваль Т.І. Полтавський державний медичний університет, Полтава, Україна

 http://orcid.org/0000-0003-2685-8665

Сизова Л.М. Полтавський державний медичний університет, Полтава, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 http://orcid.org/0000-0002-8335-3295

Прийменко Н.П. Полтавський державний медичний університет, Полтава, Україна

 https://orcid.org/0000-0002-8265-1143

Cидоренко А.Г. Полтавський державний медичний університет, Полтава, Україна

 https://orcid.org/0000-0002-9853-5892

Куліш М.В. Полтавський державний медичний університет, Полтава, Україна

 https://orcid.org/0000-0003-3226-7355

Ільченко В.І. Полтавський державний медичний університет, Полтава, Україна

 https://orcid.org/0000-0002-1451-442X

Лимаренко Н.П. Полтавський державний медичний університет, Полтава, Україна

 https://orcid.org/0000-0002-9858-8740

1. Dubynska GM, Koval TI, Sizova LM, Izyum­ska OM, Kotelevska TM, Svyrydenko NP, etal. [Analysis of antiviral therapy effectiveness for chronic hepatitis C patients in Poltava region]. Klinicheskaia infektologiia i para­zitologiia. 2016;5(4):440-48. Russian. Available from: http://repository.pdmu.edu.ua/bitstream/123456789/413/1/anails.pdf
2. Dmytiiev DV, Nazarchuk OA. [Modern views on the role of Toll-like receptors in immune and physio­lo­gi­cal homeostasis and pathology]. Aktualni Problemy Su­chasnoi Medytsyny: Visnyk Ukrainskoi medychnoi sto­matolohichnoi akademii. 2015;15,3(51):313-19. Ukrai­nian. Available from: https://cyberleninka.ru/article/n/suchasni-uyavlennya-pro-rol-toll-podibnih-retseptoriv-v-imunofiziologichnomu-gomeostazi-ta-pri-patologiyi/pdf
3. Lebedeva ОР, Qirko R. [Expression of Toll-like receptors in the female reproductive tract and its hormone regulation (review)]. Research Results in Biomedicine. 2018;4(3):3-17. doi: https://doi.org/10.18413/2313-8955-2018-4-3-0-1
4. Petrov RV, Haitov RM, Chereshnev VA. [Phy­siology of the immune system: cellular and molecular-biological mechanisms]. Vestnik RFFI. 2017;1:96-119. Russian.
5. Sizovа L, Koval T, Kaidashev I, Ilchenko V, Du­binskaya G. [The role of genetic polymorphisms Toll-like receptor 4 and 7 in the chronic hepatitis C and gender features of their distribution]. GMN. 2016;1(250):51-56. Russian.
6. Rudenko KA, Tuguz AR, Anokhina EN, Muzhe­nya DV. [Toll-like receptor gene polymorphisms, associated with a hereditary history and age of bronchial asthma manifestation]. Vestnik AGU. 2014;1(133):64-69. Russian. Available from: https://cyberleninka.ru/article/n/polimorfizmy-genov-toll-podobnyh-retseptorov-assotsiirovannye-s-nasledstvennoy-otyagoschennostyu-i-vozrastom-manifestatsii-1/viewer
7. Sizova LM. [Peculiarities of clinical and labora­tory characteristics of chronic hepatitis C in patients with polymorphism Asp299Gly of TLR4 gene and Gln11Leu of TLR7 gene]. Aktualni problemy suchasnoi medytsyny: Visnyk Ukrainskoi medychnoi stomatolohichnoi aka­demii. 2016;16.4(56).1:182-87. Ukrainian.
8. Chaiwiang N, Poyomtip T. The associations bet­ween Toll-like receptor 4 gene polymorphisms and hepatitis C virus infection: a systematic review and meta-analysis. Biosci Rep. 2019;39(2). doi: https://doi.org/10.1042/BSR20182470
9. Dubinskaya G, Sizova L, Koval Т, Kovalyova Е, Kaydashev I. Clinical and genetic predictors and prog­nostic model of rapidly progressive hepatic fibrosis in chronic hepatitis C. GMN. 2016; 7-8(256-257):37-45.
10. Nieto JC, Sánchez E, Román E, Vidal S, Oliva L, Guarner-Argente C, et al. Cytokine production in patients with cirrhosis and TLR4 polymorphisms. WJG. 2014;20(46):17516-524. doi: https://doi.org/10.3748/wjg.v20.i46.17516
11. David SP. Genomic and precision medicine: pri­mary care: Third Edition. London: Academic Press; 2017. doi: https://doi.org/10.1016/B978-0-12-800685-6.00001-1
12. Pettengill MA, van Haren SD, Li N, Dowling DJ, Bergelson I, Jans J, et al. Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naive B cells. Innate Immun. 2016;22(6):433-43. doi: https://doi.org/10.1177/1753425916651985
13. Dowling JK, Mansell A. Toll-like receptors: the swiss army knife of immunity and vaccine development. ClinTransl  2016;5(5). doi: https://doi.org/10.1038/cti.2016.22  
14. Emonts M. Polymorphisms in immune response genes in infectious diseases and autoimmune diseases. Rotterdam: Erasmus University Rotterdam; 2008.
15. Stewart EA, Wei R, Branch MJ, Sidney LE, Amoaku WM. Expression of Toll-like receptors in human retinal and choroidal vascular endothelial cells. Exp Eye Res.2015;138:114-23. doi: https://doi.org/10.1016/j.exer.2015.06.012
16. Guo J, Loke J, Zheng F, Hong F, Yea S, Fuka­ta М, et al. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology. 2009;49(3):960-68. doi: https://doi.org/10.1002/hep.22697
17. Funk E, Kottilil S, Gilliam B, Talwani R. Tick­ling the TLR7 to cure viral hepatitis. J Transрl Med. 2014;12(1). doi: https://doi.org/10.1186/1479-5876-12-129
18. Gesuete R, Kohama SG, Stenzel-Poore MP. Toll-like receptors and ischemic brain injury. J Neuropathol Exp 2014;73(5):378-86. doi: https://doi.org/10.1097/NEN.0000000000000068
19. Guo J, Friedman SL. Toll-like receptor 4 signa­ling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue 2010;3(1):21. doi: https://doi.org/10.1186/1755-1536-3-21
20. Howell J, Angus P, Gow P, Visvanathan K. Toll-like receptors in hepatitis C infection: Implications for pathogenesis and treatment. J Gastroenterol Hepatol. 2013;28(5):766-76. doi: https://doi.org/10.1111/jgh.12170
21. Zhu Q, Zou L, Jagavelu K, Simonetto DA, Huebert RC, Jiang ZD, et al. Intestinal decontami­nation inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol. 2012;56(4):893-99. doi: https://doi.org/10.1016/j.jhep.2011.11.013
22. Izmailova O. Analysis of association between the polymorphic variants of the TLR2 (RS5743708) and TLR4 (RS4986790, RS4986791) genes with the health status of apparently healthy individual. The Medical and Ecological Problems. 2018;22(1-2):17-22. doi: https://doi.org/10.31718/mep.2018.22.1-2.03
23. Jiménez-Dalmaroni MJ, Gerswhin ME, Adamo­poulos IE. The critical role of toll-like receptors − from microbial recognition to autoimmunity: a comprehensive review. Autoimmun 2016;15(1):1-8. doi: https://doi.org/10.1016/j.autrev.2015.08.009
24. Kawai Т, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity.2011;34(5):637-50. doi: https://doi.org/10.1016/j.immuni.2011.05.006
25. Kawasaki T, Kawai T. Toll-like receptor signa­ling pathways. Front Immunol [Internet]. 2014 [ci­ted 2022 Feb 02];5:461. doi: https://doi.org/10.3389/fimmu.2014.00461
26. Khakpour S, Wilhelmsen K, Hellman J. Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate 2015;21(8):827-46. doi: https://doi.org/10.1177/1753425915606525
27. Pires-Neto ODS, de SáKSG, Santana BB, Ta­tielle Monteiro Gomes S, da Silva Graça Amoras , da Silva Conde SR, et al. Lack of association between poly­morphisms of the TLR4 gene and infection with the hepatitis B and C viruses. Mediators of inflammation. 2015. doi: https://doi.org/10.1155/2015/150673
28. LesterSN, Li  Toll-like receptors in antiviral innate immunity. J Mol Biol. 2014;426(6):1246-64. doi: https://doi.org/10.1016/j.jmb.2013.11.024
29. Medvedev Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer. J Interferon Cytokine Res. 2013;33(9):467-84. doi: https://doi.org/10.1089/jir.2012.0140
30. MukherjeeS, Huda S, Sinha Babu  Toll-like receptor polymorphism in host immune response to infec­tious diseases: A review. Scand J Immunol. 2019;90(1). doi: https://doi.org/10.1111/sji.12771
31. WangS, Charbonnier LM, Rivas MN, Geor­giev P, Li N, Gerber G, et al. MyD88 adaptor-dependent microbial sensing by regulatory T cells promotes mucosal tolerance and enforces commensalism. Immunity. 2015;43(2):289-303. doi: https://doi.org/10.1016/j.immuni.2015.06.014
32. NeteaMG, Wijmenga C, O'neill  Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol. 2012;13(6):535-42. doi: https://doi.org/10.1038/ni.2284
33. LeeCM, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH, Yen  Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients. BMC gastroenterology. 2016;16(1):73. doi: https://doi.org/10.1186/s12876-016-0492-6
34. Perić M, Bošnjak Z, Šarkanj B, Barbić J, Anto­lović-Požgain A, Ružman N, et al. Polymorphisms of Toll-like receptors 2 and 4 in chronically infected hepatitis C patients from north-east Croatia. Arch Virol. 2015;160(1):297-304. doi: https://doi.org/10.1007/s00705-014-2283-0
35. Sghaier I, Mouelhi L, Ghazoueni E, Brochot E, Almawi WY, Yacoubi-Loueslati B. Role of TLRs and IL-6 in the outcome of chronic hepatitis C treatment in Tunisian population. Cytokine. 2017;99:297-304. doi: https://doi.org/10.1016/j.cyto.2017.08.010
36. Kordjazy N, Haj-Mirzaian A, Haj-Mirzaian A, Rohani MM, Gelfand EW, Rezaei N, et al. Role of toll-like receptors in inflammatory bowel disease. Pharmacol Res. 2018;129:204-15. doi: https://doi.org/10.1016/j.phrs.2017.11.017
37. Sasai M, Yamamoto М. Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors. Int Rev Immunol. 2013;3(2):116-33. doi: https://doi.org/10.3109/08830185.2013.774391
38. Saxena M, Bhardwaj N. Re-emergence of den­dritic cell vaccines for cancer treatment. Trends Сancer. 2018;4(2):119-37. doi: https://doi.org/10.1016/j.trecan.2017.12.007
39. Skevaki C, Pararas M, Kostelidou K., Tsakris A, Routsias JG. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. ClinExp  2015;180(2):165-77. doi: https://doi.org/10.1111/cei.12578
40. Takeda K, Akira S. Toll-like receptors’. Curr Protoc Immunol, 2015;109(1). doi: https://doi.org/10.1002/0471142735.im1412s109
41. Tartey S, Takeuchi O. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells. IntRev  2017;36(2):57-73. doi: https://doi.org/10.1080/08830185.2016.1261318
42. Al-Qahtani AA, Al-Anazi R, Al-Zoghaibi F, Ab­do AA, Sanai FM, Khan MQ, et al. The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients. BioMed research international; doi: https://doi.org/10.1155/2014/357062
43. Syzova LM, Koval TI, Ilchenko VI, Zviahol­ska IM, Iziumska OM. The impact of Toll-like receptors on the immune system functioning and on the immunopathogenesis of chronic hepatitis C: a modern view (literature review). Pathologia. 2020;17(1):114-21. doi: https://doi.org/10.14739/2310-1237.2020.1.203859
44. Mohamed SY, Mostafa EF, Hanafy AS, Atia H, Metwally A, Marei AM. The relationship between ex­pression of Toll-like receptor 4 in chronic hepatitis C patients and different stages of liver fibrosis. Gastro­enterol Hepatol Bed Bench. 2017;10(4):278-83. doi: https://doi.org/10.31219/osf.io/6pj56
45. Ziakas PD, Prodromou ML, El Khoury J, Zint­zaras E, Mylonakis E. The role of TLR4 896 A> G and 1196 C>T in susceptibility to infections: a review and meta-analysis of genetic association studies. PloS one. 2013;8(11). doi: https://doi.org/10.1371/journal.pone.0081047
46. Tizaoui K, Kaabachi W, Hamzaoui K, Ham­zaoui A. Association of single nucleotide polymorphisms in Toll-like receptor genes with asthma risk: a systematic review and meta-analysis. Allergy Asthma Immuno Res. 2015;7(2):130-40. doi: https://doi.org/10.4168/aair.2015.7.2.130
47. Elefanti L, Sacco G, Stagni C, Rastrelli M, Me­nin C, Russo I, et al. TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanoma. Oncol 2016;12 (1):275-80. doi: https://doi.org/10.3892/ol.2016.4584
48. Alvarado-Tapias E, Guarner-Argente C, Obli­tas E, Sánchez E, Vidal S, Román E, et al. Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites.World J Hepatol. 2018;10(1):124-33. doi: https://doi.org/10.4254/wjh.v10.i1.124
49. Iqbal MS, Ashfaq UA, Khaliq S, Masoud MS, Qasim M, Haque A, et al. Toll-like receptor 4 poly­mor­phism as pretreatment predictor of response to HCV genotype 3a interferon-based treatment. Future Virol. 2017;12(12):739-46.
    doi: https://doi.org/10.2217/fvl-2017-0076
50. Alvarado-Tapias E, Guarner-Argente C, Obli­tas E, Sánchez E, Vidal S, Román E, et al. Toll-like recep­tor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites. World J Hepatol. 2018;10(1):123-24. doi: https://doi.org/10.4254/wjh.v10.i1.124
51. Chen Yi, Me SG, Burchell J, Skinner N, Mil­len R, Matthews G, Hellard M, et al. Toll-like receptor expression and signaling in peripheral blood mononuclear cells correlate with clinical outcomes in acute hepatitis C virus infection. JID.2016;214(5):739-47. doi: https://doi.org/10.1093/infdis/jiw235
52. Piñero P, Juanola O, Caparrós E, Zapater P, Gi­ménez P, González-Navajas JM, et al. Toll-like receptor polymorphisms compromise the inflammatory response against bacterial antigen translocation in cirrhosis. Sci Rep. 2017;7. doi: https://doi.org/10.1038/srep46425
53. Hacine-Gherbi H, Denys A, Carpentier M, Hey­sen A, Duflot P, Lanos P, et al. Use of Toll-like receptor assays for the detection of bacterial contaminations in icodextrin batches released for peritoneal dialysis. Toxicol 2017;4:566-73. doi: https://doi.org/10.1016/j.toxrep.2017.10.004
54. Vesnina LE, Izmailova OV, Shlykova OA, Kida­shev I. Features of NF-kB-mediated signaltransduction and development of systemic inflammation in patients with diseases of internal organs are determined by microbial factor and individual reactivity of the body (review of own research findings). Problemy ekologii ta medytsyny. 2015;19(3-4):30-37. Available from: https://ecomed-journal.org/index.php/journal/article/view/49
55. Vijay K. Toll-like receptors in immunity and inflammatory diseases: past, present, and future. Int Immunopharmacol.2018;59:391-412. doi: https://doi.org/10.1016/j.intimp.2018.03.002
56. Volchenkov R, Sprater F, Vogelsang P, Appel S. The 2011 Nobel Prize in physiology or medicine. Scand J Immunol. 2012;75(1):1-4. doi: https://doi.org/10.1111/j.1365-3083.2011.02663.x

Штриголь С.Ю. Національний фармацевтичний університет, Харків, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-7257-9048

Койро О.О. Національний фармацевтичний університет, Харків, Україна

 https://orcid.org/0000-0002-6190-4041

Кудіна О.В. Національний фармацевтичний університет, Харків, Україна

 https://orcid.org/0000-0002-8080-2286

Юдкевич Т.К. Національний фармацевтичний університет, Харків, Україна

 https://orcid.org/0000-0001-6173-2780

Горбач Т.В. Харківський національний медичний університет, Харків, Україна

 https://orcid.org/0000-0003-4819-7220

1. Biem J, Koehncke N, Classen D, Dosman J. Out of the cold: management of hypothermia and frostbite. Canadian Medical Association Journal. 2003;168(3):305-11. PMID: 12566336. PMCID: PMC140473.
2. Centers for Disease Control and Prevention. QuickStats: Death Rates Attributed to Excessive Cold or Hypothermia Among Persons Aged ≥15 years, by Urban-Rural Status and Age Group - National Vital Statistics System, United States, 2019. MMWR Morb Mortal Wkly Rep; 2021:70(7):258. doi: https://doi.org/10.15585/mmwr.mm7007a6
3. Fudge J. Exercise in the Cold: Preventing and Managing Hypothermia and Frostbite Injury. Sports Health.2016;№8(2):133-9. doi: https://doi.org/10.1177/1941738116630542
4. Charkoudian N. Mechanisms and modifiers of reflex induced cutaneous vasodilation and vasoconstriction in humans. J Appl Physiol. 2010;109(4):1221-8. doi: https://doi.org/10.1152/japplphysiol.00298.2010
5. Haman F, Blondin DP. Shivering thermogenesis in humans: Origin, contribution and metabolic requi­rement. Temperature (Austin). 2017 May 22;4(3):217-26. PMID:   28944268;   PMCID:   PMC5605160. doi: https://doi.org/10.1080/23328940.2017.1328999
6. W van Marken Lichtenbelt. Brown adipose tissue and the regulation of nonshivering thermogenesis. Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):547-52. PMID: 23037904. doi: https://doi.org/10.1097/MCO.0b013e3283599184
7. Duong H, Patel G. [Updated 2021 Jan 27]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545239/
8. McIntosh SE, Hamonko M, Freer L, Grissom CK, Auerbach PS, Rodway GW, et al. Wilderness Medical Society Practice Guidelines for the Prevention and Treat­ment of Frostbite: 2014 Update. Wilderness & Environ­mental Medicine. 2014;2(22):156-66. PMID: 21664561. doi: https://doi.org/10.1016/j.wem.2011.03.003
9. Imray C, Grieve A, Dhillon S. Cold damage to the extremities: frostbite and non-freezing cold injuries. Post­graduate medical journal. 2009;85:481-8. PMID: 19734516. doi: https://doi.org/10.1136/pgmj.2008.068635
10. Kapelka IG, Shtrygol’ SYu. [The comparative research of frigoprotective properties of nonsteroidalanti-inflammatory drugs оn the model of acute general cooling]. Pharmacology and Drug Toxicology. 2019;13(5):338-43. Ukrainian.
11. Kapelka IG, Shtrygol` SYu, Lesyk RB, Lozyns­kyi AV, Khomyak SV, Novikov VP. [The comparative re­search of arachidonic acid cascade inhibitors for frigoprotective activity]. Pharmacology and Drug Toxicology.2020;14(2):122-8.  doi: https://doi.org/10.33250/14.02.122
12. Shtrygol SYu, Kapelka IG, Mishchenko MV, Mi­shchenko OYa. [Non-obvious effects of montelukast – leukotriene receptor blocker: frigoprotective and anti­convulsant properties]. Medicni perspektivi. 2021;26(2):19-25. doi: https://doi.org/10.26641/2307-0404.2021.2.234486
13. Shtrygol’ S, Koiro O, Kudina O, Tovchiga O, Yudkevich T, Oklei D. The influence of non-steroidal anti-inflammatory drugs with different mechanisms of action on the course of stress reaction, the functional state of kidneys, liver, and heart on the model of acute general cooling ScienceRise: Pharmaceutical Science. 2022;2(36):46-55. doi: https://doi.org/10.15587/2519-4852.2022.255797
14. Kapelka I, Shtrygol S, Koiro O, Merzlikin S, Kudina O, Yudkevych T. Effect of arachidonic acid cascade inhibitors on body temperature and cognitive functions in rats in the Morris water maze after acute cold injury. Pharmazie. 2021 Jul 1;76(7):313-6.
15. Kapelka IG, Shtrygol’ SYu. [The characteristics of the anti-inflammatory action of sodium diclofenac in cold and normal environment]. News of Pharmacy. 2020;2(100):106-12. doi: https://doi.org/10.24959/nphj.20.37
16. Bondarev EV, Shtrygol’ SYu. Drogovoz SM, Shchokіna KG. [Cold injury: preclinical study of drugs with frigoprotective properties. Methodical recom­mendations of the Ministry of Health of Ukraine]. Kharkiv: National University of Pharmacy; 2018. Ukrainian.
17. Danilovа LA, editor. [Handbook of laboratory research methods]. Sankt-Peterburg: Piter; 2003. Russian.
18. Kamyshnikova VS, editor. [Handbook of clinical biochemical research and laboratory diagnostics]. Moskva: MEDpress-inform; 2009. Russian.
19. Eshchenko ND. [Measurement of ATP content in tissues]. In: Prokhorova MI, editor. [Methods of bioche­mical research (lipid and energy metabolism)]. Leningrad: izdatelstvo leningradskogo universiteta; 1982. p. 210-212. Russian.
20. Hao L, Kearns J, Scott S, Wu D, Kodani SD, Moris­seau C, et al. Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther. 2018;365(3):467-75. doi: https://doi.org/10.1124/jpet.117.246256
21. Abumrad NA. The Liver as a Hub in Thermo­genesis. Cell Metab. 2017 Sep 5;26(3):454-5. PMID: 28877451. doi: https://doi.org/10.1016/j.cmet.2017.08.018
22. Yao R, Yang Y, Lian S, Shi H, Liu P, Liu Y, et al. Effects of Acute Cold Stress on Liver O-GlcNAcylation and Glycometabolism in Mice. Int. J. Mol. Sci. 2018;19(9). doi: https://doi.org/10.3390/ijms19092815
23. Brychta RJ, and Chen KY. Cold-induced Thermo­genesis in Humans. Eur. J. Clin. Nutr. 2017;71(3):345-52. doi: https://doi.org/10.1038/ejcn.2016.223
24. Fosslien E. Review: Cardiovascular Complica­tions of Non-Steroidal Anti-Inflammatory Drugs. Annals of Clinical & Laboratory Science. 2005;4(35):347-85. PMID: 16254252.
25. Romanovsky AA, Garami A. Prostaglandin rid­dles in energy metabolism: E is for excess, D is for depletion. Focus on "Food deprivation alters thermore­gulatory responses to lipopolysaccharide by enhancing cryogenic inflammatory signaling via prostaglandin D2". Am J Physiol Regul Integr Comp Physiol. 2010;298(6):R1509-R1511. doi: https://doi.org/10.1152/ajpregu.00253.2010
26. Shi H, Yao R, Lian S, Liu P, Liu Y, Yang YY, Yang H, Li S. Regulating glycolysis, the TLR4 signal pathway and expression of RBM3 in mouse liver in response to acute cold exposure. Stress. 2019 May;22(3):366-76. Epub 2019 Mar 1.PMID: 30821572. doi: https://doi.org/10.1080/10253890.2019.1568987
27. Gottfried E, Lang SA, Renner K, Bosserhoff A, Gronwald W, Rehli M, et al. New aspects of an old drug – diclofenac targets MYC and glucose metabolism in tumor cells. PLoS One. 2013 Jul 9;8(7):e66987. PMID: 23874405; PMCID: PMC3706586. doi: https://doi.org/10.1371/journal.pone.0066987

Кузьмінов Б.П. Львівський національний медичний університет ім. Данила Галицького, Львів, Україна

 https://orcid.org/0000-0002-8693-1046

Зазуляк Т.С. Львівський національний медичний університет ім. Данила Галицького, Львів, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-5896-0475

1. Vitiuk AV, Trachenko KR. [Contradictory trends in the development of the pharmaceutical industry of Ukraine]. Visnyk Vinnytskoho politekhnichnoho instytutu. 2018;6:35-43. doi: https://doi.org/10.31649/1997-9266-2018-141-6-35-43
2. Horokhova LH, Martynova NA, Kizichenko NV, Lohunova TD. [Hygienic aspects of the state of health of workers in chemical and pharmaceutical production]. Medytsyna v Kuzbasse. 2017;16(3):11-5. Russian.
3. Horokhova LH, Ulanova EV, Shavtsova HM, Erdeeva SV, Blazhina ON. [The state of health of workers in the chemical and pharmaceutical industry]. Medytsyna truda i promyshlennaia ekolohiia. 2018;6:38-42. Russian. doi: https://doi.org/10.31089/1026-9428-2018-6-38-42
4. [State Register of Medicines of Ukraine] [Inter­net]. Kyiv: State Service of Medicines and Drug Control of Ukraine; 2021 [updated 2021 March 31; cited 2021 Ap­ril 9]. Available from: https://www.dls.gov.ua/
5. [Economic statistics] [Internet]. Kyiv: State Statis­tics Service of Ukraine; 2021 [updated 2021 March 12; cited 2021 April 9]. Available from: http://www.ukrstat.gov.ua.
6. Zahorii HV, Ponomarenko MS, Trokhym­chuk VV, Drozdova AO, Hryhoruk YuM. [Comparative structural and statistical analysis of morbidity with temporary disability of personnel of CJSC “Pharma­ceutical firm “Darnytsia” in connection with reengineering processes in the strategy of accelerated development of the enterprise (1996-2000 and 2006-2010)]. Upravlinnia, eko­nomika ta zabezpechennia yakosti v farmatsii. 2012;1:38-44. Ukrainian.
7. Zazuliak TS. [Harmful chemical factors in the pro­duction of medicines]. Aktualni problemy profilaktychnoi medytsyny. 2021;22:94-109. Ukrainian.
8. Trakhtenberh IM, editors. [Medical toxicology. Preclinical studies]. Kyiv: Avitsena; 2020. Ukrainian.
9. Nahorna AM, Sokolova MP, Kononova IH. [Occupational morbidity of medical workers in Ukraine as a medical and social problem]. Ukrainskyi zhurnal z problem medytsyny pratsi. 2016;2(47):3-16. Ukrainian. doi: https://doi.org/10.33573/ujoh2016.02.003
10. Nahorna AM, Sokolova MP, Kononova IH. [Epi­de­miological studies of occupational health in Ukraine]. Ukrai­nskyi zhurnal z problem medytsyny pratsi. 2018;4(57):3-20. Ukrainian. doi: https://doi.org/10.33573/ujoh2018.04.003
11. Nahorna OK. [Occupational safety of workers in the pharmaceutical industry]. In: Problemy okhorony pratsi, promyslovoi ta tsyvilnoi bezpeky. Proceedings of the eighteenth all-Ukrainian scientific-methodical Сonfe­rence; 2018 May15-16; Kyiv: KPI im. Ihoria Sikorskoho; 2018. p. 190-3. Ukrainian.
12. [About medicines. Pub. L. No. 123/96-VR, 1996. Information of the Verkhovna Rada of Ukraine No. 22, Stat. 86. (Apr 04, 1996).
13. Trakhtenberh IM, Dmytrukha NM. [Industrial toxicology: main directions, results and prospects of scien­tific activity]. Ukrainskyi zhurnal z problem medytsyny pratsi. 2019;5(2):87-101. Ukrainian. doi: https://doi.org/10.33573/ujoh2019.02.087
14. Tymoshyna DP, Lubianova IP. [Health problems of medical workers in Ukraine]. Upravlinnia zakladamy okhorony zdorovia. 2015;8:54-58. Ukrainian.
15. Shafran LM, Tretiakova OV. [The concept of “TOXICITY TESTING-21” in modern toxicology]. Ak­tualni problemy profilaktychnoi medytsyny. 2021;22:8-42. Ukrainian.
16. Albert F, Bassani R, Coen D, Vismara A. Hypoglycaemia by inhalation. Lancet. 1993;342:47-8. doi: https://doi.org/10.1016/0140-6736(93)91906-3
17. Allian AD, Shah NP, Ferretti AC, Brown DB, Kolis SP, Sperry JB. Process safety in the pharmaceutical industry – part I: thermal and reaction hazard evaluation processes and techniques. Organic Process Research & Development. 2020;24(11):2529-48. doi: https://doi.org/10.1021/acs.oprd.0c00226
18. Baxter PJ, Samuel AM, Aw TC, Cocker J. Expo­sure to quinal barbitone sodium in pharmaceutical workers. Br Med J (Clin Res Ed). 1986;292:660-61. doi: https://doi.org/10.1136/bmj.292.6521.660-a
19. Bhusnure OG, Dongare RB, Gholve SB, Giram PS. Chemical hazards and safety management in pharma­ceutical industry. Journal of Pharmacy Research. 2018;12(03):357-69.
20. Conde-SalazarL, Blancas-Espinosa R, Pérez-Hor­tet Occupational airborne contact dermatitis from ome­prazole. Contact Dermatitis. 2007 Jan;56(1):44-6. doi: https://doi.org/10.1111/j.1600-0536.2007.00921.x
21. European competition authorities working to gether for affordable and innovative medicines: Report from the commission to the council and the European Parliament. Competition enforcement in the pharma­ceutical sector (2009-2017). [Internet]. Brussels; 2019 Jan 28 [cited 2021 April 15]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52019DC0017
22. Fung VSWC. Risk Assessment and Communi­cation in Pharmaceuticals: Recognizing the Differences in Occupational Health and Medication Safety. J Toxicol Risk 2019;5:019. doi: https://doi.org/10.23937/2572-4061.1510019
23. Gathuru IM, Buchanich JM, Marsh GM, Dolan DG. Health Hazards in the Pharmaceutical Industry. Pharmaceut Reg Affairs. 2015;4(3):1-15. doi: https://doi.org/10.4172/2167-7689.1000145
24. Gomez Torrijos E, Borja J, Galindo PA, et al. Allergic contact dermatitis from mitomycin C. Allergy. 1997;52:687.
    doi: https://doi.org/10.1111/j.1398-9995.1997.tb01061.x
25. Goon ATJ, McFadden JP, McCann M, Royds C, Rycroft RJG. Allergic contact dermatitis from melphalan and chlorambucil: cross-sensitivity or cosensitization? Contact 2000;47:309. doi: https://doi.org/10.1034/j.1600-0536.2002.4705101.x
26. Gunnarsson L, Jason R. Snape JR, Ver­bruggen B, Owen SF, Kristiansson E, et al. Phar­macology beyond the patient – the environmental risks of human drugs. Environment International. 2019 Aug;129:320-32. doi: https://doi.org/10.1016/j.envint.2019.04.075
27. Heron RJL, Pickering FC. Health effects of expo­sure to active pharmaceutical ingredients (APIs). Occupa­tional 2003;53:357-62. doi: https://doi.org/10.1093/occmed/kqg115
28. Jeebhay M, Mbuli S, Uebel Assessment of exposure to chloramphenicol and azathioprine among workers in a South African pharmaceutical plant. Int Arch Occup Environ Health. 1993;65(1 Suppl):119-22. doi: https://doi.org/10.1007/BF00381321
29. Kiffmeyer ТК, Drrernat, Schmidt KG, Paul JM, Sessink PJM. Vapourpressures, evaporation behaviour and airborne concentrations of hazardous drugs: implications for occupational safety. The pharmaceutical journal. 2002;268:331-7.
30. Kuzminov BP, Zazulyak TS, Hrushka OI, Kuzmi­nov AB, Shvets IA, Brejdak AA. System Approach to Regulation of the Harmful Influence of Medicines in the Conditions in the Manufacturing Process and Environ­ment. Eksperymentalna ta klinichna fiziolohiia i biokhimiia. 2018;2(82):15-20. doi: https://doi.org/10.25040/ecpb2018.02.015
31. Milković-KrausS, Jelena Macan J, Bozica Kan­celjak-Macan Occupational allergic contact dermatitis from azithromycin in pharmaceutical workers: a case series. Contact Dermatitis. 2007 Feb;56(2):99-102. doi: https://doi.org/10.1111/j.1600-0536.2007.00999.x
32. Neumark M, Arieh Ingber A, Michael Levin M, Dan Slodownik Occupational airborne contact derma­titis caused by pantoprazole. Contact Dermatitis. 2011 Jan;64(1):60-1.
    doi: https://doi.org/10.1111/j.1600-0536.2010.01783.x
33. Park HS, Nahm  New occupational allergen in a pharmaceutical industry: serratial peptidase and lyso­zyme chloride. Ann Allergy Asthma Immunol. 1997 Feb;78(2):225-9.
    doi: https://doi.org/10.1016/S1081-1206(10)63392-3
34. PrasadMH, Pushpavathi K, Devi GS, Reddy Reproductive epidemiology in sulfonamide factory wor­kers. J Toxicol Environ Health. 1996 Feb 9;47(2):109-14. doi: https://doi.org/10.1080/009841096161816
35. Reichard JF, Maiera MA, NaumannBD, Pec­quet AM, Pfister T, Sandhu R, et al. Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals. Regulatory Toxicology and Pharmacology. 2016;79(1,15):67-78. doi: https://doi.org/10.1016/j.yrtph.2016.05.027
36. Romanowska-Słomka I, Szołkowski A. [Dangers of chemical substances in the pharmaceutical industry]. Zeszyty naukowe wyższej szkoły zarządzania ochroną pracy w Katowicach. 2019;1(15):43-57. Polish. doi: https://doi.org/10.32039/WSZOP/1895-3794-2019-01
37. RyanPJJ, Rycroft RJG, Aston Allergic contact dermatitis from occupational exposure to ranitidine hydrochloride. Contact Dermatitis. 2003 Feb;48(2):67-8. doi: https://doi.org/10.1034/j.1600-0536.2003.480202.x
38. SahuRK, Yadav R, Prasad P, Roy, Chand­rakar S. Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. Springer­plus. 2014 Nov;3:695.
    doi: https://doi.org/10.1186/2193-1801-3-695
39. Sarkis M, Bernardi A., Shah N, Papatha­na­siou MM. Emerging Challenges and Opportunities in Phar­maceutical Manufacturing and Distribution. Processes. 2021;9(3):457. doi: https://doi.org/10.3390/pr9030457
40. Schenk L, Johanson G. Use of uncertainty factors by the European Commission Scientific Committee on Occupational Exposure Limits: a follow-up. Crit Rev Toxicol.2018;48(7):513-21. doi: https://doi.org/10.1080/10408444.2018.1483891
41. Scott Occupational health in the pharma­ceutical industry: an overview. Occup Med (Lond). 2003 Sep;53(6):354-6. doi: https://doi.org/10.1093/occmed/kqg114
42. Shuai Deng, Yige Sun, Tianyi Zhao, Yang Hu, Tianyi Zang. A Review of Drug Side Effect Identification Methods. Current Pharmaceutical Design. 2020;26(26):3096-104. doi: https://doi.org/10.2174/1381612826666200612163819
43. Singal M, Patnode R. Health Hazard Evaluation Report 81-322-1228. [Internet]. Mylan Pharmaceuticals, Morgantown, West Virginia. National Institute for Occupational Safety and Health, Cincinnati, OH: Report No. HETA 81-322-1228; 1982 Nov. [cited 2021 April 15]. Available from: https://www.cdc.gov/niosh/hhe/reports/pdfs/81-322-1228.pdf.
44. TaskinenH, Lindbohm ML, Hemminki Spon­taneous abortions among women working in the pharma­ceutical industry. Br J Ind Med. 1986 Mar;43(3):199-205. doi: https://doi.org/10.1136/oem.43.3.199
45. Thomson KF, Sheehan-Dare RA, Wilkinson SM. Allergic contact dermatitis from topical carmustine. Contact Dermatitis. 2000;42:112. PMID: 10703643.
46. TomeiF, Iavicoli S, Iavicoli A, Papaleo B, Bac­colo Liver damage in pharmaceutical industry workers. Arch Environ Health. 1995 Jul-Aug;50(4):293-7. doi: https://doi.org/10.1080/00039896.1995.9935957
47. Whitaker P. Occupational allergy to pharma­ceutical products. Current Opinion in Allergy and Clinical Immunology. 2016 April;16(2):101-6. doi: https://doi.org/10.1097/ACI.0000000000000248
48. Yan BB, Ma YY, Guo J, Wang YC. Self-micro­emulsifying delivery system for improving bioavailability of water insoluble drugs. Journal of nanoparticle research. 2020 Jan 4;22(1):1-14. doi: https://doi.org/10.1007/s11051-019-4744-6
49. Zuskin E, Mustajbegovic J, Schachter NE, Kern J, Deckovic-Vukres V, Pucarin-Cvetkovic J, Nola-Pre­mec IA. Respiratory findings in pharmaceutical workers. Am J Ind Med. 2004 Nov;46(5):472-9. doi: https://doi.org/10.1002/ajim.20085

Менексе Оксар Університет Хатая Мустафи Кемаля, Антакья, провінція Хатай, Туреччина,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-8641-6741

Хасібе Г. Байтан Приватна лікарня TOBB ETU, Анкара, Туреччина

 https://orcid.org/0000-0003-0828-9219

Селім Турханоглу Університет Хатая Мустафи Кемаля, Антакья, провінція Хатай, Туреччина

 https://orcid.org/0000-0002-4929-9889

Тайфун Айбек Приватна лікарня TOBB ETU, Анкара, Туреччина

 https://orcid.org/0000-0002-8565-6863

Назіфе Й. Ардікоглу Приватна лікарня TOBB ETU, Анкара, Туреччина

 https://orcid.org/0000-0002-4109-0220

Огужан Озджан Університет Хатая Мустафи Кемаля, Антакья, провінція Хатай, Туреччина

 https://orcid.org/0000-0001-7486-503X

1. Benoit R, Nougier C, Desmurs-Clavel H, Si­mon M, Dargaud Y. The modification of the thrombin generation assay for the clinical assessment of hypercoagu­lability in patients receiving heparin therapy. International Journal of Laboratory Hematology. 2022;44(2):371-8. doi: https://doi.org/10.1111/ijlh.13735
2. Zhao Y-C, Zhao X, Fu G-W, Liu Q-L, Li H-B. Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy. Throm­bosis 2022;20(1):36. doi: https://doi.org/10.1186/s12959-022-00396-w
3. Guo F, Zhu X, Wu Z, Wu J, Zhang F. Clinical applications of machine learning in the survival prediction and classification of sepsis: coagulation and heparin usage matter. Journal of Translational Medicine. 2022;20(1):265. doi: https://doi.org/10.1186/s12967-022-03469-6
4. Chen Y, Phoon PHY, Hwang NC. Heparin Resis­tance During Cardiopulmonary Bypass in Adult Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia.2022;36(11):4150-60. doi: https://doi.org/10.1053/j.jvca.2022.06.021
5. To L, Attar D, Lines B, Coba V, Lekura J. Inci­dence of Heparin-Induced Thrombocytopenia in Patients With Newly Implanted Mechanical Circulatory Support Devices. Annals of Pharmacotherapy. 2022;56(5):565-71. doi: https://doi.org/10.1177/10600280211038705
6. Tian L, Liu Y, Fei Y, Li L, Shi J. Effect of Cle­mastine Fumarate on Perioperative Hemodynamic Instabi­lity Mediated by Anaphylaxis During Cardiopulmonary Bypass Surgery. Medical Science Monitor. 2022;28:e936367. doi: https://doi.org/10.12659/MSM.936367
7. Chiba Y, Otsuka Y, Lefor AK, Sanui M. Efficacy of point-of-care thromboelastography 6s to evaluate platelet function in a patient with pseudothrombocytopenia undergoing cardiopulmonary bypass: a case report. JA Clinical 2022;8(1):8. doi: https://doi.org/10.1186/s40981-022-00496-6
8. He Y-Y, Huang Y-P, Wang L, Song B. A case with no administration of protamine to neutralize heparin in aortic valve replacement with cardiopulmonary bypass. Transplant 2022;73:101601. doi: https://doi.org/10.1016/j.trim.2022.101601
9. Asai H, Yamamoto R, Kuromiya K, Kurosaki H, Fukuishi N. A Rapid and Sensitive Determination of His­tamine in Mast Cells Using a Didansyl Derivatization Method. International Archives of Allergy and Immunology.2022;183(10):1050-5. doi: https://doi.org/10.1159/000525588
10. Huang W, Zhou X. Anti-histamine effects of dipo­tassium glycyrrhizinate on lung fibroblasts, impli­cating its therapeutic mechanism for pulmonary fibrosis. The Journal of pharmacy and pharmacology. 2022;74(9):1241-50. doi: https://doi.org/10.1093/jpp/rgac030
11. De Almeida AD, Silva IS, Fernandes-Braga W, Cassali GD, Klein A. A role for mast cells and mast cell tryptase in driving neutrophil recruitment in LPS-induced lung inflammation via protease-activated receptor 2 in mice. Inflammation Research. 2020;69(10):1059-70. doi: https://doi.org/10.1007/s00011-020-01376-4
12. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. The New England Journal of Medicine. 1987;316:622-6. doi: https://doi.org/10.1056/NEJM198706253162603
13. Schwartz LB, Min HK, Ren S, Xia HZ, Hu J, Zhao W. Tryptase precursors are preferentially and spon­taneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. Journal of Immunology. 2003;170:5667-73. doi: https://doi.org/10.4049/jimmunol.170.11.5667
14. Xie H, Chen L, Zhang H, Wang S, He S. Increased expressions of CD123, CD63, CD203c, and Fc epsilon receptor I on blood leukocytes of allergic asthma. Frontiers inMolecular  2022;9:907092. doi: https://doi.org/10.3389/fmolb.2022.907092
15. Krishna MT, York M, Chin T, Gnanakumaran G, Heslegrave J, Derbridge C. Multi-center retrospective analysis of anaphylaxis during general anesthesia in the United Kingdom: etiology and diagnostic performance of acute serum tryptase. Clinical and Experimental Immunology.2014;178:399-404. doi: https://doi.org/10.1111/cei.12424
16. Fellinger C, Hemmer W, Wohrl S, Sesztak-Greinecker G, Jarisch R, Wantke F. Clinical characte­ristics and risk profile of patients with elevated baseline serum tryptase. Allergologia et Immunopathologia. 2014;42:544-52. doi: https://doi.org/10.1016/j.aller.2014.05.002
17. Antunes J, Kochuyt AM, Ceuppens JL. Periope­rative allergic reactions: experience in a Flemish referral center. Allergologia et Immunopathologia. 2014;42:348-54. doi: https://doi.org/10.1016/j.aller.2013.08.001
18. Sokolowska E, Kalaska B, Miklosz J, Mogiel­nicki A. The toxicology of heparin reversal with pro­tamine: past, present and future. Expert Opinion on Drug Metabolism and Toxicology. 2016;12(8):897-909. doi: https://doi.org/10.1080/17425255.2016.1194395
19. Chooriyil N, Jom D, Panattil P, Sreedharan S. Protamine-induced hypotension and pulmonary arterial hypertension. Journal of Pharmacology and Pharmaco­therapeutics. 2021;12(1):23-25.
20. Bircher AJ, Hauser C, Pichler W, Varonier H, Wüthrich B. Importance and indication of specific IgE and IgG antibody determination in allergy diagnostics. Allergologie.2002;25(6):338-40. doi: https://doi.org/10.5414/ALP25338
21. Dewachter P, Savic L. Perioperative anaphylaxis: pathophysiology, clinical presentation and management. BJA 2019;19(10):313-20. doi: https://doi.org/10.1016/j.bjae.2019.06.002
22. Mo Y, Qian Y. Successful re-treatment in a patient with protamine allergy by a slow intravenous injection method. Adverse Drug Reactions Journal. 2020;22(2):117-9.
23. Pastorello EA, Farioli L, Scibilia G. Baseline tryp­tase levels are related to age, total IgE, and anti-rPru p 3 IgE levels in peach-allergic patients. Journal of Allergy and Clinical Immunology. 2013;23:127-8.
24. Blum S, Gunzinger A, Muller UR, Helbling A. Influence of total and specific IgE, serum tryptase, and age on severity of allergic reactions to Hymenoptera stings. Allergy.2011;66:222-8. doi: https://doi.org/10.1111/j.1398-9995.2010.02470.x
25. Borer-Reinhold M, Haeberli G, Bitzenhofer M. An increase in serum tryptase even below 11.4 ng mL−1 may indicate a mast cell-mediated hypersensitivity reac­tion: a prospective study in Hymenoptera venom allergic patients. Clinical and Experimental Allergy. 2011;41:1777-83. doi: https://doi.org/10.1111/j.1365-2222.2011.03848.x
26. Laroche D, Gomis P, Gallimidi E, Mali­novs­ky JM, Mertes PM. Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anaesthesia. Anaesthesiology. 2014;121:272-9. doi: https://doi.org/10.1097/ALN.0000000000000276
27. BaimbetovA, Bizhanov K, Yakupova I, Baira­mov B, Medeubekov U, Madyarov  Long-term results of simultaneous hybrid ablation of therapy-resistant atrial fibrillation. European Heart Journal. 2020;41:626.
28. Baimbetov A, Bizhanov K, Yergeshov K, Bayra­mov B, Yakupova I, Bozshagulov T. One year continuous­ly monitoring follow up results after single procedure atrial fibrillation ablation using cryoballoon second generation. European Heart Journal. 2018;39:1225. doi: https://doi.org/10.1093/eurheartj/ehy566.P5772

Заболотний Д.І. ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України», Київ, Україна

 https://orcid.org/0000-0002-4848-840X

Заболотна Д.Д. ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України», Київ, Україна

 https://orcid.org/0000-0001-7807-8148

Бабкіна Т.В. ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України», Київ, Україна

Цвірінько І.Р. ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0003-2186-1312

Телуха К.І. ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України», Київ, Україна

 https://orcid.org/0000-0002-0184-1827

Кізім Я.В. ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України», Київ, Україна

 https://orcid.org/0000-0001-5062-7707

Вальчишин С.В. ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України», Київ, Україна

 https://orcid.org/0000-0003-2668-188X

1. Dimitrijevic MV, Jesic SD, Mikic AA, Arso­vic NA, Tomanovic NR. Parapharyngeal space tumors: 61 case reviews. Int J Oral Maxillofac Surg. 2010;39:983-9. doi: https://doi.org/10.1016/j.ijom.2010.06.005
2. Horowitz G, Ben-Ari O, Wasserzug O, Weiz­man N, Yehuda M, Fliss DM. The transcervical approach for parapharyngeal space pleomorphic adenomas: Indi­cations and technique. PLoS One. 2014;9:e90210. doi: https://doi.org/10.1371/journal.pone.0090210
3. Chen H, Sun G, Tang E, Hu Q. Surgical treatment of primary parapharyngeal space tumors: a single-institution review of 28 cases. J Oral Maxillofac Surg. 2019;77(7):1520.e1-e16. doi: https://doi.org/10.1016/j.joms.2019.03.001
4. Razek A, Khalek AA, Sieza S, Germeen AA. Cha­racterization of Parotid Tumors With Dynamic Suscep­tibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging. Comput Assist 2017;41:131-6. doi: https://doi.org/10.1097/RCT.0000000000000486
5. Lien KH, Young CK, Chin SC, Liao CT, Huang SF. Parapharyngeal space tumors: a serial case study. J Int Med Res. 2019 Aug;47(8):4004-13. Epub 2019 Jul 29. PMID: 31353995; PMCID: PMC6726805. doi: https://doi.org/10.1177/0300060519862659
6. Fermi M, Serafini E, Ferri G, Alicandri-Ciu­felli M, Presutti L, Mattioli F. Management of parapha­ryngeal space tumors with transparotid-transcervical approach: analysis of prognostic factors related with disease-control and functional outcomes. Eur Arch Otorhi­no­laryngol. 2022 May;279(5):2631-9. Epub 2021 Sep 16. PMID: 34529157.
   doi: https://doi.org/10.1007/s00405-021-07074-z
7. Patadia S, Keshri A, Shah S, Shrivastava A. Benign Parapharyngeal Tumours: Surgical Intricacies by Transcervical Approach. Otolaryngology. 2016;6:219. doi: https://doi.org/10.4172/2161-119X.1000219
8. Arnason T, Hart RD, Taylor SM, Trites JR, Nas­ser JG, Bullock MJ. Diagnostic accuracy and safety of fine-needle aspiration biopsy of the parapharyngeal space. Diagn 2012;40:118-23. doi: https://doi.org/10.1002/dc.21508
9. Jichi K, Murakami S. Surgical treatment of para­pharyngeal space tumors: A report of 29 cases. Oncol Lett. 2017;14(3):3249-54. doi: https://doi.org/10.3892/ol.2017.6480
10. Chen Z, Chen YL, Yu Q, Zhou SH, Bao YY, Shang DS, Ruan LX. Excision of tumors in the para­pharyngeal space using an endoscopically assisted transoral approach: a case series and literature review. J Int Med Res.2019;47(3):1103-13. doi: https://doi.org/10.1177/0300060518816190
11. Vallabhaneni AC, Mandakulutur SG, Vallabha­neni S, Prabha A, Banavara RK. True parapharyngeal space tumors: case series from a teaching oncology center. Indian J Otolaryngol Head Neck Surg. 2017;69(2):225-9. doi: https://doi.org/10.1007/s12070-017-1099-0
12. Tryggvason G, Barnett A, Kim J, Soken H, Maley J, Hansen MR. Radiographic association of schwannomas with sensory ganglia. Otol Neurotol. 2012;33:1276-82. doi: https://doi.org/10.1097/MAO.0b013e318263d315
13. Bulut OC, Giger R, Alwagdani A, Aldabal N, Stenzinger A, Heimgartner S, et al. Primary neoplasms of the parapharyngeal space: diagnostic and therapeutic pearls and pitfalls. Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4933-41. Epub 2021 Mar 19. PMID: 33740083; PMCID: PMC8553685. doi: https://doi.org/10.1007/s00405-021-06718-4
14. Sun F, Yan Y, Wei D, Li W, Cao S, Liu D, et al. Surgical management of primary parapharyngeal space tumors in 103 patients at a single institution. Acta Otolaryngol.2018;138(1):85-89. doi: https://doi.org/10.1080/00016489.2017.1378433
15. Rzepakowska A, Osuch-Wójcikiewicz E, Żu­rek M, Durmaj A, Niemczyk K. Tumor, host and sur­gery related factors predisposing to cranial nerve defi­cits after surgical treatment of parapharyngeal space tu­mors. Eur Arch Otorhi­nolaryngol. 2021 Jun;278(6):1973-81. Epub 2020 Aug 10. doi: https://doi.org/10.1007/s00405-020-06261-8
16. López F, Suárez C, Vander Poorten V, Mäkitie A, Nixon IJ, Strojan P, et al. Contemporary management of primary parapharyngeal space tumors. Head Neck. 2019;41(2):522-35. doi: https://doi.org/10.1002/hed.25439
17. Pool CD, Goyal N. Parapharyngeal Space Tumors Treatment & Management. MedScape [internet]. 2017 Nov [cited 2022 Jun 12]. Avaliable from: https://emedicine.medscape.com/article/849385-overview
18. van Hees T, van Weert S, Witte B, et al. Tumors of the parapharyngeal space: the VU University Medical Center experience over a 20-year period. Eur Arch Otorhinolaryngol. 2018;275:967-72. doi: https://doi.org/10.1007/s00405-018-4891-x
19. Lajud SA, Aponte-Ortiz JA, Garraton M, et al. A novel combined transoral and transcervical surgical approach for recurrent metastatic medullary thyroid cancer to the parapharyngeal space. J Robotic Surg. 2019;14(1):233-6.
    doi: https://doi.org/10.1007/s11701-019-00930-5
20. Meng L, Zhong Q, Fang J, et al. Early experience in endoscopic transoral resection for parapharyngeal space tumors. Ear Nose Throat J. 2018;97(4-5):E5-9. doi: https://doi.org/10.1177/0145561318097004-501
21. Larson AR, Ryan WR. Transoral Excision of Parapharyngeal Space Tumors. Otolaryngol Clin N Am. 2021;54:531-41. doi: https://doi.org/10.1016/j.otc.2021.03.001
22. Nornadiah R, Wah, Yap Bee. Power comparisons of Shapiro–Wilk, Kolmogorov–Smirnov, Lilliefors and Anderson–Darling tests. Journal of Statistical Modeling and Analytics. 2011;2(1):21-33. Retrieved 30 March 2017.

Сірко А.Г. Дніпровський державний медичний університет; Дніпропетровська обласна клінічна лікарня ім. І.І. Мечникова, Дніпро, Україна

 https://orcid.org/0000-0001-6536-2035

Дзяк Л.А. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0002-2827-3663

Перепелиця В.А. Дніпровський державний медичний університет; Дніпропетровська обласна клінічна лікарня ім. І.І. Мечникова, Дніпро, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-9336-5639

Чередниченко Ю.В. Дніпропетровська обласна клінічна лікарня ім. І.І. Мечникова, Дніпро, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-7709-3984

1. Antomonov MYu. [Mathematical processing and analysis of biomedical data]. Kyiv: Medinform. 2018. Ukrainian.
2. Wang X, Wang MY, Qian K, Chen L, Zhang FC. Classification and Protection of Peritumoral Draining Veins of Parasagittal and Falcine Meningiomas. World Neurosurg. 2018;117:362-70. doi: https://doi.org/10.1016/j.wneu.2018.06.037
3. Wang S, Ying J, Wei L, Li S, Jing J. Effects of pa­rasagittal meningiomas on intracranial venous circulation assessed by the virtual reality technology. Int J Clin Exp Med. 2015;8(8):12706-15.
4. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Clas­sification of Tumors of the Central Nervous System: a summary. Neuro-Oncology.2021:23(8);1231-51. doi: https://doi.org/10.1093/neuonc/noab106
5. Yin T, Zhang H, Wang W, Zhang L, Wang S. Fal­cine Sinus and Parafalcine Collateral Veins in Menin­giomas Invading the Superior Sagittal Sinus. World Neurosurg.2019;132:434-42. doi: https://doi.org/10.1016/j.wneu.2019.08.120
6. Giordan E, Sorenson TJ, Lanzino G. Optimal sur­gical strategy for meningiomas involving the superior sagittal sinus: a systematic review. Neurosurg Rev. 2020;43(2):525-35. doi: https://doi.org/10.1007/s10143-018-1026-1
7. Mathiesen T. Parasagittal meningiomas. Handb Clin 2020;170:93-100. doi: https://doi.org/10.1016/B978-0-12-822198-3.00031-8
8. Gatterbauer B, Gevsek S, Höftberger R, Lütgen­dorf-Caucig C, Ertl A, Mallouhi A, et. Multimodal treatment of parasagittal meningiomas: a single-center experience. J Neurosurg. 2017;127(6):1249-56. doi: https://doi.org/10.3171/2016.9.JNS161859
9. Ricci A, Di Vitantonio H, De Paulis D, Del Maes­tro M, Gallieni M, Dechcordi SR, et. al. Parasagittal me­ningiomas: Our surgical experience and the reconstruction technique of the superior sagittal sinus. Surg Neurol Int. 2017 Jan;8:1.
   doi: https://doi.org/10.4103/2152-7806.198728
10. Zeeshan Q, Patel A, Cheng CY, Zhao NH, Bar­ber J, Ghodke BV, et al. Resection of Meningiomas Invol­ving Major Dural Venous Sinuses: Classification, Technique, and Long-Term Results. World Neurosurg. 2019;125:521-36. doi: https://doi.org/10.1016/j.wneu.2019.01.128
11. Ottavio Tomasi S, Umana GE, Scalia G, Rau­dino G, Graziano F, Palmisciano P, et. al. The Superficial Anastomosing Veins of the Human Brain Cortex: A Microneurosurgical Anatomical Study. Front. Surg. 2022;8:817002. doi: https://doi.org/10.3389/fsurg.2021.817002

Радченко А.О. ДУ «Національний інститут терапії імені Л.Т. Малої Національної Академії Медичних Наук України», Харків, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-9687-8218

Колеснікова О.В. ДУ «Національний інститут терапії імені Л.Т. Малої Національної Академії Медичних Наук України», Харків, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-5606-6621

1. Kolesnikova OV, Radchenko AO. [Modern view on the mechanisms of oxidative stress and its biomarkers in a larger number of non-communicable diseases]. Ukrain. Therap. J. 2020;1:51-61. Ukrainian.
2. Delitala AP, Scuteri A, Maioli M, Mangatia P, Vilardi L, Erre GL. Subclinical hypothyroidism and cardio­vascular risk factors. Minerva medica. 2019 Nov 11;110(6):530-45. doi: https://doi.org/10.23736/S0026-4806.19.06292-X
3. Kilic U, Gok O, Bacaksiz A, Izmirli M, Elibol-Can B, Uysal O. SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases. PloS one. 2014 Feb 28;9(2):e90428. doi: https://doi.org/10.1371/journal.pone.0090428
4. Peeters AV, Beckers S, Verrijken A, Mertens I, Roe­vens P, et al. Association of SIRT1 gene variation with visceral obesity. Human genetics. 2008 Nov 1;124(4):431. doi: https://doi.org/10.1371/journal.pone.0115339
5. Alamdari DH, Paletas K, Pegiou T, Sarigianni M, Befani C, Koliakos G. A novel assay for the evaluation of the prooxidant–antioxidant balance, before and after antioxidant vitamin administration in type II diabetes pa­tients. Clinical biochemistry. 2007 Feb 1;40(3-4):248-54. doi: https://doi.org/10.1016/j.clinbiochem.2006.10.017
6. Voitenko VP, Tokar AV, Rudaia ES. [Method of determining biological age]. Voprosy gerontologii. 1989;11:9. Russian.
7. Levine ME, Lu AT, Quach A, Chen BH, Assi­mes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018 Apr;10(4):573. doi: https://doi.org/10.18632/aging.101414
8. Antomonov MYu. [Mathematical processing and analysis of biomedical data]. Kyiv: Medinform; 2017. Russian.
9. Habieb MS, Abdel-Aziz WF, Ismail AH, Sal­lam KM, El-Shafie MK. Sirtuin1 and Sirtuin3 gene polymorphisms and acute myocardial infarction susceptibility. Meta Gene. 2021 Dec 1;30:100965. doi: https://doi.org/10.1016/j.mgene.2021.100965
10. Shimoyama Y, Mitsuda Y, Tsuruta Y, Suzuki K, Hamajima N, Niwa T. SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients. Journal of Renal Nutrition. 2012 Jan 1;22(1):114-9. doi: https://doi.org/10.1053/j.jrn.2011.10.025
11. Kilic U, Gok O, Erenberk U, Dundaroz MR, To­run E, Kucukardali Y, et al. A remarkable age-related increase in SIRT1 protein expression against oxidative stress in elderly: SIRT1 gene variants and longevity in human. PloS one. 2015 Mar 18;10(3):e0117954. doi: https://doi.org/10.1371/journal.pone.0117954
12. Letonja J, Završnik M, Makuc J, Šeruga M, Peterlin A, Cilenšek I, Petrovič D. Sirtuin 1 rs7069102 polymorphism is associated with diabetic nephropathy in patients with type 2 diabetes mellitus. Bosnian Journal of Basic Medical Sciences. 2021 Oct;21(5):642. doi: https://doi.org/10.17305/bjbms.2020.5368
13. Ji JS, Liu L, Shu C, Yan LL, Zeng Y. Sex Dif­ference and Interaction of SIRT1 and FOXO3 Candidate Longevity Genes on Life Expectancy: A 10-Year Prospective Longitudinal Cohort Study. The Journals of Gerontology: Series A. 2021 Dec 20;2021:glab378. doi: https://doi.org/10.1093/gerona/glab378

Степанов Ю.М. ДУ «Інститут гастроентерології НАМН України», Дніпро, Україна

 https://orcid.org/0000-0002-6721-2468

Діденко В.І. ДУ «Інститут гастроентерології НАМН України», Дніпро, Україна, 
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-8953-396X

Кленіна І.А. ДУ «Інститут гастроентерології НАМН України», Дніпро, Україна

 https://orcid.org/0000-0002-5878-179X

Татарчук О.М. ДУ «Інститут гастроентерології НАМН України», Дніпро, Україна

 https://orcid.org/0000-0002-0672-972X

Петішко О.П. ДУ «Інститут гастроентерології НАМН України», Дніпро, Україна

 https://orcid.org/0000-0002-4559-4055

1. Younossi ZM, Stepanova M, Younossi Y, Go­labi P, Mishra A, Rafiq N, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69(3):564-8.
   doi: https://doi.org/10.1136/gutjnl-2019-318813
2. Petta S, Ting J, Saragoni S, Degli Esposti L, Shreay S, Petroni ML, et al. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy. Nutrition, metabolism, and cardiovascular diseases. 2020;30(6):1014-22. doi: https://doi.org/10.1016/j.numecd.2020.02.016
3. Durazzo M, Ponzo E, Bonetto S, Fagoonee S, Pel­licano R. Liver diseases in the elderly. Minerva medica. 2019;110(1):35-51.
   doi: https://doi.org/10.23736/S0026-4806.18.05858-5
4. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J. Hepatol. 2019;70:151-71.
   doi: https://doi.org/10.1016/j.jhep.2018.09.014
5. Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV, Webber L, et al. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. Journal of hepatology. 2018;69(3):718-35. doi: https://doi.org/10.1016/j.jhep.2018.05.011
6. Park SH, Plank LD, Suk KT, Park YE, Lee J, Choi JH, et al. Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017. Clinical and molecular hepatology. 2020;26(2):209-15. doi: https://doi.org/10.3350/cmh.2019.0065
7. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. Journal of hepatology.2019;70(1):151-71.  doi: https://doi.org/10.1016/j.jhep.2018.09.014
8. Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the Global Burden of Chronic Li­ver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Hepatology (Baltimore, Md.). 2020;72(5):1605-16. doi: https://doi.org/10.1002/hep.31173
9. Roehlen N, Crouchet E, Baumert TF. Liver Fib­rosis: Mechanistic Concepts and Therapeutic Perspectives. Cells.2020;9(4):875. doi: https://doi.org/10.3390/cells9040875
10. Stepanov Y, Didenko V, Konenko I, Tatarchuk O, Petishko O. [The characteristics of immune status and carbohydrate metabolism at different stages of liver fibrosis in patients with hepatitis C virus-related chronic hepatitis]. Gastroenterology. 2021;54(1):18-23. Ukrainian. doi: https://doi.org/10.22141/2308-2097.54.1.2020.199137.
11. Niederreiter L, Til H. Cytokines and fatty liver diseases. Liver Research. 2018;2(1):14-20. doi: https://doi.org/10.1016/j.livres.2018.03.003
12. Caballería L, Pera G, Arteaga I, Rodríguez L, Alumà A, Morillas RM, et al. High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study. Clin Gastroenterol Hepatol.2018;16(7):1138-45. doi: https://doi.org/10.1016/j.cgh.2017.12.048
13. Stepanov YM, Didenko VI, Konenko IS, Yah­mur VB, Petishko OP. [Method for diagnosing hepatic steatosis in patients with non-alcoholic fatty liver disease]. Patent 136479 Ukraina: A61B8/00, A61B8/12. №u201900966, 30.01.2019. 27.08.2019. Ukrainian.
14. [Unified clinical protocol of primary, secondary (specialized) medical care for alcoholic hepatitis. Order of the Ministry of Health of Ukraine dated November 6, 2014 No. 826]. (2014). Ukrainian.
15. Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. International Journal of Molecular Sciences. 2015;17(1):14. doi: https://doi.org/10.3390/ijms17010014
16. Zayadeen AR, Hijazeen S, Smadi M, Fayyad L, Halasa M, AlQusous S. et al. Comparing shear wave elastography with liver biopsy in the assessment of liver fibrosis at King Hussein Medical Center. Egypt Liver Journal. 2022;12(24). doi: https://doi.org/10.1186/s43066-022-00186-z
17. Stepanov YuM, Didenko VI, Konenko IS, Kle­nina IA, Yagmur VB, Petishko OP. [Role of biochemical and hemodynamic indicators in assessing the progression of liver fibrosis of various origins]. Suchasna gastro­enterolohiia. 2019:5:5-13. Ukrainian. doi: https:// doi.org/10.30978/MG-2019-5-5
18. Strakhova OP, Androsov OI. [Statistical methods of processing the results of medical and biological re­search: educational and methodological manual]. Ryzho­va OA, editor. Lviv: Vydavets Marchenko T.V.; 2021. Ukrainian.
19. Zviahintseva TD, Chernobai AI. [Metabolically associated fatty liver disease: focus on metabolic disorders and their correction]. Zdorovia Ukrainy. 2021;4(62). Ukrainian.
20. Zhang D, Huang J, Luo D, Feng X; Liu Y, Liu Y. Glycosylation change of alpha1-acid glyco­protein as a serum biomarker for hepatocellular carci­noma and cirrhosis. Biomark Med. 2017;11(15):423-30. doi: https://doi.org/10.2217/bmm-2016-0284
21. Tanabe K, Kitagawa K, Kojima N, Iijima S. Multifucosylated alpha-1-acid glycoprotein as a novel marker for hepatocellular carcinoma. J Proteome Res. 2016;15(9):2935-44. doi: https://doi.org/10.1002/hep.21242
22. Hastings KL, Green MD, Gao B, Ganey PE, Roth RA, Burleson GR. Beyond metabolism: role of the immune system in hepatic toxicity. Int J Toxicol. 2020;39(2):151-64. doi: https://doi.org/10.1177/109158181989839914
23. Tatarchuk OM, Didenko VI, Melanich SL, Kud­ryavtseva VYe. [Immunological reactivity in patients with chronic diffuse liver diseases]. Hastroenterolohiia. 2018;52(4):222-6. Ukrainian. doi: https://doi.org/10.22141/2308-2097.52.4.2018.154142.

Клигуненко О.М. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0001-8470-4790

Кравець О.В. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0003-1340-3290

Марзан О.О. Дніпровський державний медичний університет, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0003-1263-2198

1. Gestational Hypertension and Preeclampsia ACOG Practice Bulletin, Number 222. Obstetrics & Gynecology.2020 June;135(6). doi: https://doi.org/10.1097/AOG.0000000000003891
2. Cater JH, Kumita JR, Zeineddine Abdallah R, Zhao G, Bernardo-Gancedo A, Henry A, et al. Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer's-associated amy­loid beta peptide. Proc Natl AcadSciUSA. 2019;116:61016110. doi: https://doi.org/10.1073/pnas.1817298116
3. Süleyman Serkan Karaşin, Tayfur Çift. The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia. Rev Bras Ginecol Obstet. 2020 Mar;42(3):133-9. doi: https://doi.org/10.1055/s-0040-1709662
4. Regitz-Zagrosek V, Roos-Hesselink JW, Bauer­sachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur. Heart J. 2018;39(34):3165-241. doi: https://doi.org/10.1093/eurheartj/ehy340
5. Burton GJ, Redman CW, Roberts JM, et al. Preeclampsia: pathophysiology and clinical implications. BMJ.2019;366:l2381. doi: https://doi.org/10.1136/bmj.l2381
6. Ridder A, Giorgione V, Khalil A, et al. Preeclam­psia: the relationship between uterine artery blood flow and trophoblast function. Int. J. Mol. Sci. 2019;20(13):3263. doi: https://doi.org/10.3390/ijms20133263
7. Staff AC, Fjeldstad HE, Fosheim IK, et al. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am. J. Obstet. Gynecol. 2020;S0002-9378(20):31116-9. doi: https://doi.org/10.1016/j.ajog.2020.09.026
8. Alnaes-Katjavivi P, Roald B, Staff AC. Utero­placental acute atherosis in preeclamptic pregnancies: rates and clinical outcomes differ by tissue collection methods. Pregnancy Hypertens. 2020;19:11-17. doi: https://doi.org/10.1016/j.preghy.2019.11.007
9. Than NG, Romero R, Tarca AL, Kekesi KA, Xu Y, Xu Z, et al. Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia. Front Immunol. 2018;9(1661). doi: https://doi.org/10.3389/fimmu.2018.01661
10. McCarthy FP, Adetoba A, Gill C, Bramham K, Bertolaccini M, Burton GJ, et al. Urinary congophilia in women with hypertensive disorders of pregnancy and preexisting proteinuria or hypertension. Am J Obstet Gynecol. 2016;215:464.e1-e7. doi: https://doi.org/10.1016/j.ajog.2016.04.041
11. Aouache R, Biquard L, Vaiman D, Miralles F. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018;19(1496). doi: https://doi.org/10.3390/ijms19051496 
12. Brown MA, Magee LA, Kenny LC, Karuman­chi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291-310. doi: https://doi.org/10.1016/j.preghy.2018.05.004 
13. Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2017;50:589-95. doi: https://doi.org/10.1002/uog.17531
14. Poon LC, Shennan A, Hyett JA, Kapur A, Ha­dar E, Divakar H, et al. The international federation of gynecology and obstetrics (FIGO) initiative on preeclam­psia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):S1-S33. doi: https://doi.org/10.1002/ijgo.12802
15. Webster K, Fishburn S, Maresh M, Findlay SC, Chappell LC. Diagnosis and management of hypertension in pregnancy: Summary of updated NICE guidance. BMJ. 2019;366(l5119). doi: https://doi.org/10.1136/bmj.l5119
16. Artiomenko VV, Berlinskaya LI. [Risk factors of preeclampsia development]. Visnyk morskoi medytsyny. 2018;1(78):108-114. Ukrainian. doi: https://doi.org/5281/zenodo.1240781
17. Klygunenko EN, Zozulya ОА. [Human serum albumin (past and future)]. Meditsina neotlozhnykh sostoianii. 2017;5(84):26-30. Russian. doi: https://doi.org/10.22141/2224-0586.5.84.2017.109356
18. Klygunenko EN, Volkov AO. [Correlation of pro- and anti-inflammatory cytokines in pregnant women in the third trimester]. Meditsina neotlozhnykh sostoianii. 2013;6(53):162-4. Russian.
19. Klygunenko EN, Marzan OO. [The influence of pregnancy that is complicated by preeclampsia on the main parameters of central and peripheral hemodynamics and body water compartments volume]. Ukrainskyi medychnyi chasopys. 2021;2(142):71-73. Ukrainian. doi: https://doi.org/32471/umj.1680-3051.142.203830
20. [On approval of the protocol «Hypertensive disorders during pregnancy, childbirth and the postpartum period»]. Order of the Ministry of Health of Ukraine from 2022, Pub. No. 151. (Jan 24, 2022). Ukrainian. Available from: https://www.dec.gov.ua/mtd/gipertenzyvni-rozlady-y-vagitnyh/
21. Whittier N, Wildhagen T, Gold H. Statistics for Social Understanding With Stata and SPSS. Rowman & Littlefield Pub. 2019;(17):210-45.

Хасхачих Д.А. Дніпровський державний медичний університет, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

  https://orcid.org/0000-0001-5097-6667

Потапов В.О. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0001-7498-7416

1. Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M. En­dometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022 Aug;306(2):407-21. PMID: 35001185; PMCID: PMC9349105. doi: https://doi.org/10.1007/s00404-021-06380-5
2. Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT. New concepts for an old prob­lem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017 Mar 1;23(2):232-54. PMID: 27920066; PMCID: PMC5850217. doi: https://doi.org/10.1093/humupd/dmw042
3. Raffone A, Travaglino A, Saccone G, Insabato L, Mollo A, De Placido G, Zullo F. Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis. Arch Gynecol Obstet. 2019 May;299(5):1233-42. Epub 2019 Feb 27.PMID: 30810881. doi: https://doi.org/10.1007/s00404-019-05103-1
4. Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M. Endo­metrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022 Jan 10. Epub ahead of print. PMID: 35001185.
   doi: https://doi.org/10.1007/s00404-021-06380-5
5. Al Nemer AM, Al Bayat MI, Al Qahtani NH. The accuracy of endometrial sampling for the diagnosis of patterns of endometrial pathology in women presenting with abnormal uterine bleeding. More conservative thera­peutic approaches. Saudi Med J. 2019 Aug;40(8):815-9. PMID: 31423519; PMCID: PMC6718861. doi: https://doi.org/10.15537/smj.2019.8.24449
6. Lax SF. Vorläuferläsionen der Endometrium­karzi­nome [Precursor lesions of endometrial carcinoma]. Patho­loge. 2019 Feb;40(1):13-20. Deutsch.
   PMID: 30707274.
   doi: https://doi.org/10.1007/s00292-019-0568-5
7. Sobczuk K, Sobczuk A. New classification system of endometrial hyperplasia WHO 2014 and its clinical implications. Prz Menopauzalny. 2017 Sep;16(3):107-11. Epub 2017 Oct 12. PMID: 29507578; PMCID: PMC5834925. doi: https://doi.org/10.5114/pm.2017.70589
8. Khaskhachikh DA, Potapov VO, Kukina GO. Differentiated approach to the treatment of endometrial hyperplasia without atypia in women of reproductive age. Current issues of pediatrics, obstetrics and gynecology. 2019;2(24):149-54. Ukranian. doi: https://doi.org/10.11603/24116-4944.2019.2.10935
9. Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod 2017;23(2):232-54. PMCID: PMC5850217. PMID: 27920066.
10. Gromova OL, Potapov VO, Khaskhachykh DA, Fin­kova OP, Gaponova OV, Kukina GO, Penner KV. Epi­genetic profile of endometrial proliferation in the different morphotypes of endometrial hyperplasia. Reproductive Endocrinology.2021;57:68-78. doi: https://doi.org/10.18370/2309-4117.2021.57.68-78
11. Hassan WA, Ibrahim R. Expression of CD117, CD34, and VEGF proteins in progression from endo­metrial hyperplasia to endometrioid carcinoma. Int J Clin Exp Pathol. 2020 Aug 1;13(8):2115-22. PMID: 32922608; PMCID: PMC7476947.
12. Huvila J, Pors J, Thompson EF, Gilks CB. Endo­metrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis. J Pathol. 2021 Apr;253(4):355-65. Epub 2021 Feb 6. PMID: 33368243. doi: https://doi.org/10.1002/path.5608
13. Craciunas L, Gallos I, Chu  , Bourne T, Quenby S, Brosens JJ, Coomarasamy A. Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis. Hum Reprod Update. 2019 Mar 1;25(2):202-23. PMID: 30624659. doi: https://doi.org/10.1093/humupd/dmy044
14. Uysal G, Acmaz G, Madendag Y, Cagli F, Ak­kaya H, Madendag I, Karakilic EU. The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia. Gynecol Obstet Invest. 2018;83(2):151-5. Epub 2017 Jul 15. PMID: 28715800. doi: https://doi.org/10.1159/000477618
15. MacLean JA, Hayashi K. Progesterone Actions and Resistance in Gynecological Disorders. Cells. 2022 Feb 13;11(4):647. PMID: 35203298; doi: https://doi.org/10.3390/cells11040647
16. Sletten E, Arnes L, Lyså М, Larsen M, Orbo A. Significance of progesterone receptors (PR-A and PR-B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study. BJOG.2019;126(7):936-43. doi: https://doi.org/10.1111/1471-0528.15579
17. Tanos V, Balami S, Lingwood L. Junctional zone endometrium alterations in gynecological and obstetrical disorders and impact on diagnosis, prognosis and treat­ment. Curr Opin Obstet Gynecol. 2019 Dec;31(6):418-27. PMID: 31573995. doi: https://doi.org/10.1097/GCO.0000000000000572
18. Yu J. Hormone Resistance. Adv Exp Med Biol. 2021;1187:391-401. PMID: 33983590. doi: https://doi.org/10.1007/978-981-32-9620-6_20
19. Maciel LFS, Silva ESM, Oliveira-Filho JP, Fritsch SC, Rossi RS, Lourenção JAC, Meira C. Endo­metrial expression of estrogen and progesterone receptors in non-cyclic mares treated only with long-acting pro­gesterone. [Internet]. Theriogenology. 2018 Mar 1;108:185-91. Epub 2017 Dec 2. PMID: 29223656. doi: https://doi.org/10.1016/j.theriogenology.2017.11.037
20. Gromova OL, Potapov VO, Khaskhachikh DA, Kukina GO, Gaponova OV, Penner KV. [Receptor status of the endometrium in hyperplastic processes in premenopausal women]. Neonatology, surgery and perinatal medicine. 2021;1(39):33-38. Ukranian. doi: https://doi.org/10.24061/2413-4260.XI.1.39.2021.5
21. Gallos ID, Alazzam M, Clark T, Faraj R, Ro­senthal A, Smith PGJ. Management of Endometrial Hyper­plasia. Royal College of Obstetricians & Gynaecologists. Retrieved from. [Internet]. RCOG/BSGE Green-top Guideline; 2016 [cited 2022 Apr 14]. Available from: https://rcog.org.uk/en/guidelines-research-services/guidelines/
22. Campo G, Rebecchi A, Vanni VS, Pagliardini L, Patruno C, Papaleo E, et al. Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia. Reprod Biomed Online. 2021 Nov;43(5):864-70. Epub 2021 Aug 30. PMID: 34629315. doi: https://doi.org/10.1016/j.rbmo.2021.08.022
23. Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N. Oral and intrauterine progestogens for atypical endometrial hyperplasia. [Internet]. Cochrane Database Syst Rev; 2018 Dec 4;12(12):CD009458 [cited 2022 Apr 14]. PMID: 30521671; PMCID: PMC6517239. doi: https://doi.org/10.1002/14651858.CD009458.pub3
24. Clark K, Westberg SM. Benefits of Levonor­gestrel Intrauterine Device Use vs. Oral or Transdermal Progesterone for Postmenopausal Women Using Estro­gen Containing Hormone Therapy. Innov Pharm. 2019 Jul 22;10(3):10.24926/iip.v10i3.2002. PMID: 34007573; PMCID: PMC8127097. doi: https://doi.org/10.24926/iip.v10i3.2002
25. Doherty MT, Sanni OB, Coleman HG, Card­well CR, McCluggage WG, Quinn D, McMenamin UC. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and metaanalysis. PloS 2020;15(4):e0232231. doi: https://doi.org/10.1371/ journal.pone.0232231
26. Khaskhachikh DA, Potapov VO, Kukina GO. [Dif­ferentiated approach to the treatment of endometrial hyperplasia without atypia in women of reproductive age]. Actual Problems of Pediatrics, Obstetrics and Gynecology. 2019;2(24):149-54. Ukranian. doi: https://doi.org/10.11603/24116-4944.2019.2.10935
27. Maker A, Gumbiner BM. Reconstitution of the full transmembrane cadherin-catenin complex. Protein Expr Purif [Internet]. 2022 May;193:106056 [cited 2022 Apr 14]. Epub 2022 Jan 18. PMID: 35063654. doi: https://doi.org/10.1016/j.pep.2022.106056
28. Gul IS, Hulpiau P, Saeys Y, van Roy F. Evolution and diversity of cadherins and catenins. Exp Cell Res. 2017 Sep 1;358(1):3-9. Epub 2017 Mar 6. PMID: 28268172. doi: https://doi.org/10.1016/j.yexcr.2017.03.001
29. Blaschuk OW. Potential Therapeutic Applications of N-Cadherin Antagonists and Agonists. Front Cell Dev Biol [Internet]. 2022 Mar 3;10:866200 [cited 2022 Feb 02]. PMID: 35309924. PMCID: PMC8927039. doi: https://doi.org/10.3389/fcell.2022.866200
30. Chatzipantelis P, Koukourakis M, Balaska K, Giatromanolaki A. Endometrial Stromal Expression of ER, PR, and B-Catenin Toward Differentiating Hyperplasia Diagnoses. Int J Surg Pathol. 2022 Aug;30(5):492-8. Epub 2021 Dec 6. PMID: 34866456. doi: https://doi.org/10.1177/10668969211065110
31. Auclair MH, Yong PJ, Salvador S, Thurston J, Col­gan TTJ, Sebastianelli A. Guideline No. 390-Clas­sification and Management of Endometrial Hyperplasia. J Obstet Gynaecol Can. 2019 Dec;41(12):1789-800. doi: https://doi.org/10.1016/j.jogc.2019.03.025
32. Antomonov MYu. [Mathematical processing and analysis of biomedical data]. Kyiv: Medinform; 2018. Russian.
33. [Decree of the Ministry of Health of Ukraine dated 05.05.2021 No. 869 "On the approval of the Unified Cli­nical Protocol for Primary, Secondary (Specialized), Ter­tiary (Highly Specialized) Medical Assistance "Hyper­plasia Endometriya"]. [Internet]. (2021). [cited 2022 Feb 02]. Ukrainian. Available from: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-05052021--869-pro-zatverdzhennja-unifikovanogo-klinichnogo-protokolu-pervinnoi-vtorinnoi-specializovanoi-tretinnoi-visokospecializovanoi-medichnoi-dopomogi-giperplazija-endometrija

Юр’єва Л.М. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0002-1713-1037

Шустерман Т.Й. Дніпровський державний медичний університет, Дніпро, Україна,
е-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-5422-1624

Подольська Л.В. Дніпровський державний медичний університет, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-3615-7048

1. Antomonov MY. [Mathematical processing and analysis of biomedical data]. 2nd ed. Kyiv: Medinform; 2018.
2. Yuryeva LM, Ogorenko VV, Gnenna OM, Koka­shinskii VO. [The influence of the level of self-esteem of medical students on the confidence in choosing a future specialization]. Modern engineering and innovative technologies [Internet]. 2020;13(5):49-53. Russian.
3. Gutnik VV, Chepelev SN. [The prevalence of signs of asthenic syndrome in medical students]. Fundamentalnaia nauka v sovremennoi meditsine [Іnter­net]. 2021:388-92. Available from: http://rep.bsmu.by:8080/handle/BSMU/31642
4. Zhurakovskaya L. [Educational (educational) mig­ration to Ukraine: state, problems and prospects]. Moldoscopie. 2017;4(79):127-43. Russian.
5. Leshhenko TO, Yufimenko VG. [The Ukrainian language as a tool for professional adaptation of foreign students in Ukraine. Actual issues of medical (pharma­ceutical) education of foreign citizens: problems and prospects]. Conference. 2018 Nov 22; Poltava. 2018. p. 54-56. Ukrainian.
6. Trofimov EA, Trofimova TI. [Features of edu­cational migration in the context of globalization. In: Trends and problems in the Russian economy: theoretical and practical aspects]. Materials of the All-Russian scientific and practical conference; 2017 March 23. Irkutsk: Baikal State University. 2017. p. 219-24. Russian. doi: https://doi.org/10.17223/978-5-94621-954-9-2020-1
7. Haustov MM. [Medico-psychological view on the problem of adaptation disorders in students]. Medytsyna sohodni i zavtra. 2020 Dec 19;83(2). Ukrainian. doi:  https://doi.org/10.35339/msz.2019.83.02.06
8. Osório FL, Loureiro SR, Hallak JE, Machado‐de‐Sousa JP, Ushirohira JM, Baes CV, et al. Clinical validity and intrarater and test–retest reliability of the Structured Clinical Interview for DSM‐5 – Clinician Version (SCID‐5‐CV). Psychiatry and Clinical Neurosciences [Internet]. 2019 Oct 14;73(12):754-60. doi: https://doi.org/10.1111/pcn.12931
9. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research [Internet]. 1995;39(3):315-25. doi: https://doi:10.1016/0022-3999(94)00125-o
10. The Universal Declaration on Bioethics and Human Rights. International Social Science Journal [Internet]. 2005 Dec [cited 2021 Oct 29];57(186):745-53. doi: https://doi.org/10.1111/j.1468-2451.2005.00592
11. Zdun-Ryżewska A, Nadrowska N, Basiński K, Walkiewicz M, Błażek M. Who is a tired student? Fatigue and its predictors from a gender perspective. Journal of University Teaching & Learning Practice. 2021;18(6):139-54. doi: https://doi.org/10.53761/1.18.6.10
12. World Medical Association Declaration of Helsinki. JAMA [Internet]. 2013 Nov 27 [cited 2021 Oct 29];310(20):2191. doi: https://doi.org/10.1001/jama.2013.281053

Огоренко В.В. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0003-0549-4292

Шорніков А.В. Дніпровський державний медичний університет, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-8196-9128

Завалко Ю.М. КП «Дніпровська багатопрофільна клінічна лікарня з надання психіатричної допомоги» ДОР», Дніпро, Україна, е-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-7579-5002

1. Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the Hip: A Primer. The Permanente journal. 2019;23:18-100. doi: https://doi.org/10.7812/TPP/18-100
2. Pidlubnyi VL. [Prognostic and socio-economic significance of using the mental health assessment system model]. ZaporozhyeMedical  2021 Apr 16;23(2):286-92. doi: https://doi.org/10.14739/2310-1210.2021.2.205344
3. Osawa Y, Seki T, Takegami Y, Kasai T, Hi­guchi Y, Ishiguro N. Do femoral head collapse and the contralateral condition affect patient-reported quality of life and referral pain in patients with osteonecrosis of the femoral head? International Orthopaedics (SICOT). 2018;42(7):1463-8. doi: https://doi.org/10.1007/s00264-018-3867-1
4. He D, Xue Y, Li Z, Tang Y, Ding  H, Yang Z, et al. Effect of Depression on Femoral Head Avascular Necrosis From Femoral Neck Fracture in Patients Younger Than 60 Years. Orthopedics.2014;37(3):e244-51. doi: https://doi.org/10.3928/01477447-20140225-56
5. Chen S-B, Hu H, Gao Y-S, He H-Y, Jin D-X, Zhang C-Q. Prevalence of Clinical Anxiety, Clinical Depression and Associated Risk Factors in Chinese Young and Middle-Aged Patients with Osteonecrosis of the Femoral Head. PLOS ONE. 2015;10(3):e0120234. doi: https://doi.org/10.1371/journal.pone.0120234
6. Richard HM, Cerza SP, De La Rocha A, Podesz­wa DA. Preoperative mental health status is a significant predictor of postoperative outcomes in adolescents treated with hip preservation surgery. Journal of Children's Orthopaedics.2020;14(4):259-65. doi: https://doi.org/10.1302/1863-2548.14.200013
7. Wouters RM, Vranceanu A-M, Slijper HP, Ver­meulen GM, et al. Patients With Thumb-base Osteoarthritis Scheduled for Surgery Have More Symptoms, Worse Psychological Profile, and Higher Expectations Than Non­sur­gical Counterparts: A Large Cohort Analysis. Clinical Ortho­paedics and Related Researches. 2019;477(12):2735-46. doi: https://doi.org/10.1097/CORR.0000000000000897
8. Takemoto G, Seki T, Osawa Y, Takegami Y, Ku­sano T, Imagama S. Preoperative Risk Factors for Dis­satisfaction After Total Hip Arthroplasty Among Patients With Osteonecrosis of the Femoral Head. Research Square [Internet];
   doi: https://doi.org/10.21203/rs.3.rs-103521/v1
9. Atula S. [Guideline 00708. Mental disorders due to somatic disease]. The Finnish Medical Society Duodecim. [Internet]; 2017 [cited 2022 Jun 16]. Available from: https://guidelines.moz.gov.ua/documents/3503.
10. Laukkala T. [Guideline 01068. Psychiatric exami­nation of adults]. The Finnish Medical Society Duodecim. [Internet]; 2017 [cited 2022 Jun 16]. Ukrainian. Available from: https://guidelines.moz.gov.ua/documents/3785.
11. Leppävuori A, Räsänen А. [Guideline 00708. Pa­tient with psychosomatic symptoms]. The Finnish Medical Society Duodecim. [Internet]; 2017 [cited 2022 Jun 16]. Ukrainian. Available from: https://guidelines.moz.gov.ua/documents/3504
12. Ivanchuk M, Polishchuk O. [Features of statistical analysis of medical and psychological research]. PMGP. 2020;5(3):e0504255. Ukrainian. Available from: https://uk.e-medjournal.com/index.php/psp/article/view/255

Басанець А.В. ДП «Науковий центр превентивної токсикології, харчової та хімічної безпеки імені академіка Л.І. Медведя МОЗ України», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-8236-4251

Гвоздецький В.А. ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-4663-141X

1. Nahorna AM, Sokolova MP, Vitte PM. [State of occupational morbidity in the period of legislation chan­ges]. Ukrainian Journal of Occupational Health. 2016;46(1):3-15. Ukrainian. doi: https://doi.org/10.33573/ujoh2016.01.003
2. Cameron Barton, Piyush Kalakoti, Nicholas A Be­dard, Nathan R Hendrickson, Comron Saifi, Andrew J Pu­gely. What are the aosts of LSR Radiculopathy prior to surgi­cal treatment. Spine (Phila Pa 1976). 2019 Jul 1;44(13):937-42. doi: https://doi.org/10.1097/BRS.0000000000002983
3. Sadaf Shafique, Shakeel Ahmad, Syed Shakil-Ur-Rehman. Effect of Mulligan spinal mobilization with arm movement along with neurodynamics and manual traction in LSRP patients: a randomized controlled trial. J Pak Med Assoc. 2019 Nov;69(11):1601-4.
   doi: https://doi.org/ 10.5455/JPMA.297956
4. John-Michael Li, Jinny Tavee. Electrodiagnosis of radiculopathy. Handb Clin Neurol. 2019;161:305-16. doi: https://doi.org/10.1016/B978-0-444-64142-7.00056-4
5. Selkirk SM, Ruff Low back pain, radi­culopathy. Handb Clin Neurol. 2016;136:1027-33. doi: https://doi.org/10.1016/B978-0-444-53486-6.00053-3
6. Jae Hyeon Park, Sun G Chung, Keewon Kim. Electrodiagnostic characteristics of upper lumbar stenosis: Discrepancy between neurological and structural levels. Muscle 2020 May;61(5):580-6. doi: https://doi.org/10.1002/mus.26844
7. Antomonov MY. [Mathematical processing and analysis of biomedical data]. Kyiv: Medinform; 2018;2:31-45. Ukrainian.
8. Gorblyanskiy YuYu, Yakovleva NV, Kosoro­tova NS, Bulavina MV. [Prevention of lumbosacral radicu­lopathy in coal miners]. Med Tr Prom Ekol. 2016;(9):5-10. Russian.
9. Arash Babaei-Ghazani, Bina Eftekharsadat, Bah­ram Samadirad, Vida Mamaghany, Saeed Abdollahian. Traumatic lower extremity and lumbosacral peripheral nerve injuries in adults: Electrodiagnostic studies and patients symptoms. J Forensic Leg Med. 2017 Nov;52:89-92. doi: https://doi.org/10.1016/j.jflm.2017.08
10. Stålberg E, van Dijk H, Falck B, Kimura J, Neu­wirth C, Pitt M, et al. Standards for quantification of EMG and neurography. Clin Neurophysiol. 2019 Sep;130(9):1688-729. Epub 2019 Jun 10. PMID: 31213353. doi: https://doi.org/10.1016/j.clinph.2019.05.008
11. Battakova S, Shraimanov B. Neurophysiological changes in the afferent somatosensory system indices in the case of vertebrogenic spine pathology in miners. Int J Occup Med Environ Health. 2013 Apr;26(2):230-4. Epub 2013 Jun 15. PMID: 23771862. doi: https://doi.org/10.2478/s13382-013-0109-z

Ісаєв О.А. Дніпровський державний медичний університет; КП «Дніпропетровська обласна клінічна офтальмологічна лікарня», Дніпро, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-6737-677X

Сердюк В.М. Дніпровський державний медичний університет; КП «Дніпропетровська обласна клінічна офтальмологічна лікарня», Дніпро, Україна, e-mail:  Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-9495-2472

1. Ling JD, Bell NP. Role of cataract surgery in the management of glaucoma. Int Ophthalmol Clin. 2018;58(3):87-100. doi: https://doi.org/10.1097/IIO.0000000000000234
2. Cieza A, Keel S, Kocur I, Mccoy M, Mariotti SP. World report on vision. Geneva: World Health Organiza­tion. [Internet]; 2019. Available from: https://www.who.int/health-topics/blindness-and-vision-loss#tab=tab_1
3. Wang W, He M, Li Z, Huang W. Epidemiological variations and trends in health burden of glaucoma worldwide. Acta Ophthalmol. 2019;97(3):e349-e355. doi: https://doi.org/10.1111/aos.14044
4. Flaxman SR, Bourne RR, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Vision loss expert group of the global burden of disease study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221-e34. doi: https://doi.org/10.1016/S2214-109X(17)30393-5
5. Bourne RR. Vision 2020: where are we? Curr Opin Ophthalmol. 2020;31(2):81-84. doi: https://doi.org/10.1097/ICU.0000000000000647
6. Torres LA, Hatanaka M. Correlating structural and functional damage in glaucoma. J Glaucoma. 2019;28(12):1079-85. doi: https://doi.org/10.1097/IJG.0000000000001346
7. Hymes J. Glaucoma. American Optometric Asso­ciation. [Internet]; 2020. Available from: https://www.aoa.org/healthy-eyes/eye-and-visionconditions/glaucoma?sso=y
8. Mudassar IB, Yew KK, Thambiraja R, Sulong S, Ghulam RA, Ahmad TL. Microvascular endothelial func­tion and primary open angle glaucoma. Ther Adv Ophthalmol. 2019;11:2515841419868100. doi: https://doi.org/10.1177/2515841419868100
9. Vargas-Valderrama A, Messina A, Mitjavila-Gar­cia MT, Guenou H. The endothelium, a key actor in organ development and hPSC-derived organoid vascularization. JBiomed  2020;27(1):67. doi: https://doi.org/10.1186/s12929-020-00661-y
10. Krüger-Genge A, Blocki A, Franke RP, Jung F. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20(18):4411. doi: https://doi.org/10.3390/ijms20184411
11. Picciano AL, Crane BR. A nitric oxide synthase-like protein from Synechococcus produces NO/NO3- from l-arginine and NADPH in a tetrahydrobiopterin- and Ca2+-dependent manner. J Biol Chem. 2019;294(27):10708-19. doi: https://doi.org/10.1074/jbc.RA119.008399
12. Liu Y, Allingham RR. Major review: Molecular genetics of primary open-angle glaucoma. Exp Eye Res. 2017;160:62-84. doi: https://doi.org/10.1016/j.exer.2017.05.002
13. Salari N, Bokaee S, Farshchian N, Moham­ma­di M, Kazeminia M. The role of polymorphisms rs2070744 and rs1799983 eNOS gene in patients with POAG: a systematic review and meta-analysis. Int Ophthalmol. 2021 Apr 10. doi: https://doi.org/10.1007/s10792-021-01832-y
14. Terminology and Guidelines for Glaucoma. 4th Edition. European Glaucoma Society. Available on: eugs.org
15. Antomonov M.Yu. [Mathematical processing and analysis of medical and biological data]. 2 ed. Kyiv: Malyi druk. 2017.
16. Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow  2013 Mar;48(3):452-8. doi: https://doi.org/10.1038/bmt.2012.244
17. Magalhães da Silva T, Rocha AV, Lacchini R, Marques CR, Silva ES, Tanus-Santos JE, et al. Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population. Gene. 2012;502(2):142-6. doi: https://doi.org/10.1016/j.gene.2012.04.047
18. Kang JH, Wiggs JL, Haines J, Abdrabou W, Pas­quale LR. Reproductive factors and NOS3 variant interactions in primary open-angle glaucoma. Mol. Vis. 2011;17:2544-51. PMCID: PMC3198482. PMID: 22025889.
19. Emam WA, Zidan HE, Abdulhalim BE, Da­bour SA, Ghali MA, Kamal AT. Endothelial nitric oxide synthase polymorphisms and susceptibility to high-tension primary open-angle glaucoma in an Egyptian cohort. Mol. Vis.2014;20:804-11. PMID: 24940036; PMCID: PMC4057245.
20. Xiang Y, Dong Y, Li X, Tang X. Association of Com­mon Variants in eNOS Gene with Primary Open Angle Glau­coma: A Meta-Analysis. J Ophthalmol. 2016;2016:1348347. doi: https://doi.org/10.1155/2016/1348347
21. Kondkar AA, Azad TA, Sultan T, Osman EA, Almobarak FA, Al-Obeidan SA. Association of endo­thelial nitric oxide synthase (NOS3) gene polymorphisms with primary open-angle glaucoma in a Saudi cohort. PLoS ONE. 2020;15(1):e0227417. doi:  https://doi.org/10.1371/journal.pone.0227417

Гавриляк І.В. Національний медичний університет імені О.О. Богомольця, Київ, Україна, 
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

Гребінь Н.К. Національний медичний університет імені О.О. Богомольця, Київ, Україна

Білоус В.Л. Інститут біохімії ім. О.В. Палладіна Національної академії наук України, Київ, Україна

Корса В.В. Інститут біохімії ім. О.В. Палладіна Національної академії наук України, Київ, Україна

Жабоєдов Д.Г. Національний медичний університет імені О.О. Богомольця, Київ, Україна

Агджа Дж.А. Університет Бінгьоль, м. Бінгьоль, 12000, Туреччина, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

Тихомиров А.О. Інститут біохімії ім. О.В. Палладіна Національної академії наук України, Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

1. Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015 Nov; 49:17-45. doi: https://doi.org/10.1016/j.preteyeres.2015.07.002
2. Willmann D, Fu L, Melanson SW. Corneal Injury. 2022 May 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 29083785.
3. Jones G, Lee TJ, Glass J, Rountree G, Ulrich L, Estes A, et al. Comparison of different mass spectrometry workflows for the proteomic analysis of tear fluid. Int J Mol Sci. 2022 Feb 19;23(4):2307. doi: https://doi.org/10.3390/ijms23042307
4. Pang K, Lennikov A, Yang M. Hypoxia adapta­tion in the cornea: current animal models and underlying mecha­nisms. Animal Model Exp Med. 2021 Nov 28;4(4):300-10. doi: https://doi.org/10.1002/ame2.12192
5. Voelter K, Tappeiner C, Riond B, Nuss K, Bruetsch D, Pot SA. Evaluation of D-dimer levels in aqueous humor of rabbit eyes with and without induced intraocular fibrin and fibrinolytic treatment. Vet Ophthalmol. 2020 Mar;23(2):212-8. doi: https://doi.org/10.1111/vop.12706
6. Lee D, Miwa Y, Kunimi H, Ibuki M, Shoda C, Nakai A, Kurihara T. HIF inhibition therapy in ocular diseases. Keio J Med. 2022 Mar 25;71(1):1-12. doi: https://doi.org/10.2302/kjm.2021-0004-IR
7. Wolf M, Clay SM, Oldenburg CE, Rose-Nussbau­mer J, Hwang DG, Chan MF. Overexpression of MMPs in co­rneas requiring penetrating and deep anterior lamellar kera­toplasty. Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1734-47. doi: https://doi.org/10.1167/iovs.18-25961
8. Singh A, Maurya OP, Jagannadhan MV, Pa­tel A. Matrix metalloproteinases (MMP-2 and MMP-9) activity in co­rneal ulcer and ocular surface disorders determined by gela­tin zymography. J Ocul Biol Dis Infor. 2012 Dec 29;5(2):31- doi: https://doi.org/10.1007/s12177-012-9096-8
9. Waszczykowska A, Podgórski M, Waszczy­kows­ki M, Gerlicz-Kowalczuk Z, Jurowski P. Matrix metal­loproteinases MMP-2 and MMP-9, their inhibitors TIMP-1 and TIMP-2, vascular endothelial growth factor and sVEGFR-2 as predictive markers of ischemic retinopathy in patients with systemic sclerosis-case series report. Int J Mol Sci. 2020 Nov 18;21(22):8703. doi: https://doi.org/10.3390/ijms21228703
10. Petrenko OM, Tykhomyrov AA. Levels of angio­genic regulators and MMP-2, -9 activities in Martorell ulcer: a case report. Ukr Biochem J. 2019 Jan-Feb;91(1):100-7. doi: https://doi.org/10.15407/ubj91.01.100
11. Stoscheck CM. Quantitation of protein. Methods Enzymol. 1990;182:50-68. doi: https://doi.org/10.1016/0076-6879(90)82008-P
12. Taylor SC, Posch A. The design of a quantitative western blot experiment. Biomed Res Int. 2014;2014:361590. doi: https://doi.org/10.1155/2014/361590
13. Ranganathan P. An introduction to statistics: choosing the correct statistical test. Indian J Crit Care Med. 2021 May;25(Suppl 2):S184-S186. doi: https://doi.org/10.5005/jp-journals-10071-23815
14. Fu R, Klinngam W, Heur M, Edman MC, Hamm-Alvarez SF. Tear proteases and protease inhi­bitors: potential biomarkers and disease drivers in ocular surface disease. Eye Contact Lens. 2020 Mar;46(Suppl 2):S70- doi: https://doi.org/10.1097/ICL.0000000000000641
15. Coppini LP, Visniauskas B, Costa EF, Filho MN, Rodrigues EB, Chagas JR, et al. Corneal angiogenesis modulation by cysteine cathepsins: In vitro and in vivo studies. Exp Eye Res. 2015 May;134:39-46. doi: https://doi.org/10.1016/j.exer.2015.03.012
16. Hagan S, Martin E, Enríquez-de-Salamanca A. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. EPMA J. 2016 Jul 13;7(1):15. doi: https://doi.org/10.1186/s13167-016-0065-3
17. Zhan X, Li J, Guo Y, Golubnitschaja O. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine. EPMA J. 2021 Dec 3;12(4):449-75. doi: https://doi.org/10.1007/s13167-021-00265-y
18. Bukowiecki A, Hos D, Cursiefen C, Eming SA. Wound-healing studies in cornea and skin: parallels, differences and opportunities. Int J Mol Sci. 2017 Jun 12;18(6):1257. doi: https://doi.org/10.3390/ijms18061257
19. Nishida T, Kojima T, Kataoka T, Isogai N, Yoshi­da Y, Nakamura T. Comparison of corneal biome­chanical properties and corneal tomography between customized and accelerated corneal crosslinking in eyes with keratoconus. Cornea. 2021 Jul 1;40(7):851-8. doi: https://doi.org/10.1097/ICO.0000000000002572
20. Sugioka K, Fukuda K, Nishida T, Kusaka S. The fibrinolytic system in the cornea: a key regulator of corneal wound healing and biological defense. Exp Eye Res. 2021 Mar;204:108459. Epub 2021 Jan 23. doi: https://doi.org/10.1016/j.exer.2021.108459
21. Bitirgen G, Korkmaz C, Zamani A, Ozkagnici A, Zengin N, Ponirakis G, Malik RA. Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID. Br J Ophthalmol. 2021 Jul 26:bjophthalmol-2021-319450. doi: https://doi.org/10.1136/bjophthalmol-2021-319450
22. Hashimoto T, Shibasaki F. Hypoxia-inducible factor as an angiogenic master switch. Front Pediatr. 2015 Apr 24;3:33. doi: https://doi.org/10.3389/fped.2015.00033
23. Peral A, Mateo J, Domínguez-Godínez CO, Carra­cedo G, Gómez JA, Crooke A, Pintor J. Therapeutic potential of topical administration of siRNAs against HIF-1α for corneal neovascularization. Exp Eye Res. 2022 Jun;219:109036. doi: https://doi.org/10.1016/j.exer.2022.109036
24. Lee YH, Bang SP, Shim KY, Son MJ, Kim H, Jun JH. Association of tear matrix metalloproteinase 9 immu­noassay with signs and symptoms of dry eye disease: a cross-sectional study using qualitative, semiquantitative, and quanti­tative strategies. PLoS One. 2021 Oct 18;16(10):e0258203. doi: https://doi.org/10.1371/journal.pone.0258203
25. Bilous VL, Kapustianenko LG, Tykhomyrov AA. Production and application of angiostatins for the treatment of ocular neovascular diseases. Biotech Acta. 2021;14(1):5-24. doi: https://doi.org/10.15.407/biotech14.01.005
26. Sack RA, Beaton AR, Sathe S. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization. Curr Eye Res. 1999 Mar;18(3):186-93. doi: https://doi.org/10.1076/ceyr.18.3.186.5367
27. Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020;138:575-8. doi: https://doi.org/10.1001/jamaophthalmol.2020.1291
28. Jiang L, Yang Y, Gandhewar J. Bilateral corneal endothelial failure following COVID-19 pneumonia. BMJ Case Rep. 2021 Sep 20;14(9):e242702. doi: https://doi.org/10.1136/bcr-2021-242702

Святенко Т.В. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0003-4303-2937

Старостіна О.О. Дніпровський державний медичний університет, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-7304-9911

Захаров С.В. Дніпровський державний медичний університет, Дніпро, Україна

 https://orcid.org/0000-0002-2278-5692

Соловйова С.В. Дніпровський державний медичний університет, Дніпро, Україна

1. Vyumvuhore RR, Michael-Jubeli R, Verzeaux L, Boudier D, Le Guillou M, BordesS, et al. Lipid organi­zation in xerosis: the key of the problem? Int J Cosmet Sci. 2018;40(6):549-54. doi: https://doi.org/10.1111/ics.12496
2. Kovalova TM, Polovko NP. [Xerosis: Causes and Review of the Progressive Correction]. Collection of scientific works of NMAPE named after PL Shupyk. 2015;24(2):405-09. Ukrainian.
3. Kaliuzhnaia LD. [Modern external therapy for dry aging skin]. Ukr. J. dermatol., venerol., kosmetol. 2005;18(3):33-35. Ukrainian.
4. Sviatenko TV, Kharitonova OG, Starostina OA. [Complex therapy and rehabilitation of patients with rosacea]. Dermatolohiia ta venerolohiia. 2014;(4):93-99. Ukrainian.
5. Sviatenko TV, Starostina OA. [Analysis of the antipruritic effect of the combined use of desloratadine and dimethindemaleate in the treatment of allergic dermatosis in children]. Health of Ukraine. 2021;16(4):46-52. Ukrainian.
6. Arora D, Garg S. Skin Care of Acne Vulgaris in Sensitive Skin. The Sensitive Skin: Treatment Modalities and Cosmeceuticals. 2019:3.
7. Guanti MB, Bonzano L, Rivi M, Alicandro T, Liberati S, Hebert AA, et al. Efficacy and Safety of an Antioxidant-Enriched Medical Device for Topical Use in Adults with Eczematous Dermatitis. Dermatology and Therapy. 2022;12(4):1015-25. doi: https://doi.org/10.1371/journal.pone.0231078
8. Huang Y-x, Li J, Zhao Z-x, Zheng B-l, Deng Y-x, Shi W, et al. Effects of skin care habits on the development of rosacea: a multi-center retrospective case-control survey in Chinese population. PLoS ONE. 2020;15(4):e0231078. doi: https://doi.org/10.1371/journal.pone.0231078
9. Stettler H, Crowther JM, Brandt M, Lu B, Box­shall A, de Salvo R, et al. Targeted dry skin treatment using a multifunctional topical moisturizer. International Journal of Cosmetic Science. 2021;43(2):191-200. doi: https://doi.org/10.1111/ics.12680
10. Yosipovitch G, Misery L, Proksch E, Metz M, Ständer S, Schmelz M. "Skin Barrier Damage and Itch: Review of Mechanisms, Topical Management and Future Directions." Acta Derm Venereol 2019;99:1201-9. doi: https://doi.org/10.2340/00015555-3296
11. Sutton E, Shaw AR, Ridd MJ, Santer M, Ro­berts A, Baxter H, et al. How parents and children evaluate emollients for childhood eczema: a qualitative study. British Journal of General Practice. 2022;72(719):e390-e7. doi: https://doi.org/10.3399/BJGP.2021.0630
12. Koliadenko VG, Chernyshov PV. [Indicators of the quality of life in dermatological ailments]. Ukr. J. dermatol., venerol., kosmetol. 2005;2:11-14. Ukrainian.
13. Peacock J. Peacock P. Oxford Handbook of Medical Statistics. Oxford medical handbook; 2010. doi: https://doi.org/10.1093/med/9780199551286.001.0001
14. Cekiera A, Popiel Ja, Siemieniuch M, Jaworski Z, Slowikowska M, Siwinska N, et al. The examination of biophysical parameters of the skin in Polish Konik horses. PloS ONE. 2021;16(6):e0250329. doi: https://doi.org/10.1371/journal.pone.0250329
15. Moore DJ, Rawlings AV. The chemistry, function and (patho) physiology of stratum corneum barrier ceramides. International journal of cosmetic science. 2017;39(4):366-72. doi: https://doi.org/10.1111/ics.12399
16. Zelenkova H, Pavlickova D. Effectiveness of acti­vated piroctone olamine in the treatment of psoriasis and seborrheic dermatitis. Dermatology DOST Svidnik. 2022;1:43.
17. Baurecht H, et al. Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration. Journal of Allergy and Clinical Immunology. 2018;141(5):1668-76.e16 doi: https://doi.org/10.1016/j.jaci.2018.01.019
18. Lefèvre-Utile A, Braun C, Haftek M, Aubin F. Five functional aspects of the epidermal barrier. Inter­na­tional Journal of Molecular Sciences. 2021;22(21):11676. doi: https://doi.org/10.3390/ijms222111676
19. [Expert conclusion No. K-486]. Kyiv: Chamber of Commerce and Industry [Internet]. 2021 April 27. Ukrai­nian. Available from: https://kiev-chamber.org.ua/
20. Batpenova GR, Tsoi NO. [The results of a clinical study and assessment of the effectiveness of the casting of Blue Cap^® Foam]. Theses of Astana cal University. 2022:4-6. Ukrainian.

Печковський К.Є. Національний медичний університет імені О.О. Богомольця, Київ, Україна, 
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-5143-2768

Колотілов М.М. Національний медичний університет імені О.О. Богомольця, Київ, Україна

 https://orcid.org/0000-0003-2062-1499

Печковська І.М. ПВНЗ «Київський медичний університет», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0003-1795-0566

Тімохіна Т.О. Національний медичний університет імені О.О. Богомольця, Київ, Україна

 https://orcid.org/0000-0002-0220-0220

1. Antomonov MYu. [Mathematical processing and analysis of biomedical data]. Kyiv: Medynform; 2018. ISBN 978-966-409-202-6.
2. Amrein K, Scherkl M, Hoffmann M. Vitamin D deficiency 2.0: an update on the current status worldwide. EurJ Clin  2020;74:1498-513. doi: https://doi.org/10.1038/s41430-020-0558-y
3. Balaji TM, Vasanthi HR, Rao SR. Gingival, Plas­ma and Salivary Levels of Melatonin in Periodontally Healthy Individuals and Chronic Periodontitis Patients: A Pilot Study. Journal of Clinical and Diagnostic Research. 2015;9(3):ZC23. doi: https://doi.org/10.7860/JCDR/2015/11311.5652
4. Balaji TM, Varadarajan S, Jagannathan R, Mahen­dra J, Fageeh HI, Fageeh HN, et al. Melatonin as a To­pical/Systemic Formulation for the Management of Periodontitis: A Systematic Review. Materials (Basel). 2021;14(9):2417. doi: https://doi.org/10.3390/ma14092417
5. Borysenko AV. Periodontal and Oral Mucosa Diseases. In 2 volumes. Kyiv: AUS Medicine Publishing; 2018. p. 224-253.
6. Cashman KD. Vitamin D Deficiency: Defining, Prevalence, Causes, and Strategies of Addressing. Calcif Tissue 2020;106:14-2. doi: https://doi.org/10.1007/s00223-019-00559-4
7. Ferlazzo N, Andolina G, Cannata A, Costan­zo MG, Rizzo V, Currò M, et al. Is Melatonin the Cor­nucopia of the 21st Century? Antioxidants (Basel). 2020;9(11):1088. doi: https://doi.org/10.3390/antiox9111088
8. Ghallab NA, Hamdy E, Shaker OG. Malon­dial­dehyde, superoxide dismutase and melatonin levels in gingival crevicular fluid of aggressive and chronic periodontitis patients. Australian Dental Journal. 2016;61(1):53-61. doi: https://doi.org/10.1111/adj.12294
9. Hassan RS, Salman SA. Evaluation of salivary mela­tonin and periodontal parameters in type II diabetic patients with chronic periodontitis: A comparative study. Indian J of Public Health Research and Development. 2019;10(10):2740-5. doi: https://doi.org/10.5958/0976-5506.2019.03283.2
10. Konečná B, Chobodová P, Janko J, Baňasová L, Bábíčková J, Celec P, Tóthová Ľ. The Effect of Melatonin on Periodontitis. Int J Mol Sci. 2021;22(5):2390. doi: https://doi.org/10.3390/ijms22052390
11. Lodhi K, Saimbi CS, Khan MA, Nath C, Shu­kla R. Evaluation of melatonin levels in saliva in gingivitis and periodontitis cases: A pilot study. Contemp Clin Dent. 2016;7(4):519-23. doi: https://doi.org/10.4103/0976-237X.194115
12. Permuy M, López-Peña M, González-Canta­la­piedra A, Muñoz F. Melatonin: A Review of Its Potential Functions and Effects on Dental Diseases. Int J Mol Sci. 2017 Apr 19;18(4):865. PMID: 28422058; PMCID: PMC5412446. doi: https://doi.org/10.3390/ijms18040865
13. Ramesh A, Prakash A, Thomas B, Shetty M. Sali­vary melatonin and total antioxidant capacity in repro­ductive and postmenopausal women. Journal of the International Clinical Dental Research Organization. 2016;8(1):39. doi: https://doi.org/10.4103/2231-0754.176249
14. Sharan K, Lewis K, Furukawa T, Yadav VK. Re­gulation of bone mass through pineal-derived melatonin-MT2 receptor pathway. J. Pineal Res. 2017;4:63. doi: https://doi.org/10.1111/jpi.12423
15. Shariq N, Zohaib K, Sana Z, Muhammad S. The­rapeutic potential of melatonin in oral medicine and periodontology. The Kaohsiung Journal of Medical Sciences. 2016;32(8):391-6. doi: https://doi.org/10.1016/j.kjms.2016.06.005
16. Ternovoy NK, Drobotun OV, Kolotilov NN. Poly­morbidity and heterogeneity of intact bone tissue in patients with malignant and metastatic bone tumors. Radiation Diagnostics, Radiation Therapy. 2019;3:25-29. doi: https://doi.org/10.37336/2707-0700-2019-3-3

Омельченко Е.М. ДУ «Інститут громадського здоров'я ім. О.М.Марзєєва Національної академії медичних наук України», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0003-1933-5495

Єлізарова О.Т. ДУ «Інститут громадського здоров'я ім. О.М.Марзєєва Національної академії медичних наук України», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-2860-9059

Полька Н.С. ДУ «Інститут громадського здоров'я ім. О.М.Марзєєва Національної академії медичних наук України», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-3026-7801

Полька О.О. ДУ «Інститут громадського здоров'я ім. О.М.Марзєєва Національної академії медичних наук України», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-7987-8355

Гозак С.В. ДУ «Інститут громадського здоров'я ім. О.М.Марзєєва Національної академії медичних наук України», Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-6379-7331

1. Roth GA, Mensah GA, Johnson CO, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019. Update From the GBD 2019 Study. J Am Coll Cardiol.2020 Dec 22;76(25):2982-3021. doi: https://doi.org/10.1016/j.jacc.2020.11.010
2. Dempsey PC, Matthews CE, Dashti SG, et al. Sedentary Behavior and Chronic Disease: Mechanisms and Future Directions. J Phys Act Health. 2020 Jan 1;17(1):52-61. doi: https://doi.org/10.1123/jpah.2019-0377
3. World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment. World Health Organization [Internet]; 2020. Available from: https://apps.who.int/iris/handle/10665/334136.
4. Andrieieva O, Kashuba O, Yarmak O, et al. Ef­ficiency of children's fitness training program with elements of sport dances in improving balance, strength and posture. Journal of Physical Education and Sport. 2021;21(5):2872-9. doi: https://doi.org/10.7752/jpes.2021.s5382
5. Che WI, Westerlind H, Lundberg IE, et al. Fami­lial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies. Ann Rheum Dis.2021 Nov;80(11):1461-6. doi: https://doi.org/10.1136/annrheumdis-2021-219914
6. Barbosa J, Basso L, Bartholomeu T, et al. Familial aggregation and heritability of markers of metabolic risk, physical activity, and physical fitness in nuclear families from Muzambinho (Minas Gerais, Brazil). Arch Endo­crinol 2019 May-Jun;63(3):215-21. doi: https://doi.org/10.20945/2359-3997000000137
7. Blomquist GE. Unpacking the heritability of body mass index and other ratios. Am J Hum Biol. 2019 Sep;31(5):e23289. doi: https://doi.org/10.1002/ajhb.23289
8. Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020 Dec;54(24):1451-62. doi: https://doi.org/10.1136/bjsports-2020-102955
9. Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA. 2018 Nov 20;320(19):2020-8. doi: https://doi.org/10.1001/jama.2018.14854
10. Yelizarova O, Stankevych T, Parats A, et al. Spe­cific Features of the Ukrainian Urban Adolescents' Phy­sical Activity: A Cross-Sectional Study. J Environ Public 2020 Apr 9;2020:3404285. doi: https://doi.org/10.1155/2020/3404285
11. Bouchard C, Malina RM, Pérusse L. Genetics of Fitness and Physical Performance. Champaign, IL: Human Kinetics; 1997.
12. Lezhenko G. [Features of obesity in adolescents]. Dytiachyi likar. 2017;1(52):20-26. Ukrainian. Available from: https://d-l.com.ua/uploads/issues/2016/2(47)/DL16-2_20-26_b71a6779e2e6263607fd9f142171edcf.pdf.
13. Lembryk I, Cycjura O, Pryjmak R. [Clinical cour­se and prevalence of obesity in combination with Oddi's sphincter dysfunction in adolescents]. Child`s health. 2019;14(3):159-64. doi: https://doi.org/10.22141/2224-0551.14.3.2019.168767
14. Ogniev VA, Pomohaibo KG. [Medico-social sub­stantiation of the model of quality management of obesity of children]. Visnyk socialnoi hihiieny ta organizatsii ohorony zdorovia Ukrainy. 2018;1(75):52-60. Ukrainian. Availablefrom: http://repo.knmu.edu.ua/handle/123456789/21046
15. Sorokman TV, Popeliuk OM, Ushakova KJu. [Prognostic criteria for the development of metabolic syndrome in children]. Child`s health. 2016;2:29-32. Ukrainian. Available from: http://nbuv.gov.ua/UJRN/Zd_2016_2_6

Лебець І.С. ДУ "Інститут охорони здоров’я дітей та підлітків НАМН України", Харків, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-5243-6031

Диннік В.О. ДУ "Інститут охорони здоров’я дітей та підлітків НАМН України", Харків, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-7692-1856

Матковська Т.М. ДУ "Інститут охорони здоров’я дітей та підлітків НАМН України", Харків, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-2349-3632

Медведовська Н.В. ДУ "Інститут охорони здоров’я дітей та підлітків НАМН України"; Національна академія медичних наук України, Харків, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0003-3061-6079

Кашкалда Д.А. ДУ "Інститут охорони здоров’я дітей та підлітків НАМН України", Харків, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-3683-3915

1. Diab M, Peltonen K, Qouta SR, Palosaari E, Puna­mäki RL. Can functional emotion regulation protect children's mental health from war trauma? A Palestinian study. Int J Psychol. 2019;54(1):42-52. Epub 2017 Apr 19. PMID: 28421608. doi: https://doi.org/10.1002/ijop.12427
2. Jayuphan J, Sangthong R, Hayeevani N, et al. Mental health problems from direct vs indirect exposure to violent events among children born and growing up in a conflict zone of southern Thailand. Soc Psychiatry Psychiatr 2020;55:57-62. doi: https://doi.org/10.1007/s00127-019-01732-8
3. Kadir A, Shenoda S, Goldhagen J, Pitterman S. Section On International Child Health. The Effects of Ar­med Conflict on Children. Pediatrics. 2018;142(6):e20182586. PMID: 30397168. doi: https://doi.org/10.1542/peds.2018-2586
4. Karam EG, Fayyad J, Karam AN, Melhem N, Mneimneh Z, Dimassi H, Tabet CC. Outcome of dep­ression and anxiety after war: a prospective epidemiologic study of children and adolescents. J Trauma Stress. 2018;27(2):192-9.PMID: 24740870. doi: https://doi.org/10.1002/jts.21895
5. Slone M, Mann S. Effects of War, Terrorism and Armed Conflict on Young Children: A Systematic Review. Child Psychiatry Hum Dev. 2016;47(6):950-65. PMID: 26781095.
   doi: https://doi.org/10.1007/s10578-016-0626-7
6. Veronese G, Pepe A, Almurnak F, Jaradah A, Hamdouna H. Quality of life, primary traumatisation, and positive and negative affects in primary school students in the Gaza Strip. Lancet. 2018;21:391. Epub 2018 Feb 21. doi: https://doi.org/10.1016/S0140-6736(18)30380-5
7. Veronese G, Pepe A, Jaradah A, Al Muranak F, Hamdouna H. Modelling life satisfaction and adjustment to trauma in children exposed to ongoing military violence: An exploratory study in Palestine. Child Abuse Negl. 2017;63:61-72. Epub 2016 Nov 28. PMID: 27907846. doi: https://doi.org/10.1016/j.chiabu.2016.11.018
8. Davydov VV, Kashkalda DA, Goloborod'ko AV. [The norms of the content of biologically active substances in children and adolescents: Handbook]. Kharkov: Fedorko, 2008; Russian.
9. Calam R. Public health implications and risks for children and families resettled after exposure to armed conflict and displacement. Scand J Public Health. 2017;45(3):209-11. Epub 2016 Oct 30. PMID: 27799420. doi: https://doi.org/10.1177/1403494816675776
10. Garry S, Checchi F. Armed conflict and public health: into the 21st century. Journal of Public Health. 2020;42(3):e287-98. doi: https://doi.org/10.1093/pubmed/fdz095
11. Sánchez-Villegas M, et al. Mental health prob­lems, family functioning and social support among children survivors of Colombia’s armed conflict. Journal of aggression, conflict and peace research. 2021;1:61-72. doi: https://doi.org/10.1108/JACPR-08-2020-0535
12. Gómez-Restrepo C, Cruz-Ramírez V, Medina-Rico M, Rincón CJ. Mental health in displaced children by armed conflict - National Mental Health Survey Colombia 2015. Actas Esp Psiquiatr. 2018;46(2):51-7. Epub 2018 Mar1. PMID: 29616713.
13. Marroquín Rivera A, Rincón Rodríguez CJ, Padil­la-Muñoz A, Gómez-Restrepo C. Mental health in ado­lescents displaced by the armed conflict: findings from the Colombian national mental health survey. Child Adolesc Psychiatry Ment Health. 2020;14:23. PMID: 32467726; PMCID: PMC7236943. doi: https://doi.org/10.1186/s13034-020-00327-5
14. Piñeros-Ortiz S, Moreno-Chaparro J, Garzón-Orjuela N, Urrego-Mendoza Z, Samacá-Samacá D, Es­lava-Schmalbach J. [Mental health consequences of armed conflicts in children and adolescents: An overview of literature reviews]. Biomedica. 2021;41(3):424-448. Spanish. PMID: 34559491; PMCID: PMC8525875. doi: https://doi.org/10.7705/biomedica.5447
15. Ichanska OM., Kliuzko KIe. [Dynamics of expe­riencing a crisis during psycho-rehabilitation of children affected by the armed conflict in Donbas. Individuality in the psychological dimensions of communities and pro­fes­sions: a collection of scientific papers]. Kyiv; 2018;145-50. Ukraine.
16. Ihnatenko K. [Social protection of children in the activities of state organizations in eastern Ukraine]. Social Work and Education. 2021;8(3):329-40. Ukraine. doi: https://doi.org/10.25128/2520-6230.21.3.2
17. Rudenko TP. [Social protection of victims of armed conflicts: summary of lectures]; 2021. Ukraine.

Коробчанський В.О. Харківський національний медичний університет, Харків, Україна

 https://orcid.org/0000-0002-8118-6884

Саркіс-Іванова В.В. Харківський національний медичний університет, Харків, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-3953-550X

Богачова О.С. Харківський національний медичний університет, Харків, Україна

 https://orcid.org/0000-0003-2844-5813

Олійник Ю.О. Харківський національний медичний університет, Харків, Україна

 https://orcid.org/0000-0003-3214-0422

Білецька С.В. Дніпровський державний медичний університет, Дніпро, Україна; Медичний центр для біженців з України «Luxmed», Краків, Польща, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

1. Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. Kyiv: Medinform; 2018. Russian.
2. Bohachova OS. [Hygienic assessment and optimi­zation of learning conditions in professional agricultural lyceums]. Kharkiv: Kharkiv National Medical University; 2019. Ukrainian. Available from: http://repo.knmu.edu.ua/handle/123456789/24532
3. Bogachova OS, Korobchanskiy VO. [Donosolo­gical diagnostics of pre-pathological mental states in students of Professional Agrarian Lyceum using the «Agrotest» computer program]. Medicni perspektivi. 2019;23(4):95-100. doi: https://doi.org/10.26641/2307-0404.2018.4.153010
4. Korobchanskyi PO. [Hygienic aspects of the impact of physical training on the formation of health and professional success of medical students]. Extended abstract of candidate’s thesis. Kharkiv: Kharkiv National Medical University; 2014. Ukrainian. Available from: http://www.irbis-nbuv.gov.ua/cgi-bin/irbis_nbuv/cgiirbis_64.exe?Z21ID=&I21DBN=EC&P21DBN=EC&S21STN=1&S21REF=10&S21FMT=fullwebr&C21COM=S&S21CNR=20&S21P01=0&S21P02=0&S21P03=I=&S21COLORTERMS=1&S21STR=%D0%A0%D0%90407594$
5. Korobchanskyi VO, Vasilchenko IO, Staru­seva VV, et al. [Lifestyle questionnaire as a method of assessing risk factors in adolescents]. Kyiv: Information letter of the Ministry of Health of Ukraine; 2005.
6. Korobchansky VO, Padavalenko OV, Vasilchen­ko IO, Vitrishchak SV. [Psychodiagnostic questionnaire for high school students as a method of assessing pre-nosological mental states of adolescents: textbook]. Kyiv; 2005. Ukrainian.
7. BogachovaОС et al. [Medicine of border states: 30-year experience of psychohygienic research: mono­graph]. Odessa; 2016. Ukrainian.
8. Oliinyk YuO. [Psychohygienic assessment and cor­rection of vital activity of high school students in the industrial and agricultural region]. Extended abstract of candidate’s thesis. Donetsk: Donetsk National Medical University; 2010. Ukrainian. Available from: http://www.irbis-nbuv.gov.ua/cgi-bin/irbis_nbuv/cgiirbis_64.exe?C21COM=2&I21DBN=ARD&P21DBN=ARD&Z21ID=&Image_file_name=DOC/2010/10oyopar.zip&IMAGE_FILE_DOWNLOAD=1
9. Reznichenko OH. [Hygienic assessment of the impact of the nature and conditions of learning on the functional state and health of medical students]. Extended abstract of candidate’s thesis. Kharkiv: Kharkiv National Medical University; 2013. Ukrainian. Available from: http://irbis-nbuv.gov.ua/cgi-bin/irbis_nbuv/cgiirbis_64.exe?&I21DBN=EC&P21DBN=EC&S21STN=1&S21REF=10&S21FMT=fullwebr&C21COM=S&S21CNR=20&S21P01=0&S21P02=0&S21P03=I=&S21COLORTERMS=0&S21STR=%D0%A0%D0%90401364
10. Boda Z, Elmer T, Vörös A, Stadtfeld C. Short-term and long-term effects of a social network intervention on friendships among university students. Sci Rep. 2020 Feb 19;10(1):2889. PMID: 32076003; PMCID: PMC7031228. doi: https://doi.org/10.1038/s41598-020-59594-z
11. de PaulaW, Breguez GS, Machado EL, Meire­les  Prevalence of anxiety, depression, and suicidal ideation symptoms among university students: A systematic review. Brazilian Journal of Health Review. 2020;3(4):8739-56. doi: https://doi.org/10.34119/bjhrv3n4-119
12. da Silva AW, Huckins JF, Wang R, Wang W, Wag­ner DD, Campbell AT. Correlates of Stress in the College Environment Uncovered by the Application of Penalized Generalized Estimating Equations to Mobile Sensing Data.  JMIR Mhealth Uhealth. 2019 Mar 19;7(3):e12084. doi: https://doi.org/10.2196/12084
13. Gruzieva TS, Galiienko LI, Pelo IM, Omel­chuk ST, Antonuk OY. Health and lifestyle of students' youth: status, problems and ways of solution. Wiad Lek. 2018;71(9):1753-8. PMID: 30737935.
14. Liu RT. The microbiome as a novel paradigm in studying stress and mental health. American Psychologist. 2017;72(7):655-67. doi: https://doi.org/10.1037/amp0000058
15. Liu Y, Wu S, Li Y, Shao F, Su J, Liu A survey of mental symptoms of Chinese population based on SCL-90. Chinese Mental Health Journal. 2018;32(5):437-41.
16. Twenge JM, Joiner TE, Rogers ML, Martin GN. Increases in Depressive Symptoms, Suicide-Related Out­comes, and Suicide Rates Among U.S. Adolescents After 2010 and Links to Increased New Media Screen Time. Clin Psychol 2017 Nov 14;6(1):3-17. doi: https://doi.org/10.1177/2167702617723376
17. Ye L, Posada A, Liu Y. A review on the rela­tionship between Chinese adolescents’ stress and academic achievement. New directions for child and adolescent development. 2019;2019(163):81-95. doi: https://doi.org/10.1002/cad.20265

Шевченко О.А. Дніпровський державний медичний університет, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-2295-170X

Шевяков О.В. Дніпропетровський державний університет внутрішніх справ, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.in.ua

 https://orcid.org/0000-0001-8348-1935

Корнієнко В.В. Дніпропетровський державний університет внутрішніх справ, Дніпро, Україна

 https://orcid.org/0000-0002-8043-3046

Бурлакова І.А. Дніпропетровський державний університет внутрішніх справ, Дніпро, Україна

 https://orcid.org/0000-0002-6043-4359

Cлавська Я.А. Дніпропетровська академія музики імені М. Глінки, Дніпро, Україна

 https://orcid.org/0000-0003-2498-3323

Cізов В.В. Дніпропетровська академія музики імені М. Глінки, Дніпро, Україна

 https://orcid.org/0000-0002-0679-8602

Дорогань С.Б. Дніпровський державний медичний університет, Дніпро, Україна, 
e-mail: dkdpua@gmail.com

 https://orcid.org/0000-0002-6920-4461

1. Arshava I, Kornienko V, Baratynska A. Influence of personal and pathophychological characteristics on adaptation possibilities of patients with depression in the process of medical-psychological rehabilitation. Psycho­logical perspectives on health and disease: collective monograph. Malgorzata Tatala. Rīga: Baltija Publishing; 2019. p. 1-18. doi: https://doi.org/10.5709/PPHD-2-5
2. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. World Health Organization, [Internet]. 2020[cited 2022 May 02]. Available from: http://www.who.int/disabilities/world_report/2020/summary_ru.pdf?ua=1
3. Yevdokimova O. [The personality of the police in a transformational society. Mental health of the individual in a crisis society: Proceedings of the 4 All-Ukrainian science and practice conference]; 2019 Oct 18; Lviv, Ukraine. Lviv: Lviv State University of Internal Affairs; 2019. p. 85-89. Ukrainian.
4. Zelenska KO, Koltsova GG. [Clinical and psycho­pa­thological analysis of modern depressive disorders associated with suicidal behavior in women]. ScienceRise. Medical science [Internet]. 2017;12:39-42 [cited 2022 Apr 01].
   doi: https://doi.org/10.15587/2519-4798.2017.119939
5. Kim TK. A test as parametric statistic. Korean J Anasthesiol. 2015;68(6):540-6. doi: https://doi.org/10.4097/kjae.2015.68.6.540
6. Kornienko VV. [Conceptualization of the study of the problem of socio-psychological foundations of the rehabilitation potential of the individual. In: Kor­nienko VV, editor. Theoretical and applied problems of psychology and social work: collection of science Proceedings of the Eastern Ukrainian National University named after Volodymyr Dahl]. Severodonetsk: Publishing house of SNU named after V. Dahl; 2021. p. 36-45.
7. Kornienko VV. [System of social and psycho­logical support of the process of development of reha­bilitation potential of personality. In: Kornienko VV, editor. Theoretical and applied problems of psychology and social work: collection of science. Proceedings of the Volodymyr Dahl East Ukrainian National University]. Severodonetsk: Publishing house of SNU named after V. Dahl; 2021. p. 15-24.
8. Panina N. Structure of Political Success Factors as an Indicator of political direction in electoral system development. In Y. Golovakha, editor. Ukrainian Socio­logical Review 2002-2003 [Internet]. Kyiv: Institute of Sociologyof the National Academy of Sciences of Ukraine; 2005 p. 27-53 [cited 2022 Jun 29]. Available from: https://nbn-resolving.org/urn:nbn:de:0168-ssoar-104845
9. Popovych V, Ragimov F, Kornienko V, Ivanova I, Buryk Z. Development of social and communicative pa­radigm of the field of social networks. International Journal of Data and Network Science. 2020;4:319-28. doi: https://doi.org/10.5267/j.ijdns.2020.6.001
10. Fetisov V.S. [Package of statistical data analysis STATISTICA]. Nizhin: NSU named after M. Gogol; 2018. p. 100-114.
11. Shevchenko PF. [Criteria for assessing the severity of depression. Proceedings of the IV International Scien­tific and Practical Conference "Personality in Crisis and Critical Situations"]. Sumy: Sumy State Pedagogical University named after A.S. Makarenko; 2018. p. 312-4.
12. Shevchenko O, Burlakova I, Sheviakov O, Agar­kov O, Shramko I. Psychological foundations of occupa­tional health of specialists in the economic sphere. Medicni perspektivi.2020;25(2):163-7. doi: https://doi.org/10.26641/2307-0404.2020.2.206890
13. Sheviakov OV, Doroshenko EYu, Mykha­liuk YeL, Prykhodko VV, Liakhova IM, Nikanorov OK, et al. [Features of social-psychological rehabilitation of sport­smen-paralympians specialized in powerlifting]. Zapo­rozhye medical journal. 2020;22(1):96-102. Ukrai­nian. doi: https://doi.org/10.14739/2310-1210.2020.1.194632
14. Sheviakov O, Korniienko V, Shu Gao Han. Sys­tem of psychological support for the development of rehabilitation potential of power structures specialists. Phylosophy, Economics and Law Review. 2022;2(1):7-15. doi: https://doi.org/10.31733/2786-491X-2022-1-7-15

Безверхнюк Т.М. ДУ «Український науково-дослідний інститут медичної реабілітації та курортології МОЗ України», Одеса, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-2567-8729

Бабова І.К. ДЗ «Південноукраїнський національний педагогічний університет ім. К.Д. Ушинського», Одеса, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0003-1018-8302

1. [Fundamentals of Ukrainian legislation on health care]. Law of Ukraine of 1992, renovation 2020, Pub. L. No. 2802-ХІІ. (2020). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/2801-12#Text
2. [About rehabilitation in health care sphere]. Law of Ukraine of 2020, Pub. L. No. 103-IX. (Dec 03, 2020). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/1053-20#Text
3. [Methodology for development and implemen­tation of medical standards of medical care based on evidence-based medicine]. Order of the Ministry of Health of Ukraine of 2012, Pub. No. 751. (Sep 28, 2012). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z2001-12#Text
4. Diachuk D, Zyukov O, Lishchyshyna O. [Ratio­nale of perspective directions of standardization of medical care of the population of Ukraine at the turn of 2020]. Clinichna ta profilactychna medycyna. 2020;3(13):4-11. Ukrainian. doi: https://doi.org/10.31612/2616-4868.3(13).2020.01
5. Golik V, Syvak O. Assessment of national disabi­lity, health and rehabilitation system in Ukraine. Reflec­tions disability and rehabilitation subcluster meeting. Ukraynskyi visnyk mediko-sotsialnoi ekspertyzy. 2016 March 11;1(19):26-62.
6. International classification of functioning, disabi­lity and health: ICF. World Health Organization; 2001.
7. Situation assessment of rehabilitation in Ukraine. Copenhagen: WHO Regional Office for Europe; 2021.
8. [About state financial guarantees of medical care for the population]. Law of Ukraine of 2017, Pub. L. No. 2168-VІІІ. (Oct 19, 2017). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/2168-19#Text
9. [On the approval of licensing conditions for conducting business activities in medical practice]. Resolution of the CMU of 2016, Pub. No. 285. (March 02, 2016).Available from: https://zakon.rada.gov.ua/laws/show/285-2016-%D0%BF#Text
10. [The procedure for reimbursement of expenses for the provided social services for the treatment of insured persons and their family members after diseases and injuries in the rehabilitation departments of health-resort institutions at the expense of the funds of the Social Insurance Fund of Ukraine]. Resolution of the Board of the FSS of Ukraine of 2017, Pub. No. 39. (Jun 13, 2017). Ukrainian. Available from: https://zakon.rada.gov.ua/rada/show/v0039890-17#Text
11. gov [Internet]. [Health-resort and health facilities]. c1998 [cited 2022 Aug 11]. Ukrainian. Available from: www.ukrstat.gov.ua
12. [About recognizing some orders of the Ministry of Health of Ukraine as having lost their validity]. Order of the Ministry of Health of Ukraine of 2019, Pub. No. 448. (Feb 22, 2019). Ukrainian. Available from: http://search.ligazakon.ua/l_doc2.nsf/link1/MOZ31142.html
13. [The efficiency index of medical rehabilitation at the expense of the Social Insurance Fund reached 81.8%]. Uriadovyi portal [Internet]. 2022  [cited 2022 Aug 11). Ukrainian. Available from: https://www.kmu.gov.ua/news/pokaznik-efektivnosti-medichnoyi-reabilitaciyi-za-koshti-fondu-socialnogo-strahuannya-syagnuv-818
14. Donabedian A. Evaluating the quality of medical care. The Milbank quarterly. 2005;83(4):691-729. doi: https://doi.org/10.1111/j.1468-0009.2005.00397.x
15. [About the procedure for quality control of the provision of medical care]. Order of the Ministry of Health of Ukraine of 2012, Pub. No. 752. (Sep 28, 2012). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z1996-12#Text
16. Lobas VМ, Slabkyi GА, Kravets ОА. [Model of management of the medical rehabilitation process at the primary level of medical care providing]. Pytannia ekspe­rymentalnoi ta klinichnoi medycyny: zbirnyk statei. 2013;1(17):158-63. Ukrainian.
17. White Book on Physical and Rehabilitation Medi­cine in Europe. European Physical and Rehabilitation Medicine Bodies Alliance. Eur J Phys Rehabil Med. 2018;54(2). Available from: http://www.whitebookprm.eu/2019/03/21/white-book-iii-ed-complete-pdf-version/
18. Stepanenko АV, Parii VD, Morozov АМ, et al. [Unified methodology for the development of local medical care protocols for health care institutions of Ukraine: methodological recommendations]. Kyiv; 2012. Ukrainian.
19. [Multidisciplinary working groups and topics]. [Internet]. Kyiv: State expert center. c1990-2022 [cited 2022 Aug 11]. Ukrainian. Available from: https://www.dec.gov.ua/mtd/multydysczyplinarni-robochi-grupy/
20. Babova ІК, Rozkov VS. [Health-resort rehabi­litation of servicemen in Ukraine: public-administration aspect]. Publichne upravlinnia i administruvannia v Ukraini. 2020;19:21-26.
21. [List of health-resort facilities in terms of medical rehabilitation profiles for reimbursement of costs for reha­bilitation treatment services provided to insured persons]. [Internet]. Kyiv: Social Insurance Fund of Ukraine. c2014 [cited 2022 Aug 11]. Ukrainian. Available from: http://www.fssu.gov.ua/fse/control/main/uk/publish/article/952253
22. [Requirements PMG 2022]. [Internet]. Kyiv: Natio­nal Health Service of Ukraine. 2022 [cited 2022 Aug 11].Available from: https://contracting.nszu.gov.ua/vimogi-pmg-2022
23. [The tariff for rehabilitation medical services has been increased in PMG]. [Internet]. Kyiv: National Health Service of Ukraine. 2021 Marсh 09 [cited 2022 Aug 11]. Ukrainian. Available from:
    https://nszu.gov.ua/novini/u-programi-medichnih-garantij-zbilsheno-tarif-na-medichni-po-496
24. Rehabilitation needs of people recovering from COVID-19. [Internet]. WHO: Scientific brief. 20212 Nov 09 [cited 2022 Aug 11]. Available from: https://WHO/2019-nCoV/Sci_Brief/Rehabilitation/2021.1
25. [In case of complications from COVID-19, employees can undergo rehabilitation at the Fund's expense]. Kyiv: Social Insurance Fund of Ukraine. c2014 [cited 2022 Aug 11]. Ukrainian. Available from: http://www.fssu.gov.ua/fse/control/main/uk/publish/article/972583
26. [Coronavirus disease 2019 (COVID-19)]. [Inter­net]. Kyiv: State expert center. c1990-2022 [ci­ted 2022 Aug 11]. Ukrainian. Available from: https://www.dec.gov.ua/mtd/koronavirusna-hvoroba-2019-covid-19/

Кодинець А.О. Київський національний університет ім. Тараса Шевченка; Науково-дослідний інститут інтелектуальної власності Національної академії правових наук України, Київ, Україна, 
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-0954-1474

Дорошенко О.Ф. Науково-дослідний інститут інтелектуальної власності Національної академії правових наук України, Київ, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-2542-2328

Волинець І.П. Науково-дослідний інститут інтелектуальної власності Національної академії правових наук України

 https://orcid.org/0000-0002-2029-2165

Дорожко Г.К. Науково-дослідний інститут інтелектуальної власності Національної академії правових наук України

 https://orcid.org/0000-0001-6506-3203

Петренко В.О. Український державний університет науки і технологій, інститут промислових та бізнес технологій, Дніпро, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-5017-1674

Білецький В.В. Дніпровський державний медичний університет, Дніпро, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0002-2841-7372

1. Prescription Drugs: Medicare Spending on Drugs with Direct-to-Consumer Advertising [Internet]. Wa­shington: U.S. Government Accountability Office (U.S. GAO); 2021 [cited 2022 Aug 12]. Available from: https://www.gao.gov/products/gao-21-380/
2. [During the year, drug manufacturers spent 7.2 billion hryvnias on advertising]. [Internet]. Eko­nomichna pravda. 2016 Mar 14 [cited 2022 Aug 12]. Ukrainian. Available from: https://www.epravda.com.ua/news/2016/03/14/585194/
3. media [Internet]. [The company Ocean Media Plus pointed out the risks for the Ukrainian media market due to the introduction of a moratorium on the advertising of medicinal products]; 2021 Aug 19 [cited 2022 Aug 12]. Ukrainian. Available from: https://detector.media/infospace/article/191295/2021-08-19-kompaniya-ocean-media-plus-vkazala-na-ryzyky-dlya-ukrainskogo-mediarynku-cherez-vvedennya-moratoriyu-na-reklamu-likarskykh-zasobiv/
4. Volynets I. [Protection against unfair advertising on the drug market. Creation, protection, protection and commercialization of objects of intellectual property rights]. 5th All-Ukrainian scientific and practical con­ference with international participation; 2022 Apr 26; Kyiv, Ukraine. Kyiv: KPI im. I. Sikorskoho; 2022. p. 358-63. Ukrainian. Available from: https://km.kpi.ua/wp-content/uploads/Zbirnyk-IV-2022.pdf
5. [On protection against unfair competition: Law of Ukraine of 1996, Pub. No. 236/96-VR. (Oct 16, 2020). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/236/96-vr#Text.
6. [About advertising: Law of Ukraine of July 3, 1996,No. 270/96-VR. (Aug 3, 2022). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/270/96-vr#Text
7. [About some issues of prohibition of advertising of medicinal products: Order of the Ministry of Health of Ukraine of Juny 06, 2012, Pub. No. 422. (Feb 18, 2022). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z1189-12#Text
8. [On making changes to the Criteria used in the determination of medicinal products, the advertising of which is prohibited: Order of the Ministry of Health of Ukraine of Nov 23, 2021, Pub. No. 2593. (2021). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z0092-22#Text
9. Chabarai H. [How to wean Ukrainians from Google therapy. Analytics, security, economics, inter­national politics, culture. Content matters!] [Internet]. Kyiv: Tyzhden. 2018 May 18 [cited 2022 Aug 12]. Ukrainian. Available from: https://tyzhden.ua/Society/214112
10. Lapii F, Lavrovskyi N, Denysenko A, Shcher­ban O. [Money on the wind: which drugs with dubious effectiveness spend billions of hryvnias in Ukraine and what to do about it]. Ukrainska pravda [Internet]. 2021 Oct 13 [cited 2022 Aug 12]. Ukrainian. Available from: https://life.pravda.com.ua/health/2021/10/13/246197/
11. Most advertised drugs on U.S. TV 2021. Statista Research Department [Internet]. 2022 Sep 5 [cited 2022 Aug 12]. Available from: https://www.statista.com/statistics/639356/tv-advertise-drugs-usa/
12. Guttmann Pharmaceutical industry TV ad spend in the U.S 2016-2020. Statista [Internet]. 2021 [cited 2022 Aug 12]. Available from: https://www.statista.com/statistics/953104/pharma-industry-tv-ad-spend-us/
13. Lee B. How Is Consumer Drug Advertising Regulated in the United States? GoodRx Health [Internet]. 2022 July 1 [cited 2022 Aug 12]. Available from: https://www.goodrx.com/healthcare-access/patient-advocacy/prescription-drug-advertising-regulation-united-states
14. Kracov D, Davar M. International Comparative Legal Guides International Business Reports. Pharma­ceutical Advertising Laws and Regulations Report 2022 USA [Internet]; 2022 [cited 2022 Aug 12]. Available from: https://iclg.com/practice-areas/pharmaceutical-advertising-laws-and-regulations/usa
15. Faerber AE, Kreling DH. Content Analysis of False and Misleading Claims in Television Advertising for Prescription and Nonprescription Drugs. Journal of General Internal Medicine. 2013 Sep 13;29(1):110-8. doi: https://doi.org/10.1007/s11606-013-2604-0
16. [According to the results of the study on the detection and termination of unfair practices in the field of advertising of medicinal products, biologically active additives, medical procedures, antiseptics and disin­fectants: Report of the Antimonopoly Committee of Ukraine. Office of Unfair Competition Investigations]. [Internet]. Kyiv; 2020. [cited 2022 Aug 14]. Ukrainian. Available from: https://amcu.gov.ua/storage/app/uploads/public/5ff/5b9/766/5ff5b976685ac541795869.pdf
17. [On violation of the legislation on protection against unfair competition: Decision of the Antimonopoly Committee of Ukraine of October 22, 2020, Pub. No. 654-r]. [Internet]; (Oct 22, 2020). Ukrainian. Available from: https://amcu.gov.ua/storage/app/uploads/public/5f9/fd7/08d/5f9fd708dd9f7819532980.pdf
18. [On violation of the legislation on protection against unfair competition and imposition of a fine: Decision of the Antimonopoly Committee of Ukraine of July 2, 2020, Pub. No. 421-r]. [Internet]; (Jul 02, 2020). Ukrainian. Available from: https://amcu.gov.ua/storage/app/uploads/public/5f0/852/ae6/5f0852ae6c6f2854410852.pdf
19. [On violation of the legislation on protection against unfair competition and the imposition of a fine: Decision of the Antimonopoly Committee of Ukraine of July 2, 2020, Pub. No. 430-r]. [Internet]; (Jul 02 2020). Ukrainian. Available from: https://amcu.gov.ua/npas/pro-porushennya-zakonodavstva-pro-zahist-vid-nedobrosovisnoyi-konkurenciyi-ta-nakladennya-shtrafu-5
20. [Regarding the application of the provisions of Article 151 of the Law of Ukraine "On Protection from Unfair Competition" in relation to the advertising of medicinal products: Recommendation clarifications of the Antimonopoly Committee of Ukraine of March 16, 2021, Pub. No.13-rr]. [Internet]; (2021). Ukrainian. Available from: https://amcu.gov.ua/npas/shchodo-zastosuvannya-polozhen-statti-151-zakonu-ukrayini-pro-zahist-vid-nedobrosovisnoyi-konkurenciyi-stosovno-reklami-likarskih-zasobiv
21. [On the state of the national health care system and urgent measures to provide citizens of Ukraine with medical aid: Decision of the National Security and Defense Council of Ukraine of July 30, 2021]. [Internet]; (2021). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/n0052525-21#Text
22. [Do self-medication now and then: in Ukraine, antibiotics will be sold by electronic prescription]. Vikna [Internet]; 2022 [cited 2022 Aug 12]. Ukrainian. Available from: https://vikna.tv/styl-zhyttya/zdorovia-ta-krasa/z-1-serpnya-v-ukrayini-antybiotyky-prodavatymut-lyshe-za-elektronnym-reczeptom/
23. [From August 2022, patients will start receiving electronic prescriptions for antibiotics]. [Internet]. Kyiv: Ministry of Health; 2022 [cited 2022 Aug 12]. Ukrainian. Available from: https://moz.gov.ua/article/news/z-serpnja-2022-roku-pacienti-pochnut-otrimuvati-elektronni-recepti-na-antibiotiki.
24. Aikin KJ, Southwell BG, Paquin RS, Rupert DJ, O'Donoghue AC, Betts KR, Lee PK. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay. Research in Social and Administrative Pharmacy. 2017 Mar;13(2):378-88. doi: https://doi.org/10.1016/j.sapharm.2016.04.004
25.  Corrective advertising [Internet]. Multitran dic­tionary; 2022 [cited 2022 Aug 12]. Available from: https://www.multitran.com/m.exe?l1=1&l2=2&s=corrective+advertising\&langlist=2

Литовченко В.П. Українська військово-медична академія, Київ, Україна,
e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0003-1869-6168 

1. Bronіkova S. [Practices of communicative culture in a medical institution: patient-centered approach: text­book]; 2020. Ukrainian.Available from: http://ekmair.ukma.edu.ua/handle/123456789/21027
2. [Universal Declaration on Bioethics and Human Rights of the General Conference of UNESCO: adopted by the resolution of the General Conference of UNESCO on the report of Commission III at the 18th plenary meeting of 19 October 2005]. Russian. Available from: http://portal.unesco.org/en/ev.php-URL_ID=31058&URL_DO=DO_TOPIC&URL_SECTION=201.html
3. [Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects: The World Medical Association; Declaration, International document of June 1, 1964] [Internet]. Kyiv; 2008 Oct 1. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/990_005#Text
4. [Convention on the Rights of Persons with Disabilities, Pub. L. No. 1767-VI]. (Dec 16, 2009). Ukrai­nian. Available from: https://zakon.rada.gov.ua/laws/show/995_g71#Text
5. Lytovchenko VP, Lytovchenko SV. [Availability of dental services for people with hearing impairments: communication between doctor and patient]. Ukrain­skyi nau­kovo-medychnyi molodіzhnyi zhurnal. 2021;125(3):52-63. Ukrainian. doi: https://doi.org/10.32345/USMYJ.3(125).2021.52-63
6. Cohen M. [Interdisciplinary planning of dental treatment. Principles, goals, practical application. Illustra­ted lectures]. Moskva: Azbuka; 2012. Russian. Available from: https://www.dental-azbuka.ru/books/raznoe/kniga_120.html
7. Bottaev NA, Diachenko EV, Samoilenko NV, et al. [Skills of effective communication for rendering patient-oriented medical care: scientific and methodical edition]. Moskva: ROSOMED; 2018. Russian. Available from: https://rosomed.ru/system/documents/files/000/000/102/original/
8. [On approval of the Procedure for conducting clinical trials of medicinal products and examination of clinical trial materials and standard regulations on ethics commissions: Order of the Ministry of Health of Ukraine No. 690]. (Sep 23, 2009). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z1010-09#Text
9. Becker C, Hunziker S. [The importance of com­munication between physicians and patients]. Ther Umsch. 2019;76(5):231-238. PMID: 31577188. doi: https://doi.org/10.1024/0040-5930/a001095
10. Berger R, Bulmash B, Drori N, Ben-Assuli O, Herstein R. The patient-physician relationship: an account of the physician's perspective. Isr J Health Policy Res. 2020 Jun 30;9(1):33. PMID: 32605635. PMCID: PMC7325021. doi: https://doi.org/10.1186/s13584-020-00375-4
11. Bird J, Cohen-Cole SA. The three-function model of the medical interview. An educational device. Adv Psychosom Med. 1990;20:65-88. PMID: 2239506. doi: https://doi.org/10.1159/000418260
12. Bokhour BG, Fix GM, Mueller NM, Barker AM, Lavela SL, Hill JN, et al. How can healthcare organiza­tions implement patient-centered care? Examining a large-scale cultural transformation. BMC Health Serv Res. 2018 Mar 7;18(1):168. PMID: 29514631; PMCID: PMC5842617. doi: https://doi.org/10.1186/s12913-018-2949-5
13. Burt J, Abel G, Elmore N, Campbell J, Roland M, Benson J, Silverman J. Assessing communication quality of consultations in primary care: initial reliability of the Global Consultation Rating Scale, based on the Calgary-Cambridge Guide to the Medical Interview. BMJ Open. 2014 Mar 6;4(3):e004339. PMID: 24604483; PMCID: PMC3948635. doi: https://doi.org/10.1136/bmjopen-2013-004339
14. Dalaya M, Ishaquddin S, Ghadage M, Hatte G. An interesting review on soft skills and dental practice. J Clin Diagn Res. 2015 Mar;9(3):ZE19-21. PMID: 25954720; PMCID: PMC4413170. doi: https://doi.org/10.7860/JCDR/2015/12725.5719
15. DeCamp M, Dukhanin V, Hebert LC, Himmel­rich S, Feeser S, Berkowitz SA. Patients' Views About Patient Engagement and Representation in Healthcare Go­vernance. J Healthc Manag. 2019 Sep-Oct;64(5):332-46. PMID: 31498210; PMCID: PMC6865800. doi: https://doi.org/10.1097/JHM-D-18-00152
16. Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care. 2001 Sep;10(Suppl 1):i9-13. PMID: 11533431; PMCID: PMC1765742. doi: https://doi.org/10.1136/qhc.0100009
17. Feletti G, Firman D, Sanson-Fisher R. Patient satisfaction with primary-care consultations. J Behav Med. 1986 Aug;9(4):389-99. PMID: 3746905. doi: https://doi.org/10.1007/BF00845122
18. Hashiyama DT, Mori N. Osler's nodes: dialogue with Sir William Osler. QJM. 2021 Nov 13;114(9):667-68. doi: https://doi.org/1093/qjmed/hcab139
19. Hofhansl A, Horn W, Kainberger F, Zlabinger G, Rieder A. ["To be a good doctor": how are medical stu­dents prepared for the future]. Wien Med Wo­chenschr.  2015 Mar;165(5-6):83-5. PMID: 25786601. Deutsch. doi: https://doi.org/1007/s10354-015-0349-6
20. Krot K, Rudawska I. The Role of Trust in Doctor-Pa­tient Relationship: Qualitative Evaluation of Online Feedback from Polish Patients. Econom. & Sociology. 2016;9(3):76-88.
    doi: https://doi.org/10.14254/2071-789X.2016/9-3/7
21. Krzikallová K, Střílková Labour-intensive ser­vices and changes in value added tax revenue. Journal of Competitiveness.2016 Mar;8(1):5-18. doi: https://doi.org/10.7441/joc.2016.01.01
22. Kurtz S, Silverman J, Benson J, Draper J. Mar­rying content and process in clinical method teaching: enhancing the Calgary-Cambridge guides. Acad Med. 2003Aug;78(8):802-9. PMID: 12915371. doi: https://doi.org/10.1097/00001888-200308000-00011
23. Łakomy-Zinowik M, Horváthová Z. Public-pri­vate partnerships as a way of financing in the healthcare system (based on the examples of Poland and the United  Kingdom). Journal of International Studies. 2016 Nov;9(3):150-8.
    doi: https://doi.org/10.14254/2071-8330.2016/9-3/12
24. Machan TR. Rights, values, regulation and health care: to be well is not a fundamental right but a value. American Journal of Medical Research. 2016;3(2);115-125. doi: https://doi.org/10.22381/AJMR3220165
25. Naseribooriabadi T, Sadoughi F, Sheikhtaheri A. Barriers and Facilitators of Health Literacy among D/deaf Individuals: A Review Article. Iran J Public Health. 2017 Nov;46(11):1465-74. PMID: 29167764; PMCID: PMC5696685. Available from: https://pubmed.ncbi.nlm.nih.gov/29167764/
26. Novack DH, Dubé C, Goldstein MG. Teaching medical interviewing. A basic course on interviewing and the physician-patient relationship. Arch Intern Med. 1992 Sep;152(9):1814-20. PMID: 1520048. doi: https://doi.org/10.1001/archinte.152.9.1814
27. Patient experience in adult NHS services: impro­ving the experience of care for people using adult NHS services. London: National Institute for Health and Care Excellence (NICE); 2021 Jun 17. PMID: 34260162. Availablefrom: https://pubmed.ncbi.nlm.nih.gov/34260162/
28. Peters L, Pressey A, Gilchrist AJP, Johnson W. Involving customers in innovation: knowledgability and agency as process variables. Journal of Business and Industrial Marketing. 2018 Mar 5;33(2):164-73. doi: https://doi.org/10.1108/JBIM-04-2016-0083
29. Riccardi V, Kurtz S. Communication and coun­seling in health care. Springfield: C.C. Thomas; 1983. Available from: https://ur.booksc.eu/book/320139/798c7a
30. Silverman J, Kurtz S, Draper J. Skills for Com­municating with Patients. 3rd ed. CRC Press; 2013. Available from: https://www.routledge.com/Skills-for-Communicating-with-Patients/Silverman-Kurtz-Draper/p/book/9781846193651
31. Smith AJE. [Series: Communication in the den­tal practice. Building a good dentist-patient relationship with communication]. Ned Tijdschr Tandheelkd. 2019 Jan;126(1):37-44. Deutsch. PMID: 30636264. doi: https://doi.org/10.5177/ntvt.2019.01.18212
32. Stillman PL, Sabers DL, Redfield DL. The use of paraprofessionals to teach interviewing skills. Pediatrics. 1976 May;57(5):769-74.PMID: 940718. doi: https://doi.org/10.1542/peds.57.5.769
33. Tosyalı H, Sütçü CS, Tosyalı F. Patient Loyalty in the Hospital Patient Relationship: The Mediating Role of Social Media. Erciyes İletişim Dergisi. 2019;6(1):783-804. doi: https://doi.org/10.17680/erciyesiletisim.454347
34. Towle A, Godolphin W. Framework for teaching and learning informed shared decision making. BMJ. 1999 Sep 18;319(7212):766-71.PMID: 10488010. doi: https://doi.org/10.1136/bmj.319.7212.766.
35. Ustrell-Torrent JM, Buxarrais-Estrada MR, Ust­rell-Torrent Riutord-Sbert P. Ethical relationship in the dentist-patient interaction. J Clin Exp Dent. 2021 Jan 1;13(1):e61-e66. PMID: 33425233. doi: https://doi.org/10.4317/jced.57597
36. Van Den Assem B, Dulewicz V. Doctors' trust­worthiness, practice orientation, performance and patient satisfaction. Int J Health Care Qual Assur. 2015;28(1):82-95. PMID: 26308405. doi: https://doi.org/10.1108/IJHCQA-04-2013-0037
37. Van Dalen J, Bartholomeus P, Kerkhofs E, Lu­lofs R, Van Thiel J, Rethans JJ, Scherpbier AJ, Van Der Vleuten CP. Teaching and assessing communication skills in Maastricht: the first twenty years. Med Teach. 2001 May;23(3):245-51.PMID: 12098395. doi: https://doi.org/10.1080/01421590120042991
38. Watkins DA, Jamison DT, Mills T., Atun T., Dan­forth K, Glassman A, et al. Universal Health Coverage and Essential Packages of Care. In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd ed. Washington (DC): The Inter­national Bank for Reconstruction and Development / The World Bank; 2017 Nov 27(Chapter 3). PMID: 30212154. doi: https://doi.org/1596/978-1-4648-0527-1_ch3
39. Weeber JE. Ronald L Mace. Encyclopedia Britan­nica [Internet]; 2021 [cited 2001 Jan 01]. Available from: https://www.britannica.com/biography/Ronald-L-Mace
40. Zulman DM, Haverfield MC, Shaw JG, Brown-Johnson CG, Schwartz R, Tierney AA, et al. Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter. JAMA. 2020 Jan 7;323(1):70-81. doi: https://doi.org/10.1001/jama.2019.19003

Капустинська О.А. ДУ «Національний науковий центр радіаційної медицини Національної академії медичних наук України», Київ, Україна, е-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її. 

 https://orcid.org/0000-0001-9397-475X 

1. Kovalenko VM, Dorohoi AP. [Cardiovascular diseases: medical and social significance and strategy for the development of cardiology in Ukraine]. Ukrainian Journal of Cardiology. 2016;3:5-14. Ukrainian.
2. Drozdova IV, Babets AA, Stepanova LG, Omel­nytska LV. [Diseases of the circulatory system in Ukraine as one of the characteristics of public health]. Ukrainian therapeutic journal. 2017;(1):5-14. Ukrainian. Available from: http://nbuv.gov.ua/UJRN/UTJ_2017_1_3
3. Diachuk DD, Moroz GZ, Gidzinska IM. [Preven­tion of cardiovascular diseases: theoretical principles and practical implementation]. DNU: "NPC PKM" DUS; 2019. Ukrainian.
4. Terenda NO, Panchyshyn NYa, Lytvynova ON, Petrashyk YuM. [Risk factors in the development of myocardial infarction and ways of their correction]. The health of the nation. 2017;3(44):266-8. Ukrainian.
5. Townsend N, Wilson L, Bhatnagar P, Wickrama­singhe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal.2016;37(42):3232-45. doi: https://doi.org/10.1093/eurheartj/ehw334
6. Serdiuk AM, Bazyka DA, Los IP, Prysiazh­niuk AE, Chumak VV. [Problems of radiation medicine and safety of Ukraine in the 21st century: historical past and modern tasks]. Scientific journal of the Ministry of Health of Ukraine. 2013;(1):7-17. Ukrainian.
7. Sushko VO, Kolosynska OO, Tatarenko OM, Ne­zhovorova GA, Berestiana ZhM. [Medical examination of diseases that led to the loss of working capacity and death as a result of exposure to ionizing radiation in the conditions of the Chornobyl disaster (remote post-accident period)]. Journal of the National Academy of Sciences of Ukraine. 2019;25(1):5-12. Ukrainian.
8. Huskova AK. [30 years of the accident at the Chornobyl nuclear power plant: the experience of liquidating medical consequences]. Meditsinskaia radio­logiia i radiatsionnaia bezopasnost. 2016;(3):30-35. Russian.
9. Onishchenko GG, Popova AYu, Romanovych IK. [Radiological consequences and lessons of radiation accidents at the Chornobyl NPP and Fukushima-1 NPP]. Radiatsionnaia gigiena. 2021;14(1):6-16. Russian. doi: https://doi.org/10.21514/1998-426X-2021-14-1-6-16
10. Gurachevskii VL. [Consequences of the Chornobyl accident in Belarus and their overcoming]. Minsk: BGATU; 2017. ISBN 978-985-519-854-4. Russian.
11. Bazika DA, Sushko VO, Lohanovskyi KM, Pry­siazhniuk AYe, Bilyi DO, Fedirko PA. [Radiation medi­cine of Ukraine - a quarter of a century of progress and priorities for the future]. Journal of the National Academy of Sciences of Ukraine. 2018;24(1-2):26-42. Ukrainian.
12. Buzunov VA, Pirogova EA, Tereshchenko VM. [Epidemiology of non-neoplastic diseases of participants in the liquidation of the aftermath of the Chornobyl accident]. Problemy radiatsiinoi medytsyny ta radio­biolohii. 2004;(10):187-207. Russian.
13. Buzunov VA, Pirogov EA, Tsuprikov VA. [Non-tu­mor morbidity and mortality of the evacuated population. Twenty-five years of the Chornobyl disaster. Future safety]. Natsionalnyi doklad Ukrainy. Kyiv: KIM; 2011. p. 163-74. Russian.
14. Prykashchikova KYe, Pavlovskyi YeYe, Kos­tiuk GV, Kapustynska OA, Yaroshenko ZhS, Lukia­niuk VO, et al. [Changes in the structures of non-tumor morbidity and mortality in residents of radioactively contaminated areas: epidemiological monitoring for 1988–2015]. Dovkillia ta zdorovia. 2017;84(4):8-13. Ukrainian.
15. Chekin SYu, Maksiutov MA, Kashcheev VV. [Assessment of radiation risks of non-oncological diseases among Russian participants in the liquidation of the consequences of the accident at the Chornobyl nuclear power plant]. Radiatsiia i risk. 2021;30(1):78-93. Russian.
16. Pirogova Oya, Buzunov VO, Domashevska TE. [Cardiovascular morbidity of the population evacuated from the 30-km zone of the Chornobyl nuclear power plant in the post-evacuation period (epidemiological study)]. Problemy radiatsiinoi medytsyny ta radiobiolohii. 2011;16:50-58. Ukrainian.
17. Khomaziuk IM, et al. [Peculiarities of diseases of the circulatory system in participants in the liquidation of the consequences of the Chornobyl accident 25 years later]. Serdiuk AM, Bebeshka VG, Bazyky DA, editors. [Medical consequences of the Chornobyl: 1986–2011]. Ternopil: TDMU; 2011. p. 411-59. Ukrainian.
18. Chekin SYu, Maksiutov MA, Kashcheev VV, Tumanov KA, Korelo AM, Kochergina EV, et al. [Deter­mination of the group of radiation risk of mortality from circulatory system diseases among Russian participants in the liquidation of the accident at the Chornobyl NPP].  Radiatsiia i risk. 2016;25(3):24-34. Russian. doi: https://doi.org/10.12737/25050
19. Bilyi DO, Nastina OM, Gabulavichene ZhM, et al. [Radiation and non-radiation factors and their influence on the course of coronary heart disease in participants in the liquidation of the consequences of the Chornobyl accident]. Problemy radiatsiinoi medytsyny ta radiobio­lohii. 2014;19:213-22. Ukrainian.
20. Buzunov VO, Fedirko PA, Strii NI. [Assessment of the risk of ischemic heart disease and hypertension in participants in the liquidation of the consequences of the accident at the Chornobyl NPP]. Ukrainian Journal of Cardiology. 2006;6:101-5. Ukrainian.
21. Buzunov VA, Pirogova EA, Krasnikova LI, et al. [Indicators and methods of their calculation in the epidemiology of non-infectious diseases: educational and methodological manual]. Kyiv: Avitsena; 2014. Russian.
22. Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. Kyiv: Medinform; 2018.
23. Khomaziuk IM, et al. [Peculiarities of chronic ischemic heart disease in participants in the liquidation of the consequences of the Chornobyl accident who suffered a myocardial infarction]. Serdiuk AM, Bebeshka VG, Bazika DA, editors. [Medical consequences of the Chorno­byl disaster: 1986-2011]. Ternopil: TDMU, Ukrmedknyga; 2011. p. 436-45. Ukrainian.
24. Bilyi DO, Pleskach GV, Nastina OM, Sydo­renko GV, Kursina NV, Bazika OD, et al. [Features of the development of coronary heart disease in liquidation parti­cipants consequences of the Chornobyl accident depending on the effect of radiation and non-radiation risk factors and the carrier of genotypes according to the polymorphism Rs966221 of the phosphodiesterase 4D gene]. Problemy radiatsiinoi medytsyny ta radiobiolohii. 2016;21:204-17. Ukrainian. Available from: http://nbuv.gov.ua/UJRN/Prmtr_2016_21_17
25. Ivanov VK, Meniailo AN, Kashcheev VV. [Medi­cal radiological consequences among the participants in the liquidation of the accident at the Chornobyl NPP. Part 1. Prognostic estimates]. Radiatsiia i risk. 2011;20(3):16-39. Russian.
26. Chekin SYu, Maksiutov MA, Kascheev VV, Kar­penko SV, Tumanov KA,  et al. [Asses­sment of radiation risks of non-oncological diseases among Russian participants in the liquidation of the consequences of the Chornobyl accident]. Radiatsiia i risk. 2021;30(1):78-93. Russian.

Шкробот С.І. Тернопільський національний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна

 https://orcid.org/0000-0002-8017-4697

Мілевська-Вовчук Л.С. Тернопільський національний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна, e-mail: Ця електронна адреса захищена від спам-ботів. Вам необхідно увімкнути JavaScript, щоб побачити її.

 https://orcid.org/0000-0001-7445-9373

Дуве Х.В. Тернопільський національний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна

 https://orcid.org/0000-0001-9036-2459

Наумова Л.В. Тернопільський національний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна

 https://orcid.org/0000-0002-3135-3509

Бударна О.Ю. Тернопільський національний медичний університет ім. І.Я. Горбачевського, Тернопіль, Україна

 https://orcid.org/0000-0002-9449-8094

1. Shkrobot S, Sokhor N, Milevska-Vovchuk L, Yas­nii O, Shkrobot L. [Clinical and hemodynamic features of the course of the acute period of ischemic hemodynamic stroke]. Georgian medical news. 2017;2(263):35-44. Russian.
2. Chaturvedi S, McCrae KR. Diagnosis and mana­gement of the antiphospholipid syndrome. Blood Rev. 2017 Nov;31(6):406-17. PMID: 28784423. doi: https://doi.org/10.1016/j.blre.2017.07.006
3. Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018;378:2010-21. doi: https://doi.org/10.1056/NEJMra1705454
4. Krytskyy T, Pasyechko N, Yarema N, Naumo­va L, Mazur l. Influence of age-related androgen defi­ciency on the risk factors for cardiovascular diseases in men with hypothyroidism. Georgian medical news. 2020;298:105-9. doi: https://doi.org/10.1530/endoabs.73.EP219
5. Lin Z, Liu Y, Chen L, Cao S, Huang Y, Yang X, et al. Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.Sci China Life Sci. 2021 Jan 19. PMID: 33481164.
   doi: https://doi.org/10.1007/s11427-020-1840-1
6. Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, et al. PREGNANTS (PREGNancy in women with ANTiphospholipid Syndrome) working group. Am J Obstet Gynecol. 2017 May; 216(5):525.e1-e12. PMID: 28153662. doi: https://doi.org/10.1016/j.ajog.2017.01.026
7. Sayar Z, Moll R, Isenberg D, Cohen. Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.Thromb Res. 2021 Feb;198:213-21. PMID: 33485122. doi: https://doi.org/10.1016/j.thromres.2020.10.010
8. Schreiber K, Hunt Managing antiphospholipid syndrome in pregnancy. Thromb Res. 2019 Sep;181(Suppl 1):S41-S46. PMID: 31477227 Review. doi: https://doi.org/10.1016/S0049-3848(19)30366-4
9. Shkrobot SI, Sokhor NR, Milevska-Vovchuk LS, Krynytska IYa, Marushchak MI, Shkrobot LV, Yas­nii OR. Clinical neurological characteristics of ischemic stroke subtypes in acute phase. Zaporozhye medical journal. 2018;20(1):41-46. doi: https://doi.org/10.14739/2310-1210
10. Stack Christopher A, Cole John W, Ischemic stroke in young adults Curr Opin Cardiol. 2018 Nov;33(6):594-604. doi: https://doi.org/10.1097/HCO.0000000000000564